Transcriptional adaptation of adipose tissue in dairy cows in response to energy overfeeding by Ji, Peng
 
 
 
 
 
 TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE IN DAIRY COWS IN 
RESPONSE TO ENERGY OVERFEEDING 
 
 
 
 
 
BY  
 
PENG JI 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
 for the degree of Doctor of Philosophy in Animal Sciences 
 in the Graduate College of the  
University of Illinois at Urbana-Champaign, 2011 
 
 
 
 
Urbana, Illinois 
 
 
Doctoral Committee: 
 
Professor James K. Drackley, Chair and Director of Research 
Associate Professor Juan J. Loor, Director of Research 
Professor Walter L. Hurley 
Assistant Professor Yuan-Xiang Pan 
 
ii 
 
ABSTRACT 
In experiment 1, 18 multiparous non-pregnant non-lactating Holstein dairy cows were fed 
either moderate energy diet (MoE, NEL = 1.62 Mcal/kg DM) or controlled energy diet (LoE, 
NEL = 1.35 Mcal/kg DM) for 8 weeks and sacrificed. Compared with LoE animals, MoE cows 
had markedly increased visceral adipose mass (Nikkhah et al., unpublished data). Higher dietary 
energy plane significantly increased lipogenic gene expression in both visceral and subcutaneous 
adipose tissue (AT). Visceral AT (including mesenteric and omental fat; MES and OAT) 
exhibited higher mRNA profile for genes associated with utilization of long-chain fatty acid 
(LCFA), whereas subcutaneous AT (SUBQ) had greater gene expression related with de novo 
FA synthesis. Visceral AT, particularly MES, showed greater mRNA expression of pro-
inflammatory cytokines, chemokines, and acute-phase protein. In conclusion, overfeeding energy 
may increase visceral AT secretion of pro-inflammatory cytokines by stimulating fat 
accumulation in visceral AT depots. (For the contents in chapter 3 and 4) 
In experiment 2, mRNA samples of MES and SUBQ collected from a subset of animals 
(5 cows from each treatment) that used in experiment 1 was utilized to conduct transcriptomic 
study through microarray technique. The microarray platform contains 13k annotated bovine 
oligonucleotides. A FDR value of 0.2 was used as the cut-off threshold for determination of 
differentially expressed genes (DEG). Totally 409 and 310 DEGs were identified due to either 
adipose depot effect or dietary energy effect. Bioinformatics analysis revealed that gene sets 
associated with extracellular matrix, vasculature development and cytoskeleton formation were 
differentially expressed between MES and SUBQ. Overfeeding energy had significant impact on 
the genes in the pathway of MAPK signaling and apoptosis, and response to external stimuli. 
(For the contents in chapter 5) 
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In experiment 3, 14 Holstein dairy cows (≥ 2 parity, a subset from another study) were 
fed the same controlled energy diet during far-off dry period (-50 to -22 d) and randomly 
assigned to either moderate energy diet (Overfed, NEL = 1.47 Mcal/kg DM) or controlled energy 
diet (Controlled, NEL = 1.24 Mcal/kg DM) during close-up dry period (-21 d until parturition). 
Compared with Controlled group, Overfed animals had lower and higher serum NEFA in pre- 
and postpartum respectively, higher prepartal insulin and close-up DMI, and greater postpartal 
hepatic lipid storage and BHBA production. No difference in milking performance was found 
between the two groups. AT biopsy was carried out on -10, 7 and 21 d relative to parturition date 
for RNA extraction and gene expression analysis through quantitative PCR (qPCR). Energy 
overfeeding increased prepartal lipogenic genes and pre- and early postpartal lipolytic related 
gene (ATGL and ABHD5) expression in subcutaneous AT, but decreased PDE3B expression 
during periparturient period. Part of AT from biopsy of -10 and 7 d was used for tissue explant 
and challenged with hyperphysiological bovine insulin in vitro. Over-consumption of dietary 
energy increased and decreased insulin-stimulated IRS1 tyrosine phosphorylation in AT in pre- 
and postpartum, respectively, which may contribute to differentially regulated lipolysis in these 
overfed animals. (For contents in chapter 6) 
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CHAPTER 1 
 
LITERATURE REVIEW 
 
Overview 
To maintain a certain amount of body fat as a reserve of energy is essential for wild 
animals, as it helps animals to survive food scarcity and fierce climate change. However, for 
domestic animals, which are relatively well-protected from extreme weather and food shortage, 
body fat has been bestowed new significance based on its intrinsic interest. For beef cattle, body 
fatness was directly associated with economical values. Those cattle that produce more 
intramuscular fat rather than subcutaneous fat bring more profits to producers. For dairy cows, 
adipose tissue (AT) plays a critical role as an energy source to support lactation in high 
producing cows; however, over-mobilization of body fat during negative energy balance (NEB) 
in early lactation may induce fatty liver disease and ketosis, which may compromise milk 
production for the entire lactation (Vernon et al., 1984; Drackley, 1999; Grummer, 1993). The 
transition period, generally defined as 3 wk before and after parturition, is characterized by the 
occurrence of marked metabolic changes of AT in dairy cows, such as decreased insulin 
response and sensitivity, greatly suppressed lipogenesis, and intense lipolysis. Although 
metabolic activity of AT during this crucial period has been illustrated in several studies 
(McNamara and Hillers, 1986; McNamara et al., 1995; Vernon, 1996), the underlying molecular 
mechanisms that regulate and adapt to these metabolic changes have not been clearly established.   
The discovery of leptin in 1994 (Zhang et al., 1994) led to the recognition of an endocrine 
function of AT. Since then, a great number of protein products have been demonstrated to be 
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secreted or specifically secreted from AT during different physiological states. Many of these 
products  are pro-inflammatory cytokines, chemokines, and signaling molecules that function in 
endocrine, paracrine, or autocrine manners to regulate immune response, food intake, and 
metabolism (Tilg and Moschen, 2008; Ouchi et al., 2011). Studies in human and rodent animals 
have revealed that endocrine functions of AT exhibit depot-specific characteristics, and that 
visceral obesity is closely associated with a variety of metabolic diseases including insulin 
resistance and non-alcholic fatty liver disease (Tilg and Moschen, 2008; Palou et al., 2009). 
However, the depot-specific metabolic and endocrine characteristics and their association with 
metabolic disorders have been much less documented in ruminant animals.    
  Many nutritional strategies have been utilized in the dairy industry to regulate AT 
metabolism in dairy cows with the purpose of maximizing milk production and minimizing 
metabolic disorders. For example, recombinant bovine somatotropin (rbST) has been 
administered after mid-lactation to redirect nutrients from deposition in peripheral tissues to milk 
production. On the other hand, despite variation of results, niacin has been supplemented during 
the periparturient period to prevent fatty liver and ketosis through decreasing AT lipolysis. 
Energy status of the whole animal is an important factor that regulates lipid metabolism of AT. 
Particularly during the transition period, several studies from our laboratory have shown that the 
plane of prepartal dietary energy intake was able to manipulate lipid metabolic profiles during 
periparturient period (Dann et al., 2006; Douglas et al., 2006). However, the molecular response 
and adaptation of AT to dietary energy plane prepartum have not been illustrated before. In 
addition, despite the intensive research in human and rodent AT metabolism, the ruminant-
specific AT metabolic characteristics need to be established.  
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To study the metabolic activity of AT during different physiological states in animals 
requires that major metabolic pathways, such as lipolysis, lipogenesis, and NADPH production 
be clarified. Enzymes primarily control the nutrient flux through these pathways. Although 
enzyme activity, which is subjected to regulation from different levels, is the predominant 
driving force that regulates metabolic activity, transcriptional change is the one representing 
relatively long-term adaptations. Quantitative polymerase chain reaction (qPCR) and microarray 
are two main genomic tools utilized to study mRNA expression. Hence, utilization of tissue 
biopsy coupled with these genomic tools may shed light on tissue metabolic adaptation to 
various physiological states and nutritional regulation.  
Adipose Tissue Development in Ruminants: Hyperplasia and Hypertrophy 
Adipose tissue is present in all mammalian species. White AT is the only tissue in the 
body that can markedly change its mass after adult size is reached. The cellular development 
associated with AT growth involves both cellular hyperplasia (increase in number) and 
hypertrophy (increase in size or volume), of which the two types of adipose expension were 
collectively termed adipogenesis. Adipogenesis typically involves: the determination stage, 
namely hyperplasia; the conversion of a pluripotent stem cell to the preadipocyte, which cannot 
be distinguished morphologically from its precursor cell but has lost the potential to differentiate 
into other cell types; and the terminal differentiation stage, during which  the preadipocyte takes 
on the characteristics of the mature adipocyte by acquiring the machinery necessary for lipid 
transport and synthesis, insulin sensitivity, and the secretion of adipocyte-specific proteins. 
Hypertrophy occurs during the differentiation state, and is the result of triglyceride (TAG) 
accumulation in existing adipocytes primarily due to a positive energy balance (Rosen and 
MacDougald, 2006; Hausman et al., 2009).  
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The development of AT during the growth of animals is defined as an increase in 
adipocytes by number (hyperplasia) and/or by volume (hypertrophy). Hood (1982) summarized 
that the development of AT in ruminants (especially for beef cattle) occurred in three phases: an 
initial period of hyperplasia, a period of combined hyperplasia and hypertrophy, and a period 
when fattening occurs only by hypertrophy. Age, breed, physiological status of the animal, and 
potential limitation of adipocyte size seemed to be crucial factors in determining the major 
pathway driving adipogenesis. Hood (1982) pointed out that the age at which cell division is 
complete in AT varies among species and tissue sites. Hyperplasia is generally confined to early 
stages of postnatal development. Hood and Allen (1973a) found that bovine adipocyte 
hyperplasia in subcutaneous and perirenal depots were nearly complete at ~8 mo of life. Hood 
and Thornton (1979) found that although hyperplasia remains active in sheep AT until 
approximately 11 mo of age, hypertrophy was the predominant type of growth of body fat as 
demonstrated by the good relationships between both carcass weights and internal depot fat and 
the volume of adipose cells in the corresponding depots. Moreover, Cianzio et al. (1985) found 
that fat deposition in mesenteric and subcutaneous depots of steers during the growing phase 
occurred mainly via hypertrophy.  
The great differences in total fat content and distribution of fat among breeds had been 
observed in early studies (e.g., 20 mo-old Holstein vs. Hereford cattle in Truscott et al., 1980; 
Holstein vs. Hereford×Angus steers in Hood and Allen, 1973b). Dairy cattle generally have less 
subcutaneous fat than beef cattle at a given weight (Allen et al., 1976). Truscott et al. (1980) 
reported that 20-mo-old Hereford cattle had more subcutaneous AT than Holsteins because of an 
increased number of adipose cells. Robelin (1981) studied the development of AT (subcutaneous, 
intermuscular, and internal) in male cattle (Friesian and Charolais) growing from 15 to 65% of 
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the mature weight. In each fat tissue, adipose cells became 15 times larger from 15 to 65% of 
mature weight, whereas total adipose cell number increased only 1.8-fold during this period. 
However, a significant hyperplasia occurred at near 45% of mature weight, when mean cell 
diameter reached approximately 80 to 90 µm. In all fat depots, a pattern of two-phase 
development was observed, which began with an increase in small-sized adipocytes (hyperplasia) 
and then followed by the filling of these cells (hypertorphy) (Robelin, 1981). For mature dairy 
cows, McNamara et al. (1995) and Smith and McNamara (1990) observed an obvious trend for 
increased adipocyte number per gram of subcutaneous AT from early lactation until 120 DIM. 
However, a reciprocal decrease in size (represented by diameter) and volume of adipose cell 
occurred during the same period. Thereafter, changes in adipocyte size in semi-adult and adult 
ruminants, including lactating ruminants, may account for the majority of changes in body fat 
mass, despite the possibility of changes in absolute cell number pari passu.  
Transcriptional Control of Adipogenesis 
Adipocytes derive from multipotent mesenchymal stem cells. The conversion of the stem 
cell to mature, lipid-filled adipoctye is termed adipogenesis, also known as hyperplasia, which 
was described as proceeding in two phases of development (Hausman et al., 1999; Rosen and 
MacDougald, 2006). The first phase is known as determination, which includes the commitment 
process of a pluripotent stem cell to a preadipocyte. Preadipocytes cannot be distinguished 
morphologically from their precursor cells, but have lost the potential to differentiate into other 
cell types. Preadipocytes possess proliferating capability and can enlarge AT mass by increasing 
cell numbers. However, once preadipocytes go into the second phase, namely terminal 
differentiation, they lose the capability of proliferation (Sethi and Vidal-Puig, 2007). During 
differentiation, preadipocytes take on the characteristics of mature adipocytes by a change in 
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morphology from fibroblastic to the unilocular appearance of lipid-filled fat cells (Gregoire et al., 
1998). Meanwhile, differentiation is also characterized by the expression of a series of 
transcription factors in a sequential cascade, which finally results in the expression of genes 
related with lipogenesis, FA transport, increased insulin sensitivity, endocrine function, and 
increased lipogenic capacity (Ailhaud et al., 1992).  
The cumulative consideration of the experiments has led to a model for a transcriptional 
cascade in regulating preadipocyte differentiation (adipogenesis) and adipocyte function. This 
network of transcription factors coordinates expression of hundreds of proteins responsible for 
establishing the mature adipocyte. The center event of this network is the activation of C/EBPs 
and PPARγ, which are essential in regulating the entire terminal differentiation process. In 
particular, PPARγ is considered the master regulator of adipogenesis and enables the precursor 
cell to express any known aspect of the adipocyte phenotype (Rosen et al., 2002). In this model, 
the transient activation of C/EBPβ and δ precedes and induces expression of PPARγ (Wu et al., 
1996) and C/EBPα (Cao et al., 1991), which is likely through direct binding to C/EBP binding 
sites in the promoter regions of these two genes (Christy et al., 1991; Zhu et al., 1995; Clarke et 
al., 1997; Fajas et al., 1997). PPARγ was reported to be responsible for induction of C/EBPα 
(Rosen et al., 1999), whereas the expression of C/EBPα was suggested to be required for 
maintaining expression of PPARγ in the mature fat cell (Wu et al., 1999). In vitro studies 
demonstrated that the failure to express C/EBPα results in insulin resistance in cell culture 
systems and the loss of ability to develop WAT in vivo (Wu et al., 1999; Linhart et al., 2001). In 
addition to the above mentioned network between C/EBP family and PPARγ, the insulin-induced 
expression of SREBF1c was identified as a parallel pathway that was prior to and contributed to 
expression and activity of PPARγ (Kim and Spiegelman, 1996). The underlying mechanism of 
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SREBF1 on PPARγ expression was reported to be through a SREBP binding site in the promoter 
of PPARγ (Fajas et al., 1999), and contributing to production of an endogenous PPARγ ligand, 
which is still unknown yet, was suggested to be the method that SREBF1 increased PPARγ 
activity (Kim et al., 1998a). A brief introduction about how these TF function, including PPARγ, 
C/EBPα, and SREBF1 and their target genes, is given below.   
PPARγ: PPARγ is a nuclear receptor that has been implicated in not only adipogenesis, 
but also insulin sensitivity of adipocytes. Four mRNA isoforms of PPARγ arise from differential 
promoter action and alternative splicing (Feve, 2005). However, the mRNA of PPARγ3 and 4 
yield proteins identical to that of PPARγ1, hence only PPARγ1 and 2 receptors are finally 
translated (Gurnell, 2005). Both are expressed in adipocytes, but PPARγ2 is the form that is 
involved in differentiation by regulating gene expression (Rosen and Spiegelman, 2001; Lehrke 
and Lazar, 2005). PPARγ is not only crucial for adipogenesis but is also required for 
maintenance of the differentiated state (Rosen and MacDougald, 2006). After binding of small 
lipophilic ligands activated PPARγ exerts function to regulate gene expression through forming 
heterodimers with retinoic X receptor (RXR), and then binding to specific PPAR responsive 
elements (PPRE) in enhancer regions of target genes to initiate transcription activity (Osumi et 
al., 1991; Tugwood et al., 1992). Target genes directly regulated by PPARγ that are involved in 
this pathway include lipoprotein lipase (LPL; Schoonjans et al., 1996), fatty acid transport 
protein (FATP; Frohnert et al., 1999), oxidized LDL receptor1 (Chui et al., 2005), and 
phosphoenolpyruvate carboxykinase (PEPCK; Tontonoz et al., 1995) as well as others (see 
review in Lehrke and Lazar, 2005). Additionally, PPARγ was reported to induce expression of 
GLUT4, despite absence of a PPRE sequence in that gene (Wu et al., 1996). 
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C/EBPα: C/EBPα induces many adipocyte genes directly and in vivo studies indicate an 
important role for this factor in development of AT. Overexpression of C/EBPα in 3T3-L1 
preadipocytes induces the differentiation into mature fat, and the expression of C/EBPα antisense 
RNA in these cells blocks this process (Lin and lane, 1994). Animals that carry a homozygous 
deletion of the C/EBPα gene have dramatically reduced fat accumulation in WAT and brown AT 
pads (Wang et al., 1995). Despite the important role of C/EBPα in adipogenesis, it cannot 
function efficiently without the presence of PPARγ. However, cells lacking C/EBPα are capable 
of adipogenesis, but are not insulin sensitive (Wu et al., 1999).  
SREBF1: SREBF1 is a basic helix-loop-helix transcription factor and is regulated in 
adipogenesis (Tontonoz et al., 1993). There are three SREBF isoforms (SREBF1a, -1c and -2). 
SREBF1a and -1c are transcribed from the same gene, by a distinct promoter, and SREBF1c is 
the predominant isoform in AT (Eberlé et al., 2004). Activated SREBF1 enters into the nucleus 
and binds to specific DNA sequences in the promoters of its target genes. So far the identified 
sequences include sterol regulatory elements (SRE; Briggs et al., 1993) and classic palindromic 
E-boxes (Kim et al., 1995). The promoter regions of many lipogenic genes contain SREBF 
binding and activation sites, which vary considerably and are tentatively designated SRE-like 
sequences (Mater et al., 1999). SREBF1c is inactive in binding to SRE-reporter genes, but is 
active for E-box binding sequences and SRE-like sequences in lipogenic gene promoters 
(Tontonoz et al., 1993; Mater et al., 1999) and so is implicated in transcriptional regulation of 
adipocyte differentiation. The identified target genes include acetyl CoA carboxylase (ACACA), 
fatty acid synthase (FASN), stearoyl CoA desaturase (SCD), ATP citrate lyase (ACLY), malic 
enzyme, PPARG, LPL, acetyl CoA synthetase (ACS), glycerol-3-phosphate acyltransferase 
(GPAT), and SREBF1 itself (see review in Shimano, 2001). Although SREBF1c was identified 
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as a pro-adipogenic TF by inducing PPARγ expression and possibly by generating PPARγ 
ligands (Kim et al., 1998a), it also mediates the induction of lipid biosynthesis by insulin in 
adipocytes (Kim et al., 1998b). Its essentiality in lipogenesis was doubted in several studies, in 
which SREBF1c
-/-
  mice still possessed normal fat mass, and SREBP1c binding to the functional 
SRE/E-box site on the FASN promoter in adipocytes was not verified (Shimano et al., 1997; 
Sekiya et al., 2007).  
Specific Characteristics of Lipid Metabolism in AT of Ruminants 
In humans and rodents, liver is the major organ of de novo FA synthesis (DNS) 
(Hillgartner et al., 1995; Bernlohr et al., 2002; Bergen and Mersmann, 2005). In contrast, DNS 
capacity in liver represented about 1% of the rate in AT in non-lactating ruminants (ovine and 
bovine), assessed by comparing the incorporation rate of radiolabeled acetate in vitro in tissue 
slices of cattle (Hood et al., 1972; Ingle et al., 1972b) and sheep (Hanson and Ballard, 1967; 
Ingle et al., 1972a), or by tracking [1-
14
C] acetate in sheep in vivo in which AT accounted for 
~92% of DNS (Ingle et al., 1972a). Thus, AT is the predominant site of lipogenic activity in 
ruminants.  
Unlike humans and rodents for which glucose is the major precursor for DNS (Bergen 
and Mersmann, 2005), acetate is the principle substrate for DNS in AT of ruminants as 
determined in early studies (Hanson and Ballard, 1967; Hood et al., 1972). The normal blood 
glucose concentration in ruminants is comparatively lower than in rodents, and such a 
characteristic of AT helps spare glucose for other more important organs, such as brain. The 
supporting evidence was demonstrated from several aspects: (1) The incorporation rate of 
radiolabeled acetate was ~6-7 times higher (>20 times higher, if glucose was present in the 
media) than glucose in AT slices from either lamb or calf (perirenal and omental, Ingle et al., 
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1972b); similar results were obtained with AT slices from mature sheep (Vernon, 1976).  (2) The 
activity of cytosolic acetyl-CoA synthetase (encoded by ACSS2 gene in bovine), which was 
considered to be the isoform primarily involved in DNS, was found to be greater in ovine and 
bovine AT than in rat AT (Hanson and Ballard, 1967). (3) Ingle et al. (1972b) found that the low 
glucose incorporation rate into FA in AT slices of growing calves, even in the absence of acetate, 
coincided with the relative low activity of ACLY in comparison with nonruminant tissues. It was 
reported that ACLY activity in sheep AT is less than 20% of that of rat AT measured under 
identical conditions (Hanson and Ballard, 1967). ACLY catalyzes conversion of cytosolic citrate 
into oxaloacetate and acetyl-CoA, which represent the important step in DNS from carbohydrate 
carbon sources. Thus, the low activity of ACLY implicated a minor contribution of glucose 
carbon to DNS. (4) The low activity of pyruvate dehydrogenase (PDH) in bovine AT was 
hypothesized to be another important limiting factor that resulted in the low glucose utilization 
rate in DNS; however, research did not give sufficient direct supporting evidence for this 
possibility, which is only implicated through the high lactate output by ruminant AT 
(Khachadurian et al., 1966; Yang and Baldwin, 1973).  
The DNS process requires an adequate supply of cytosolic reducing equivalents in the 
form of NADPH. For synthesis of each molecule of palmitic acid by the DNS pathway, eight and 
fourteen molecules of acety-CoA and NADPH are needed, respectively. In rodents, NADPH 
required for DNS is primarily derived from glucose oxidation via the pentose phosphate pathway, 
which accounted for 50% of requirement, and the citrate cleavage pathway contributed the 
remainder (Flatt and Ball, 1964; Rognstad and Katz, 1966). In ruminants, glucose-6-phosphate 
dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (PGD), two enzymes 
catalyzing NADPH-producing reactions in the pentose phosphate pathway, were active in AT. 
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However, due to the lack of substantial incorporation rates of glucose, NADP-malate 
dehydrogenase, which converts cytosolic malate to pyruvate with production of NADPH, was 
measured in very low activity in AT in early studies (Ingle et al., 1972b).  This finding undercut 
the importance of the citrate cleavage pathway for NADPH production. Ingle and coworkers 
(1972b) observed the enzymatic activity of cytosolic NADP-isocitrate dehydrogenase (IDH) was 
~4-6 times higher than G6PDH and PGD in AT (perirenal, omental, and epididymal) of growing 
calves. Cytosol IDH converts isocitrate to α-ketoglutarate and produces 1 molecule of NADPH, 
which was first proposed to play a significant role in supplying NADPH for lipogenesis in 
ruminant mammary gland (Bauman et al., 1976). Thus, IDH rather than the citrate cleavage cycle 
may represent a much more important pathway for production of the cytosolic NADPH pool to 
support lipogenesis in ruminant AT as well.    
 
Visceral vs. Subcutaneous Adipose Tissue 
Difference in Cellularity  
Faulconnier et al. (2007) found that neither the nature of the diet (grass based or maize 
silage based) or nor grazing pattern had a significant effect on cell volume (size) or adipocyte 
number of three adipose sites (perirenal, intermuscular, and subcutaneous) from Charolais steers. 
Adipocyte volume varied significantly among AT depots, and was globally greater in the visceral 
depot (perirenal) than in intermuscular or subcutaneous AT. Eguinoa et al. (2003) reported that 
in both Pirenaican and Holstein heifers, the hierarchy of adipocyte size in different fat depots 
was  omental AT > perirenal AT > subcutaneous AT > intermuscular AT, which was similar to 
trends that had been observed before (Haugebak et al., 1974; Hood, 1982; Cianzio et al., 1985, 
Mendizabal et al., 1999). Growth modality (proliferation vs. differentiation) of the various AT 
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depots may be regulated by many factors, including precursor cell population, blood vessel 
enrichment (blood flow), and innervation density. An inverse relationship was observed between 
the sympathetic nervous system innervation and the propensity for adipocyte proliferation 
(DiGirolamo et al., 1998). In rodents, the richest density of sympathetic nervous system 
innervation is in mesenteric AT (MAT) and the poorest is in inguinal (subcutaneous) fat; the 
hyperplasic capacity was just the opposite (Rebuffe-Scrive, 1991). Although no data are 
available for ruminants, these characteristics probably apply as well.   
Difference in Lipogenic Capacity  
Hood and Allen (1973a, 1975) reported that subcutaneous AT (SAT) slices from 14-mo-
old steers of Holstein and Hereford × Angus breeds incorporated significantly more [1-
14
C] 
acetate for lipogenesis than did perirenal AT (expressed per 10
6
 cells basis), even though the 
SAT had relatively smaller adipocytes. Baldwin et al. (2007) observed a similar result in that 
acetate incorporation rates across depots (based on wet tissue weight) followed the order of SAT > 
omental AT (OAT) > MAT in beef steers. Consistently, the activities of enzymes (per 10
5
 cell) 
catalyzing NADPH production reactions (IDH, G6PD, and PGD) were relatively higher in SAT 
than in perirenal AT in two breeds. Ingle et al. (1970b) found that the lipogenic activity per 100 
mg tissue of internal AT (omental and perirenal) was greater than that in SAT sites (rump, 
shoulder, and abdominal) in lambs, which was measured by incorporation rate of radiolabeled 
acetate in tissue slices. In contrast, the SAT sites had the greatest lipogenic capacity in mature 
sheep and steers, averaging two- to threefold higher than the internal depots. Such results 
indicated that maturity is an important factor that influences lipogenic capacity among adipose 
depots. Faulconnier et al. (2007) observed depot-specific difference in activities of lipogenic 
enzymes, with greater activities (FASN, G3PDH, G6PDH, and LPL, expressed per 10
6
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adipocytes) in SAT and/or perirenal AT than in intermuscular AT from Charolais steers. 
Moreover, perirenal AT was found to have greater cell volume and adipocyte number than either 
intermuscular or subcutaneous AT, which was independent of diet (either grass-based diet or 
maize silage-based isoenergetic diet; Faulconnier et al., 2007). Eguinoa et al. (2003) 
demonstrated that the abdominal depots (omental and perirenal) had a greater adipose size and, 
in general, greater lipogenic enzyme activities per cell (G3PDH, FASN, MD, G6PDH, and IDH) 
than the subcutaneous and intermuscular carcass depots in either Holstein or Pirenaican bulls and 
heifers. However, for a given cell size, enzyme activities varied over a large range due to 
different depot origins. Subcutaneous depots had greater FASN, G6PDH, and MD activities than 
omental and perirenal AT, when adipocyte size was equalized (Eguinoa et al., 2003). In cellular 
aspects, the average adipose cell volumes in ruminant fat depots usually decrease in the 
following order: omental and perirenal > subcutaneous > intermuscular > intramuscular, as 
mentioned before. Thus, compared with visceral fat, the SAT has smaller cell size or volume and 
higher de novo lipogenic activity when cell size was taken into account.  
            However, this does not warrant the sweeping conclusion that SAT has higher capacity for 
TAG synthesis than does visceral AT (VAT). Lipoprotein lipase, which liberates FA from TAG 
in circulating chylomicrons and VLDL, was observed to be higher in both activity and mRNA 
expression in internal fat depots (omental and perirenal) than in SAT in male calves (Hocquette 
et al., 1998). Greater LPL mRNA abundance was also detected in perirenal AT and OAT than in 
SAT in both German Holstein and Charolais, but Holstein deposited more internal fat mass than 
Charolais (Wegner et al., 2002). The LPL system is subject to regulation at many levels, 
involving gene expression, synthesis and degradation of protein, translocation, and 
activation/inactivation by serum factors. However, LPL activity depends primarily on a balance 
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between synthesis and degradation, which can be reflected by differences in mRNA abundance 
(Cryer, 1987). Expression of LPL was reported to be greater with increased adipocyte size, and 
independent of AT depot in sheep (Barber et al., 2000). Thus, this is in consistent with the 
previous finding that VAT, being composed of larger adipocytes, is more capable of uptake of 
FA from circulation. 
            The underlying rationale for differences in formation of the intracellular FA pool may be 
attributed to the nutrient supply from blood between VAT depots and SAT. Blood flow to 
carcass depots is less than that to abdominal depots in ruminants (Gregory et al., 1986), and the 
attachment to the digestive tract enabled VAT more access to preformed (mainly dietary) FA 
through FA taken up before drainage of the portal vein; hence the greater lipogenic capacity 
expressed by SAT may be a compensatory mechanism for a reduced nutrient supply. This may 
also explain the early finding that FA of dietary origin have a greater tendency to be deposited in 
abdominal rather than carcass AT depots (Christie, 1978).  
Difference in Lipolytic Activity  
In rodents, the mRNA expression of hormone-sensitive lipase (HSL) and adipose 
triglyceride lipase (ATGL), the two proteins primarily involved in stimulated lipolysis and basal 
lipolysis, was greater in the retroperitoneal AT, followed by MAT, and lowest in SAT (inguinal 
fat) (Palou et al., 2009). Both stimulated lipolysis and basal lipolysis release glycerol during 
hydrolysis of FA from TAG. The activity of glycerol kinase in bovine AT was very low (Hood et 
al., 1972; Metz et al., 1973). Hence, measuring glycerol release rate was representative of 
lipolysis in bovine AT. Most studies, however, found similar rates of basal and stimulated 
lipolysis in abdominal AT and SAT. The maximum (i.e., catecholamine-stimulated) lipolytic rate 
of adipocytes and the sensitivity of adipocytes to catecholamines are both enhanced during 
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lactation in ruminants (Bauman and Currie, 1980; McNamara, 1995), but not in rats (Vernon, 
1996) or pigs (Parmley et al., 1996). The response and sensitivity to catecholamines during 
lactation were increased similarly in both OAT and SAT in sheep; however, the underlying 
mechanism may differ between two sites.  Increased number of β-adrenergic receptors was 
probably the primary factor within OAT, whereas an increase in the maximum activity and 
amount of adenylate cyclase appeared to be the major factor in SAT (Vernon et al., 1995).  
Visceral Obesity, Inflammation, and Metabolic Disease 
The metabolic characteristics and endocrine function of AT have been extensively 
studied in humans and rodent animal models due to the prevalence of obesity and a series of 
accompanying metabolic diseases. Accumulating evidence indicates that a state of chronic 
inflammation, which is strongly associated with obesity and in  particular visceral obesity, has a 
crucial role in the pathogenesis of obesity-related metabolic dysfunction including insulin 
resistance, dyslipidaemia, and fatty liver disease (Xu et al., 2003; Weisberg et al., 2003; Lehrke 
and Lazar., 2004). A broad spectrum of adipocytokines involved in inflammation, chemotaxis for 
immune cells, and immune response were found to be secreted from AT, either by adipocytes, 
stromal-vascular cells, or recruited immune cells, and some of the adipocytokines exhibited 
depot-specific characteristics (Ouchi et al., 2011). In obese humans, the increased plasma 
concentrations of C-reactive protein (CRP) and IL-6 are predictive of the development of type 2 
diabetes in various populations (Visser et al., 1999; Pradhan et al., 2001). Franckhauser et al. 
(2008) demonstrated that chronic overexpression of IL-6 resulted in insulin resistance, liver 
inflammation, and hyperinsulinaemia. Increased secretion of TNFα and iNOS was reported to 
attenuate adipocyte insulin sensitivity in an autocrine or paracrine manner through inhibition of 
insulin-stimulated phosphorylation of insulin receptor substrate 1 (IRS1) in muscle and AT 
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(Hotamisligil et al., 1994; Uysal et al., 1997; Unoki et al., 2008). TNFα and IL-6 also increase 
lipolysis and have been implicated in the hypertriglyceridemia and increased serum NEFA 
associated with obesity (Zhang et al., 2002). Adiponectin was identified as an adipocyte-specific 
adipokine (Hu et al., 1996), and its circulating concentration was reported to be negatively 
correlated with insulin sensitivity of AT. Visceral AT was reported to produce more pro-
inflammatory cytokines including TNFα and IL-6 and less adiponectin than SAT (Hamdy et al., 
2006; Schäffler and Schölmerich, 2010). Recently RBP4 was found to be secreted by both 
adipocytes and macrophages (Broch et al., 2010) and preferentially produced by VAT in obesity 
and insulin resistance (Klöting et al., 2007). The adipocyte expression of RBP4 was reported to 
be inversely related to the insulin-sensitive glucose transporter, SLC2A4 (Yang et al., 2005). 
RBP4 released by adipocytes had inhibitory effects on tyrosine-phosphorylation of IRS1 in an 
autocrine or paracrine manner (Ost et al., 2007).   
Another signature change in obese humans and animal models of obesity is the 
infiltration of a large number of macrophages, which is highly involved in the systemic 
inflammation and insulin resistance (Xu et al., 2003). Weisberg et al. (2003) showed that the 
accumulation of macrophages (represented by expression of CD68 or F4/80) is positively 
correlated with adipocyte size in human SAT and both VAT and SAT in mice. Bruun et al. (2005) 
found higher mRNA expression of macrophage specific markers (CD68 and CD14) in VAT than 
SAT and higher in obese individuals than leaner controls. Moreover, the transcription profile of 
monocyte chemoattractant protein (MCP-1), secreted as a chemotactic recruiter of immune cells, 
showed the same expression pattern as those macrophage marker genes. Thus, such results 
indicated that the accumulation of AT macrophages is proportional to adiposity and is more 
abundant in VAT than SAT. Activated macrophages release stereotypical profiles of cytokines 
17 
 
and biologically active molecules such as NO, TNF-a, IL-6, and IL-1 (Gordon, 1998), which 
exacerbate the inflammation status.   
Collectively, these findings have led to the notion that metabolic dysfunction due to 
excess AT mass may partly result from an imbalance in the expression of pro- and anti-
inflammatory adipokines and increased infiltration of immune cells, which accelerate the 
secretion of pro-inflammatory cytokines. Visceral AT is more subject to the infiltration of 
macrophages, hence visceral obesity is more detrimental to systemic insulin sensitivity and 
predisposes to increased risk of metabolic disease. The increased release of cytokines from VAT 
is directly drained to the liver through the portal vein, which may be more detrimental to liver 
function and health than products released from SAT.  
   Dairy cows easily overconsume dietary energy during the dry period (Dann et al., 2006; 
Douglas et al., 2006). Baldwin et al. (2004) found that VAT mass markedly increased during late 
lactation. Nikkhah et al. (2008) reported that 8 wk of overfeeding energy significantly increased 
visceral fat mass including mesenteric, omental, and perirenal AT of non-pregnant non-lactating 
dairy cows compared with animals fed a controlled-energy diet. Mukesh et al. (2009) examined 
the mRNA expression of major pro-inflammatory cytokines, acute phase proteins, and 
chemokines in MAT and SAT of dairy cows before and after a 2-h LPS challenge in vitro. 
Before the challenge, MAT had higher expression of SAA3 than SAT and both depots had 
increased mRNA abundance of TNF and IL6 after LPS challenge for 2 h, with a more 
pronounced increase in MAT. Bradford et al. (2009) observed that subcutaneous injection of 
recombinant bovine TNFα (rbTNFα) to late-lactation cows for 7 d decreased feed intake by 15%, 
increased hepatic TNF mRNA and protein, and increased liver TAG content compared with 
control animals. Taken together, evidence obtained from rodent and human studies seems to hold 
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true in ruminant animals; visceral obesity resulting from overfeeding energy may be responsible, 
at least partly, for fatty liver and other metabolic disorders.          
 
Physiological Adaptation and Lipid Metabolism During the Transition Period 
Homeorhetic Control During the Transition Period 
The transition period in the dairy cow was defined as the period from 3 wk before to 3 wk 
after parturition (Grummer, 1995; Drackley, 1999), which is also known as the periparturient 
period. This period is primarily characterized by systemic homeorhetic change. Homeorhesis 
was first elaborated by Bauman and Currie (1980) to describe ―the orchestrated or coordinated 
regulation in metabolism of peripheral tissues and nutrient partitioning to support a dominant 
physiological state‖. Three key features of homeorhetic regulation as described by Bauman and 
Currie (1980) were: (1) its chronic nature (e.g., hours or days instead of seconds or minutes); (2) 
its simultaneous influence on multiple tissues with apparently unrelated functions; and (3) its 
mediation through altered responses to homeostatic signals. In dairy cows, homeorhetic control 
during the transition period is associated with a complex series of synchronized metabolic and 
endocrine adjustments that are initiated during the last few weeks of gestation and continue 
through the first several weeks of lactation (Bauman and Currie, 1980). The rapid growth of the 
fetus during late pregnancy and copious milk synthesis during the onset and development of 
lactation are potent ―pulling‖ forces that drive nutrients away from peripheral tissues (e.g., AT 
and skeletal muscle), which usually exhibit reduced sensitivity to insulin and increased 
sensitivity to adrenergic agents (Guesnet et al, 1987; Vernon and Finley, 1988). Such drastic 
physiological changes from the periparturient period to early lactation have significant impact on 
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the nutritional (Grummer, 1993), metabolic (Bell, 1995; Drackley, 1999), and immune (Goff and 
Horst, 1997) status of dairy cows.  
Hormonal Adaptation  
An important aspect of homeorhetic regulation during the transition period is the marked 
change in hormonal environment. Since fetal development and mammary gland growth overlap 
during the last trimester of gestation (Bauman and Currie, 1980), the progressive change in 
hormones was believed to play crucial roles to initiate and sustain lactogenesis, ―switch on‖ 
parturition, regulate nutrient partitioning, and alter peripheral tissue (e.g., AT and skeletal muscle) 
responsiveness to certain hormones (e.g., insulin and catecholamines; Bell, 1995). Insulin, as the 
major homeostatic hormone, functions primarily to stimulate lipogenesis and glucose utilization 
(low rate in ruminants) and to inhibit lipolysis in bovine AT. Plasma insulin concentration peaks 
at parturition, but is maintained at lower concentrations postpartum than prepartum (Grum et al., 
1996). Thus, the increasing concentration of circulating NEFA during late gestation should be, at 
least partly, attributed to the decreased insulin. Although the insulin response of AT was 
demonstrated to be compromised prepartum (Petterson et al., 1994), drenching cows with 
propylene glycol for the last 9 d prepartum was observed to increase insulin and decrease NEFA 
release (Studer et al., 1993). Glucagon concentrations increased postpartum, which paralleled the 
period of decreased plasma glucose concentration (Hammon et al., 2009). Glucagon primarily 
affects hepatic gluconeogenesis in ruminants by stimulating conversion of propionate to glucose 
(Faulkner and Pollock, 1990; Donkin and Armentano, 1995), and infusion of glucagon into early 
lactating cows increased hepatic mRNA expression for pyruvate carboxylase (She et al., 1999). 
Conversely, insulin decreases gluconeogenesis; intravenous infusion of insulin into sheep 
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decreased glucose synthesis rate (Brockman, 1990). Hence, the decreased insulin/glucagon ratio 
is an important adaptation that favors hepatic gluconeogenesis.  
The plasma concentrations of progesterone begin to decrease gradually during the last 
few weeks of gestation, then decline immediately a few days before calving and are maintained 
at very low levels postpartum (Bauman and Currie, 1980; Bell, 1995). Meanwhile, estrogen 
(estradiol-17β) concentration in blood increases prepartum and peaks within the last week of 
pregnancy, which is followed by a transient spike of prolactin (PRL) in circulation within a few 
days around parturition (Kuhn, 1977; Bell, 1995). The coordinated change of these three 
hormones was considered to be homeorhetic control over lactogenesis and milk synthesis in the 
mammary gland (Kuhn, 1977). Prolactin functions to enhance mammary lipid synthesis through 
activation of key enzymes, such as ACC, LPL, and PDH (Field and Coore, 1976; Barber et al., 
1992a; Hang and Rillema, 1997), whereas it was reported to reduce activity of lipogenic 
enzymes in AT (ACC, FAS, and LPL) of rodents (Barber et al., 1992b). Although in ruminants 
the transient surge of PRL and its similar structure and overlapping function with GH and 
placental lactogens does not warrant PRL a crucial role in regulation of nutrient partitioning, 
how much PRL may affect lipogenesis in AT of dairy cows during the transition period and 
whether this is attributed to progressively decreased insulin response postpartum still needs 
further investigation. 
Theblood concentration of GH rises during late gestation, peaks at calving and declines to 
a moderately increased level postpartum in comparison with other lactation periods (Bell, 1995; 
Grum et al., 1996). It is well established that GH has a directing effect on nutrient repartitioning 
(Bauman and Vernon, 1993). It dramatically stimulates lipolysis through increased AT response 
to catecholamines when the animal is in negative energy balance, whereas it reduces nutrient 
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utilization by AT and redirects them for milk synthesis during positive energy balance (Sechen et 
al., 1989). In study of AT in culture, GH supplementation decreased ACC active state with no 
change in total activity (Vernon et al., 1991), which may be implicated as one aspect of GH 
inhibition on lipogenesis. Thus, the opposite effect of GH on AT metabolism compared with 
insulin may be dominant during early lactation.  
Dry Matter Intake and Energy Balance 
The transition period, particularly the last week of gestation, is characterized by a 
potentially dramatic exponential decline (20 to 40%) in dry matter intake (DMI) that begins at 
about the last 3 wk of gestation, reaches a nadir around calving, and slowly recovers after 
parturition (Ingvartsen and Anderson, 2000; Hayirli et al., 2002). Paradoxically, the drastic 
increase in demand of energy from either fetal growth or lactogenesis occurs during this period. 
The fetus acquires approximately 60% of the birth weight during the last 2 month of gestation, 
however the apparent efficiency of utilization of metabolizable energy is only about 10 to 25% 
(Bauman and Currie, 1980). As calculated by Bell (1995), the energy required for fetal growth at 
250 d of pregnancy is 2.3 Mcal/d. Lactogenesis is conveniently considered to be a two stage 
process. The first stage involves mammary differentiation and limited synthesis and secretion of 
pre-colostrum for several weeks before parturition; while the second stage is associated with the 
onset of copious milk secretion shortly before calving and for several days postpartum, which 
requires significantly greater amounts of nutrients than the first stage. Based on the calculation 
by Bell (1995), the net energy required for lactation (30 kg/d milk yield) of Holstein cows at 4 d 
postpartum was approximately 26 Mcal/d, whereas 15 kg/d DMI can only provide 23 Mcal/d as 
NEL, if conversion of ME to NEL is assumed to be 60%. Thus, during the transition period, the 
concurrence of DMI depression and increased energy demand results in NEB and increased 
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mobilization of body reserves, which is may be detrimental to both lactation performance and 
health of dairy cows if severe.            
Mechanisms that result in the depression of DMI are still largely unclear. Numerous 
factors have been reported to affect DMI during the transition period, which can be generally 
categorized as animal factors, dietary nutrients, and endocrine influence (NRC 2001). Hayirli et 
al. (2002) reported that the average DMI (expressed as a percentage of BW) for heifers and cows 
during the last 3 wk of pregnancy were 1.69 and 1.88%, respectively. Additionally, the duration 
of DMI depression is longer for cows than for heifers. However, Ingvartsen et al. (1997) 
observed a similar pattern of DMI decline for heifers and multiparous cows. Prepartum body 
condition score (BCS) was reported to be inversely related to DMI and appetites of obese dairy 
cows (Treacher et al., 1986; Hayirli et al., 2002). In addition, obese cows (BCS >4) were prone 
to mobilize body reserves to a greater extent and more rapidly than cows with lower BCS, and in 
turn were more susceptible to fatty liver and ketosis (Reid et al., 1986). Ingvartsen et al. (1995) 
reported a positive relation between prepartum weight gain and lipid mobilization postpartum in 
dairy cows as well. Thus, the above evidence indicates that overconditioning in the dry period 
potentially predisposes dairy cows to more severe NEB postpartum due to more pronounced 
decrease in DMI.  
Leptin is produced and secreted primarily by adipocytes (Maffei et al., 1995), and its 
plasma concentration is positively correlated with body reserves in rodents (Frederich et al., 
1995) and humans (Caro et al., 1996). The mechanism by which leptin inhibits feed intake is 
through decreased availability of neuropeptide Y, a potent stimulator of appetite in rodents and a 
main target of leptin for binding to dorso- and ventromedial nuclei of the hypothalamus and the 
arcuate nucleus, as reported in ovine (Dyer et al., 1997; Henry et al., 1999). Positive correlations 
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were detected between plasma leptin concentration and BCS (Ehrhardt et al., 2000), adipocyte 
volume (Chilliard et al., 1998), and feeding level (Chilliard et al., 1998) in sheep and cattle. 
However, the effect of leptin in regulation of DMI does not seem to be maintained during the 
periparturient period in dairy cows. Janovick et al. (2009) observed a constantly higher plasma 
leptin concentration in cows overfed energy than in a controlled-energy group during late 
gestation (from 28-d prepartum), but DMI was not decreased until ~10 d before calving. Reist et 
al. (2003) found the opposite result in that cows that consumed more concentrate form 1 to 10 
wk postpartum had higher leptin concentration along with higher and faster recovery of DMI.  
Increased secretion of pro-inflammatory cytokines (e.g., TNFα, IL1β, IL6) due to obesity, 
particularly visceral obesity, was demonstrated to be closely associated with systemic chronic 
low-grade inflammation, reduced appetite, fatty liver disease, and insulin resistance in human 
and rodent studies (Xu et al., 2003; Steppan and Lazar, 2004; Tilg and Moschen, 2008). In 
lactating dairy cows, subcutaneous injection of recombinant bovine TNFα (rb TNFα) drastically 
reduced DMI by 34% and increased plasma NEFA and haptoglobin concentration (Kushibiki et 
al., 2003). During the dry period, dairy cows readily overconsume energy and gain BCS (Dann et 
al., 2006). In an earlier study from our lab, we found that overfeeding dietary energy to non-
pregnant dry cows significantly increased visceral AT mass compared with those that received a 
controlled-energy diet, which was not reflected by gain in BCS (Nikkhah et al., 2008). It is well-
established that cows that are fat at parturition or overfed prior to parturition are particularly at 
risk to severe NEB and tend to eat less relative to requirements and so mobilize more fat than 
thinner cows (Grummer, 1993). Serum TNFα concentration is also increased by obesity in sheep 
(Daniels et al., 2003). Hence, we speculate that overconditioned cows prepartum may have 
higher circulating concentrations of pro-inflammatory cytokines, which is detrimental to liver 
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health and interferes with DMI postpartum. Such speculation is consistant with the phenomenon 
that obese cows experience a longer time to recover DMI postpartum and are more susceptible to 
fatty liver. However, this speculation may just highlight a factor that potentially exacerbates 
NEB and DMI depression rather than explains the reason for decreased DMI during the 
transition period.    
Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1-amide 
(GLP-1), and cholecystokinin (CCK) are well-established gut hormones secreted by the small 
intestine in response to luminal nutrient concentrations in non-ruminant animals (Hansen et al., 
2004). All three gut peptides can decrease DMI in rodents directly through effects on 
hypothalamic recptors or indirectly by reducing gut motility (Holst, 1997). In addition, increased 
GLP-1 and GIP secretion were reported to stimulate insulin secretion in sheep (McCarthy et al., 
1992; Faulkner and Martin, 1999). Decreased DMI was associated with increases in plasma CCK, 
GLP-1, and GIP when rumen-protected fat was supplemented at 3.5% of dietary DM to mid-
lactation cows (Relling and Reynolds, 2007a). However, during the transition period, dairy cows 
were found to be resistant to these gut hormones. A gradual increase in GIP, GLP-1, and CCK 
was related with the similar increase in DMI within 19 days postcalving (Relling and Reynolds, 
2007b). Several reasons may be potentially involved in this phenomenon for early lactating dairy 
cows.  (1) These gut peptide may be more associated with digestion rather than restricting DMI 
when blood glucose and insulin were in relative low concentrations during early lactation, as 
suggested by Ingvartsen and Anderson (2000). (2) In addition, certain threshold values probably 
need to be attained to trigger the mechanism to inhibit appetite, which may be associated with 
gut fill or lipid content of diet, because the concentrations of these peptides detected in the 
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Transition cow study (Relling and Reynolds, 2007b) were all lower than in study of mid-
lactation cows (Relling and Reynolds, 2007a).  
   Drackley (1999) reported that coefficients of variation for DMI during the 1
st
 wk 
postpartum range from 30 to 40%, whereas they are only 6 to 10% for DMI after peak lactation. 
Hence, many other factors (such as health problems and genetics) coupled with variation from 
individual animals also contribute to the large DMI variation during this crucial period. 
Additionally, variability may also indicate the complex crosstalk among different factors that 
affect transition period DMI.  
Adipose Tissue Metabolism 
Adipose tissue is one of the major targets of homeorhetic control during the transition 
period. The NEB and transition period-associated hormonal changes result in pronounced 
alterations in lipid metabolism, glucose utilization, and sensitivities to homeostatic and 
homeorhetic stimulation, which have been well-discussed in several elegant reviews (McNamara, 
1991; Grummer, 1993; Vernon, 2005). As shown through measuring [2-
14
C] acetate 
incorporation rate in vitro, de novo FA synthesis in AT was significantly decreased in late 
pregnancy (15 d prepartum) compared to that at 120 and 240 DIM; however, the activity was 
almost completely suppressed during early lactation (McNamara et al., 1995). The reduced 
acetate incorporation may be due to marked decreases in both mRNA expression of lipogenic 
genes (ACACA and FASN) and enzymatic activity of ACC during the transition period (Travers 
et al., 1997; Janovick et al., 2009; Sadri et al., 2010b). ACC controls the flux of lipogenic 
precursor, malonyl-CoA, and is the rate-limiting enzyme of the FA biosynthesis pathway. The 
activity of lipoprotein lipase, the major enzyme in the pathway of preformed lipid uptake, was 
also decreased with initiation of lactation (McNamara, 1997). 
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The dramatic restriction of lipogenesis in AT may result from the combination of 
multiple factors. Insulin is the key hormone that stimulates lipogenesis through both 
transcriptional activation and allosteric regulation of lipogenic enzymes such as ACC. 
Hypoinsulinemia and decreased adipose sensitivity to insulin should be one of the primary 
reasons for decreased lipogenesis. The competition for substrates by mammary gland for 
lactation may contribute as another factor. Bionaz and Loor (2008) observed a similar pattern of 
marked up-regulation and/or relative mRNA abundance in mammary gland during early lactation 
for genes associated with FA uptake (LPL and CD36), long-chain (ACSL1) and short-chain 
intracellular FA activation, de novo FA synthesis (ACACA and FASN), and TAG synthesis. The 
suppression in lipogenesis is probably due in part to increased plasma GH during early lactation. 
Growth hormone can markedly decrease AT response to the lipogenic effect of insulin and 
promote lipolysis during NEB periods (Bauman and Vernon, 1993). Additionally, McNamara 
(1995) found that dairy cows of high genetic merit experienced more pronounced suppression of 
lipogenesis during early lactation than animals of average genetic merit. Hence, the suppressed 
lipogenesis in AT may be not only a short-term homeorhetic adaptation to lactation but also a 
genetic adaptation to continuously improved milk production of cows.  
Another signature change of AT peripartum is the dramatic increase in both basal and 
catecholamine-stimulated lipolytic activity (McNamara and Hillers, 1986), which compensates 
for the slowly increased DMI to support milk production. The activity of HSL, the major enzyme 
that primarily mediates β-agonist stimulated lipolysis, was observed to be increased during 
lactation and peaked at 30 to 60 DIM, then remained elevated until 240 DIM (McNamara et al., 
1987; Smith and McNamara, 1990). Recent evidence showed that mRNA expression of HSL 
was increased during lactation with the highest value appearing at 90 DIM (Sumner and 
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McNamara, 2007). Genes encoding three β-adrenergic receptors were upregulated in AT during 
the lactation period (30, 90, and 27 DIM) compared to those at 30 d prepartum, which 
contributes to the increased responsiveness to catecholamine (Sumner and McNamara, 2007). 
Similarly, the lipolysis rate postpartum was affected by genetic merit. Adipose tissue biopsied 
from cows of high genetic merit exhibited increased basal and stimulated lipolytic rates, 
implying that high producing cows tend to mobilize more body reserves to support milk 
production (McNamara and Hillers, 1986).    
The increased blood NEFA is not simply due to the elevated lipolytic activity, but also 
exacerbated by reduced re-esterification of NEFA in AT after parturition (McNamara, 1991). 
Rukkwamsuk et al. (1999) found that both basal and stimulated (addition of glucose or glucose 
plus insulin) esterification rate of SAT was markedly decreased postpartum (tested at 0.5, 1, and 
3 wk post-calving) compared with that during the last week prepartum.  
Two studies shed light on the metabolic activity of VAT during different stages of 
lactation. Baldwin et al. (2004) demonstrated that VAT lost 2/3 of its weight during the first 120 
d of lactation, and rebounded during late lactation. When this was expressed as a percentage of 
empty body weight (EBW), the VAT accounted for approximately 4.8% of EBW at 14 DIM, but 
was reduced to ~2.1% of EBW at 120 DIM. Another earlier study from Butler-Hogg et al. (1984) 
showed that, in dairy cattle, the VAT (represented by mesenteric fat) changed in the same pattern 
as that of subcutaneous AT and intermuscular AT across various physiological stages. The 
absolute weight of both MAT and SAT markedly declined from the onset of lactation and 
reached the nadir, at about half of the weight at point of calving, at mid-lactation, then 
replenished and maximized during the dry period, which was about 7-fold the weight at mid-
lactation. Reynolds et al. (2003) showed that the net portal drained visceral (PDV) release of 
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NEFA increased moderately at late pregnancy and dramatically after parturition, of which the 
release rate at 11 d postpartum was more than 4-fold that at 19 d before parturition. Since most 
dietary FA is channeled through lymphatic circulation rather than the portal vein, the increased 
NEFA release from PDV was primarily due to lipolysis of visceral fat. Thus, these results clearly 
demonstrated that VAT is also markedly mobilized and replenished during the lactation cycle. 
As we discussed previously, overconditioned cows during the dry period tend to mobilize more 
fat in early lactation and are subject to higher risk of fatty liver disease. It is rational to propose 
that, due to the direct portal drainage and increased portal blood flow in early lactation (Reynold 
et al., 2003), the drastically increased lipolysis in VAT of these fat cows is one of the major 
factors that predisposes them to inferior liver health compared with thinner cows.       
Hyperlipidemia and Liver Dysfunction  
The liver plays a pivotal role in controlling nutrient partitioning. The requirements for 
glucose and metabolizable energy increase two- to threefold from 21 d before to 21 d after 
parturition (Drackley et al., 2001). On the other hand, the blood flow through portal vein and 
liver increased during early lactation to more than double the average rates before calving 
(Reynolds et al., 2003). The liver machinery must respond quickly to this sharply increased 
demand for glucose and energy for milk production and adapt to the overwhelming influx of 
nutrients.    
Liver cells take up NEFA from blood in proportion to its concentration (Thompson et al., 
1975), which is an important adaptation strategy to support its own function and service other 
tissues by converting NEFA to the water-soluble fuels, ketone bodies. However, sustained 
hyperlipidemia that overloads hepatocytes with lipid in excess of liver capacity to metabolize it 
will result in fatty liver. Reynolds et al. (2003) showed that the hepatic uptake rate of blood 
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NEFA was elevated at 11 d lactation (115.8 mmol/h) by more than 5-fold of the rate at 19 d 
before parturition (21 mmol/h). Based on physiologically representative parameters from 
previous studies, Drackley et al. (2001) calculated that during the periparturient period 525 g/d of 
NEFA could be available for esterification and 583 g of TAG would be produced in liver per day. 
Upon uptake into hepatocytes, NEFA can either be oxidized completely to CO2 and provide 
energy or be oxidized incompletely to ketone bodies and exported for other organs and 
peripheral tissues, or it can be esterified to TAG and secreted in the form of VLDL. Synthesis of 
TAG in excess of the rate of VLDL output leads to accumulation of TAG in liver.  Hence, 
increased VLDL export or FA oxidation may help to alleviate lipid accumulation in liver. 
Multiple factors have been demonstrated to influence the fate of NEFA metabolism in 
hepatocytes. Drackley et al. (1991) incubated liver slices in vitro and observed that the 
proportion of total palmitate uptake that was oxidized was inversely related with the whole-
animal energy balance and physiological state rather than with changes in substrate delivery, 
whereas the proportion of NEFA that was esterified decreased coordinately with NEB.  
Carnitine palmitoyltransferase I (CPT-1) is the primary regulator of translocation of 
LCFA from the cytoplasm into the mitochondria, which partitions LCFA between esterification 
and oxidation. Being associated with mitochondrial outer membrane, CPT-1 translocates LCFA 
into the inner mitochondrial membrane space by binding with carnitine. Its activity is subject to 
inhibition by malonyl-CoA to prevent a futile cycle between lipogenesis and β-oxidation. The 
total activity of CPT-1 was 49% greater at 1 d postpartum than 21 d prepartum (Douglas et al., 
2006). In a later study, Dann and Drackley (2005) analyzed mitochondrial CPT-1 activity during 
the periparturient period through longitudinal liver biopsies. The authors found that CPT-1 
activity was positively correlated with liver total lipid, liver TAG content, liver TAG to glycogen 
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ratio, and serum NEFA concentration. Sensitivity to malonyl-CoA did not differ across the 
periparturient period, in contrast to data from rodents. Insulin decreased the activity of CPT-1 
and increased affinity of CPT-1 for malonyl-CoA (Grantham and Zammit, 1988). In addition, 
insulin‘s inhibitory effect on CPT-1 is also related to its stimulatory action on activity of ACC 
and the formation of malonyl-CoA. Zammit (1999) reported that the sensitivity of CPT-1 to 
malonyl-CoA‘s inhibition effect decreased with the decline of insulin concentration in a rodent 
model. Thus, the hypoinsulinemia after parturition may contribute to increased FA oxidation and 
ketogenesis. Hence, maintaining a high activity of CPT-1 is important to attenuate hepatic TAG 
accumulation. However, Mizutani et al. (1999) observed a significant decrease in CPT-1 activity 
in dairy cows with fatty liver disease compared with healthy animals. Recently, in an in vitro 
study of bovine hepatocyte culture, Xu et al. (2011) found that both transcription and translation 
of CPT-1 were significantly up-regulated when the NEFA concentration in media increased from 
0 to 1.2 mmol/L, but were markedly down-regulated when the NEFA concentration increased 
from 1.2 to 4.8 mmol/L. Thus, the decreased mRNA and protein level due to the suppressive 
effect of high NEFA concentration may have contributed to diverting FA to esterification and 
accelerated the development of fatty liver postpartum.  
Carnitine is required for CPT-1 to import LCFA into mitochondria for oxidation. 
Drackley et al. (1991) showed that supplemental L-carnitine in liver slice culture medium 
increased oxidation of palmitate to CO2 by more than 2 fold in vitro. Carlson et al. (2006) 
showed that abomasal L-carnitine infusion decreased the liver lipid concentration in feed-
restricted cows, which was mediated through increased β-oxidation. In a following study, dietary 
supplementation of L-carnitine (6, 50, and 100 g/d as low, medium, and high level) from -14 d to 
21 d relative to calving date decreased liver total lipid and TAG accumulation on d 10 after 
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calving, and increased liver glycogen during early lactation probably through increased hepatic 
conversion of Ala to glucose (Carlson et al., 2007). However, supplementation of L-carnitine 
simultaneously increased the plasma BHBA concentration in both studies, which may have 
resulted from the excess production of acetyl-CoA that overloads the capacity of the TCA cycle 
to metabolize it due to high NADH/NAD ratio.  
Peroxisomal β-oxidation is an alternative pathway in liver that produces heat rather than 
mitochondrial ATP formation. Grum et al. (1994) found that peroxisomal β-oxidation 
represented nearly 50% of the total capacity for the initial cycle of β-oxidation of palmitate in 
liver homogenates from dairy cows. In addition, peroxisomal β-oxidation was reported to be 
negatively correlated with hepatic TAG content at 1 d postpartum (Grum et al., 1996). Hence, 
peroixsomal β-oxidation provided an additional channel to alleviate hepatic lipid accumulation 
without the risk of induction of ketosis. The regulation and modulation of this pathway may 
warrant further research.  
Export of NEFA in the form of lipoprotein (VLDL) serves as another outlet to prevent 
hepatic lipid overload; however, the secretion of TAG in VLDL is much lower in ruminant 
animals than in many non-ruminants (Pullen et al., 1989). In a review by Drackley et al. (2001), 
the authors summarized two aspects of limitations primarily involved in low VLDL formation in 
dairy cows during periparturient period. First, the relatively low concentration of apolipoprotein 
(apo) B in both plasma and liver of dairy cows during early lactation limited the secretion of 
VLDL. Moreover, the TAG in newly formed VLDL is primarily derived from a TAG pool 
within the microsomal compartment, which is highly associated with the rate of de novo 
lipogenesis. De novo lipogenesis is low in ruminant liver (Grummer, 1993), which may result in 
a smaller pool of microsomal TAG and restricted supply of secretory TAG for VLDL synthesis. 
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Bernabucci et al. (2004) examined the mRNA expression of ApoB(100), ApoE, and microsomal 
TAG transfer protein (MTP) of liver tissue at -35, 3, and 35 d relative to parturition. Plasma 
VLDL was decreased after calving. Compared with values of d -35, the ApoB mRNA expression 
was lower, whereas MTP and APoE mRNA were higher on d 3 pospartum. A negative 
correlation (r = -0.57) was observed between ApoB mRNA abundance and plasma NEFA 
concentration. MTP is responsible for transfer of TAG into VLDL particle. Thus, the results 
indicated that increased NEFA influx may compromise hepatic VLDL output by reducing ApoB 
synthesis rather than recruitment of TAG into VLDL particles.  
Insulin Resistance Symptom 
Insulin resistance (IR) was described as the state in which a physiological level of plasma 
insulin failed to produce an equivalent normal biological response (Kahn, 1978). Kahn (1978) 
described how to evaluate IR by insulin responsiveness and sensitivity, of which responsiveness 
is defined as the maximal response to insulin (Rmax), and sensitivity is defined as the hormone 
concentration required to produce a half-maximal response (ED50), implying the tissue 
responsiveness to insulin. The mechanism of IR may result from defects at different levels in 
either pancreatic β-cell or insulin-sensitive tissues and organs: (1) prior to interaction that 
includes decreased insulin from pancreas and/or increased insulin degradation rates; (2) at 
receptor level of interaction, which can derive from the reduced receptor number and/or binding 
affinity; (3) at post-receptor level, that is associated with defects in insulin signal transduction 
intracellularly. Such defects can be due to the reduced expression of certain kinases in the 
pathway, decreased availability of glucose transporter (GLUT4), and/or compromised post-
translational regulation of molecules (such as phosphorylation of insulin receptor substrates) to 
transmit signal (Hayirli, 2006). In general, defects prior to interaction result in hypoinsulinemia, 
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defects at the receptor level causes decreased insulin responsiveness, and compromised 
intracellular signal transduction results in low insulin sensitivity (Kahn, 1978).  
  As discussed previously, insulin is the key anabolic hormone that regulates lipid, 
carbohydrate, and protein metabolism in AT, skeletal muscle, and liver. Insulin resistance causes 
disturbance in regulation of nutrient metabolism. Although in ruminant AT significantly less 
glucose is used for lipogenesis (Ingle, 1972b), glucose is still required as a source of glycerol 3-
phosphate synthesis and provision of NADPH mainly through the pentose phosphate pathway for 
FA synthesis (Bauman, 1976). Thus, IR may result in decreased incorporation of glucose through 
GLUT4 in AT and decreased de novo FA synthesis due to decreased supply of reducing 
equivalents. Furthermore, insulin can promote mRNA expression of LPL and lipogenic genes, 
such as ACACA and FASN, either mediated through SREBF1 or by direct interaction with insulin 
responsive elements on the promoter region of genes. Additionally, insulin suppress lipolysis in 
AT through activation of PDE3B, which decreases the concentration of cAMP that reduces PKA 
activity and consequently reduces activation of HSL (Degerman et al., 1997). Hence, during 
insulin resistant states, decreased lipogenesis, decreased re-esterification, and increased lipolysis 
will occur in AT.   
Insulin resistance was previously observed in humans and rodents during late pregnancy 
and early lactation, which was characterized as decreased sensitivity and /or responsiveness to 
insulin‘s effect on restricting hepatic gluconeogenesis, decreasing lipolysis, increasing 
lipogenesis, and increasing glucose incorporation rate by AT and muscle. During late pregnancy, 
the fetus utilized approximately 42-50% of total glucose production in ewes (Prior and 
Christenson, 1978). Such IR was considered as an important facet of metabolic adaptation 
34 
 
through homeorhetic control to prioritize nutrient utilization for fetus growth and mammary 
gland differentiation (Hauguel et al., 1987; Ryan et al., 1985; Leturque et al., 1987).  
Petterson et al. (1993) found a prominent reduction in whole-body sensitivity to insulin‘s 
effects on glucose utilization in sheep as evidenced by increased ED50. In a following study, 
Petterson et al. (1994) reported decreased insulin responsiveness of lipolysis and NEFA 
mobilization in late-pregnant sheep. Several other studies observed an even more pronounced 
state of IR in early lactation, which is usually associated with even lower concentrations of 
plasma insulin. Vernon et al. (1981) measured lipid metabolism and insulin binding affinity in 
AT biopsied from different physiological states through in vitro tissue culture study. The insulin 
effects on rate of FA synthesis and acylglycerol glycerol synthesis in AT were significantly 
decreased in late pregnancy (105 to 135 d) and reached a nadir in early lactation (18 to 50 d). 
Activity of LPL in AT was lower in late pregnancy and early lactation than other physiological 
states. McNamara and Hillers (1986) observed that basal and norepinephrine-stimulated glycerol 
release of SAT were all increased during lactation compared with late pregnancy, and the 
elevation was more prominent in early lactation. In a tissue culture study by McNamara et al. 
(1995), lipogenic activity of AT collected during late pregnancy (15 d before parturition) was 
markedly lower than in AT during mid- and late-lactation; however, AT biopsied during early 
lactation (15 and 60 d postpartum) almost completely lost lipogenic capacity as measured 
through acetate incorporation. Faulkner and Pollock (1990) found no effect on glucose 
metabolism, but insulin-induced suppression of plasma NEFA and glycerol was reduced in ewes 
during early lactation. Taken together, these studies suggested that both late pregnancy and early 
lactation are usually marked by IR in peripheral tissues, with more pronounced IR status in early 
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lactation, thereby promoting FA release and spring glucose to support pregnancy and milk 
production. 
Although the predominant mechanism is still unclear, as mentioned before, defects at 
different levels can contribute to transition period IR. First, decreased insulin secretion in the 
periparturient period is one of the factors contributing to hyperlipidemia. During the last few 
weeks before parturition, plasma NEFA concentrations gradually increased and were markedly 
stimulated around calving, accompanied by decreased DMI; meanwhile insulin concentration 
was sharply decreased postpartum (Ingvartsen and Andersen, 2000). Although DMI depression 
was considered as a primary factor to induce lipolysis and hypoinsulinemia, preliminary 
evidence has shown that long-term exposure to NEFA substantially increased TAG accumulation 
and inhibited glucose-stimulated insulin secretion though decreasing glucose oxidation in rat 
islets (Zhou and Grill, 1994; Shimabukuro et al., 1998). The inhibitory effect on insulin secretion 
was improved by adding an insulin-sensitizing drug, trogliazone, into the incubation medium 
(Shimabukuro et al., 1998). It seems that increased TAG accumulation induced IR in islets as 
well. It has been observed that plasma insulin increment was significantly lower in sheep during 
late pregnancy (105 d and 135 d of gestation) than in non-pregnant non-lactating sheep after 
hyperglycemic clamp (Regnault et al., 2004). This finding also supported the impaired pancreatic 
response to secreting insulin during the transition period. However, hypoinsulinemia during the 
transition period cannot fully explain the IR status, because euglycemic hyperinsulinemia cannot 
totally recover insulin sensitivity in glucose utilization by AT and muscle in early lactating sheep 
(Faulkner and Pollock, 1990).  
To date GLUT4 is the only reported insulin-sensitive glucose transporter and is highly 
expressed in AT and muscle. Insulin stimulation causes GLUT4 translocation from intracellular 
36 
 
storage to the plasma membrane and uptake of glucose. Balage et al. (1997) detected decreased 
GLUT4 protein in muscles of lactating goats in comparison with muscles from non-lactating 
animals. Sadri et al. (2010a) reported the mRNA expression of GLUT4 and GLUT1 were 
significantly (although slightly) lower in AT of early lactating dairy cows compared with those 
from dry cows. The elevated NEFA during early lactation probably has an adverse effect on AT 
insulin sensitivity. Van Epps-Fung et al. (1997) found a 50% reduction in insulin-induced 
glucose transport in 3T3-L1 adipocyte cultures that were exposed to 1 mmol/L of palmitate, 
myristate, and stearate overnight; inhibition of insulin action was specific to GLUT4 
translocation after 4 h of adipocyte culture with 0.3 mmol/L palmitate. Although there was no 
corresponding data about bovine adipocytes, either 1 mmol/L of FA or 0.3 mmol/L palmitate are 
within the physiological range for dairy cows during early lactation. Hence, decreased insulin 
sensitivity of peripheral tissues for glucose utilization could be, at least partly, attributed to 
reduced transcription of GLUT4 during the transition period. 
Travers et al. (1997) reported that gene expression and enzymatic activity of ACC was 
reduced approximately 3-fold and 25- to 30-fold, respectively, in OAT and SAT of sheep during 
late pregnancy and remained low into lactation when compared with non-pregnant, non-lactating 
animals. In addition, Janovick et al. (2009) and Sadri et al. (2010b) observed the significant 
reduction in mRNA of lipogenic genes (ACACA and FASN) in SAT of dairy cows after 
parturition in comparison with the dry period. ACC is the rate-limiting enzyme in controlling the 
flux of FA in de novo synthesis. Thus, the compromised transcription and post-translational 
regulation of major lipogenic genes may be responsible for the pronounced suppression of 
lipogenic activity during the transition period. 
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The alteration at receptor level is another possible reason for reduced insulin response 
and/or sensitivity of AT. Vernon et al. (1981) observed a decreased rate of FA synthesis and LPL 
activity in AT of sheep during late pregnancy and early lactation, which paralleled a decline in 
number of high-affinity insulin receptors and total insulin receptors and reduced receptor binding 
affinity in AT. Guesnet et al. (1991) also reported that the number of total insulin receptors was 
decreased by 62% and insulin was inefficient in stimulating lipogenesis in ewes during early 
lactation. 
 However, defects at receptor level have not always been the case. In another two studies, 
Flint et al. (1979) and Vernon and Taylor (1988) reported that neither in rat nor sheep was there 
any change in the number or affinity of insulin receptors in AT, but blunted adipose sensitivity to 
insulin-stimulated lipogenesis and glucose utilization was observed between lactation and non-
lactation periods. They proposed that alteration in insulin sensitivity during lactation was due to 
defects in post-receptor signal transduction after binding of the hormone to its receptor. IRS1 and 
IRS2 are the major insulin receptor substrates that mediate intracellular insulin signal 
transduction. In earlier studies, overexpression of human IRS1 in rat adipose cells increased the 
amount of surface GLUT4 even in the absence of insulin (Quon et al., 1994). Recent evidence 
showed that AT isolated from IRS1-deficient mice exhibited reduced insulin-induced glucose 
transport (Tamemoto et al., 1994). Similar results were obtained by a short-term in vivo whole-
body reduction of IRS1 expression. These animals displayed IR and blunted insulin-induced 
GLUT4 translocation in muscle and AT (Araujo et al., 2005). In contrast, neither insulin- nor 
exercise-stimulated glucose uptake into isolated muscles of IRS2-null mice differed from that in 
wild-type animals (Withers et al., 1998). Taken together, the preliminary evidence showed that 
IRS1 is the major substrate type leading to stimulation of glucose transport in peripheral tissues. 
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The function of IRS1 and other mediators in ruminant peripheral tissues during the periparturient 
period warrants further research.  
Intriguingly, Vernon and Taylor (1988) and Vernon and Finley (1988) found that AT 
collected from early lactating sheep was initially refractory to insulin stimulation of lipogenesis 
and glucose utilization within the first 24 h of in vitro incubation with different insulin 
concentrations. However, both lipogenic activity and glucose uptake were markedly induced 
after the initial 24-h lag phase. Travers et al. (1997) observed that mRNA, enzymatic activity, 
and active enzyme proportion of ACC in both OAT and SAT from late-pregnant and early 
lactating sheep were significantly increased after a lag period of 32 to 48 h in incubation with 
insulin plus dexamethasone. These data may indicate that transition IR could be recovered by 
long-term exposure to insulin stimulation. In addition, such results probably indicate that other 
hormones may interfere with AT response and/or sensitivity to insulin. During late gestation 
serum concentrations of the hormones estradiol, progesterone, and PRL affect the sensitivity of 
peripheral tissues to insulin. Ryan and Enns (1988) demonstrated that estradiol increased 
maximum insulin binding (MIB), whereas progesterone and cortisol decreased glucose transport 
and MIB. Prolactin and placental lactogen decreased glucose transport without changing MIB in 
AT. Growth hormone is another important hormone in regulation of nutrient partitioning. 
Bauman and Vernon (1993) stated that GH promoted lipolysis and reduced glucose utilization in 
AT during NEB in early lactation. However, the underlying mechanisms by which these 
hormones regulate peripheral tissue insulin sensitivity and/or responsiveness are still unclear.  
Another focus of attention concerning transition IR is unrestricted lipolysis in AT. 
However, the accumulating evidence seems to support that the increased lipolytic activity is 
more due to increased sensitivity to lipolytic stimulators rather than reduced sensitivity to 
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antilipolytic effects of insulin. Petterson et al. (1994) demonstrated that pregnancy reduced AT 
responsiveness but not the sensitivity to the antilipolytic effect of insulin, which implied that the 
cellular basis probably was altered activity or content of certain key enzyme(s). Hypoinsulinemia 
certainly favors lipolysis during the transition period; additionally, McNamara and Murray (2001) 
reported increased sympathetic nervous system activity as grossly evaluated by norepinephrine 
concentration in AT in early lactating rats compared with non-pregnant, non-lactating control 
animals. Recently, the same group reported that the mRNA expression of genes encoding β-
adrenergic receptors (ADRB1, ADRB2, and ADRB3), HSL (LIPE), and perilipin (PLIN) were all 
increased during different lactation stages (30, 90, and 270 DIM) compared with expression at 30 
d prepartum, and the highest expression value generally occurred at 90 DIM accompanied by the 
highest blood NEFA concentration (Sumner and McNamara, 2007). Thus, I propose that reduced 
insulin sensitivity in AT during the transition period may be specific to its effect on glucose 
utilization and lipogenesis, but not to antilipolysis.  
 
Effect of Prepartal Plane of Dietary Energy on Lipid Metabolism during the Transition 
Period 
During late gestation and early lactation, the flow of nutrients to fetus and mammary 
tissues is accorded a high degree of metabolic priority. This priority coincides with decreased 
responsiveness and sensitivity of extrahepatic tissue to insulin (Nieuwenhuizen et al. 1998), 
which was considered to play a key role in development of hepatic lipidosis and ketosis 
(Holtenius, 1993). Different nutritional strategies have been pursued with purposes of (1) 
increasing hepatic TAG secretion in the form of VLDL, such as supplementation of choline into 
the diet during the transition period, (2) decreasing lipolysis of AT through supplementing niacin, 
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or (3) improving insulin sensitivity of peripheral tissues by administration of insulinotropic 
agents like chromium or insulin-sensitizing drugs such as TZD. On the other hand, the DMI 
depression and the lag time between slowly increased DMI and sharply increased milk yield 
during early lactation results in the development of NEB, hypoglycemia, hyperlipidemia, and 
presumably hypoinsulinemia. Grummer (1995) suggested that prepartum DMI was positively 
correlated with postpartum DMI and affected postpartum performance and health, and that 
increasing prepartal dietary energy density could improve DMI and energy balance. However, 
other researchers demonstrated that controlled prepartal energy intake could improve postpartal 
DMI and liver TAG accumulation (Tesfa et al., 1999; Dann et al., 2006; Douglas et al., 2006; 
Janovick and Drackley, 2010). Moreover, the dietary energy plane during far-off and close-up 
period was shown to exert different influences on postpartal DMI and lipid metabolism 
(Holcomb et al., 2001; Dann et al., 2006).  
Prepartal Dietary Energy Plane 
Increasing highly fermentable carbohydrates has been the most commonly used approach 
to increase energy density of the diet. In a large herd experiment, Mashek and Beede (2000) 
provided dry cows either a basal diet (Control, NEL = 1.52 Mcal/kg DM) or a diet supplemented 
with corn grain (SC; dry ground corn replaced 21% of the corn silage, NEL = 1.63 Mcal/kg DM) 
during the close-up period. Cows fed SC had lower plasma BHBA and tended to have increased 
insulin concentration prepartum compared with cows fed the basal diet. Increasing dietary 
nonfiber carbohydrate (NFC) could stimulate the production of propionate, which as the primary 
gluconeogenic precursor in ruminants can have a stimulatory effect on insulin secretion. 
Moreover, in the process of gluconeogenesis, propionate converges to the TCA cycle by 
formation of succinyl-CoA, which can inhibit activity of HMG-CoA synthase through 
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succinylation (Hegardt, 1999). HMG-CoA controls the regulatory step in conversion of acetyl-
CoA to ketone bodies (Hegardt, 1999). However, plasma NEFA was not changed due to dietary 
energy intake during the entire transition period. Furthermore, supplementation of SC did not 
affect blood metabolites postpartum in that study and DMI information was not provided 
(Mashek and Beede, 2000). Minor et al. (1998) showed that overfeeding energy (NEL = 1.63 
Mcal/kg DM) during the last 19 d prior to expected calving increased DMI prepartum and tended 
to increase plasma glucose concentration compared to animals fed a control diet (NEL = 1.34 
Mcal/kg DM). In addition, overfeeding energy prepartum significantly decreased plasma NEFA 
and BHBA concentration prepartum and tended to decrease liver TAG content. However, it is 
hard to tell the effect of prepartum dietary energy intake on postpartum lipid metabolism, 
because the treatments were applied through postpartum as well.  
Other studies have demonstrated that restricting NEL intake to 100% or less of NRC 
(2001) recommendations prepartum resulted in more stable transition of DMI during the 
periparturient period and reduced BCS loss postpartum. Douglas et al. (2006) showed that 
irrespective of the energy sources (moderate grain or fat supplementation), cows that were 
restricted in NEL intake to 80% of NRC (2001) requirements from -60 d to parturition had higher 
DMI and NEL intake during the first 21 d postpartum than cows fed at ad libitum (160% of 
requirement) during dry period. Restricted cows had lower plasma NEFA and BHBA and lower 
total lipid and TAG in liver postpartum, but cows from both restricted and overfed groups had 
similar insulin levels postpartum, which implicate different sensitivity of AT to antilipolytic 
effect of insulin postpartum. In a recent study, Janovick and Drackley (2010) fed dry cows a 
moderate energy diet (NEL = 1.63 Mcal/kg) for either ad libitum intake (OVR) or restricted 
intake (RES) to supply 150 or 80% of requirements, or fed a controlled-energy diet (CON; NEL 
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= 1.21 Mcal/kg) for ad libitum intake through the entire 60-d dry period. Due to the inclusion of 
32% of DM as chopped wheat straw, the energy intake of cows fed the controlled energy diet 
was limited to about 100% of requirement by bulkiness. The results showed that multiparous 
cows in the OVR group lost more BCS postpartum than those in RES and CON groups due to 
the lower DMI (as % of BW) during the first 3 wk postpartum. It seems that cows (especially 
multiparous cows) overfed during the dry period experienced more pronounced DMI depression 
and changes in energy balance, and mobilized more body fat to support lactation postpartum. 
Controlled energy intake during the dry period prevented the marked changes in DMI and energy 
intake postpartum and decreased lipid mobilization.   
Rukkwamsuk et al. (1999) observed that overfeeding energy (96 MJ/d of NEL) during the 
dry period significantly increased AT esterification rate prepartum, blood NEFA, and liver TAG 
content within first 3 wk postpartum compared with those indices from cows fed a controlled 
energy diet (44 MJ/d). Although a marked drop in esterification rate of AT was observed 
postpartum in both groups, AT from overfed cows showed reduced sensitivity to glucose- or 
glucose plus insulin-stimulated esterification. Thus, overfeeding energy during the dry period 
predisposes dairy cows to accumulate fat in AT prepartum and to higher risk to liver lipidosis 
due to increased mobilization of AT postpartum.  
In the study of Dann et al. (2006), 74 multiparous cows were randomly assigned to different 
combination of far-off [NEL intake = 80% (RES), 100% (CON) and 150% (OVR) of NRC (2001) 
requirements] and close-up [NEL intake = 80% (CCON) and 150% (COVR) of NRC (2001) 
requirements] dietary energy planes. Overall results showed that the energy plane of far-off diet 
rather than energy intake during the close-up period had more pronounced impact on 
performance and lipid metabolism within 10 d postpartum. Cows fed RES and CON had greater 
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DMI and energy balance and lower serum NEFA and BHBA during the first 10 d of lactation in 
comparison with cows overfed energy (OVR) during the far-off period. The OVR cows had the 
highest serum insulin concentration and simultaneously the highest serum NEFA concentration 
during the close-up period regardless of the close-up dietary treatment, which the authors 
presumed as an indication of IR of the overfed cows. During the first 10 day of lactation, serum 
insulin and glucose concentrations were numerically lower in cows fed CON than animals in 
OVR. Moreover, restriction of energy intake during close-up period numerically decreased 
serum NEFA concentration during early lactation for cows that received CON or RES during far-
off period. However, there was no effect of close-up energy restriction on serum NEFA in early 
lactation for cows overfed during far-off period, which probably resulted in the lack of statistical 
significance of close-up diet effect on postpartum serum NEFA concentration. Such results 
implicate a compromised insulin sensitivity of AT in cows overfed energy during close-up 
period.  
 
Hypothesis of Current Research 
Previous researches from our group repeatedly found that, compared with controlled-
energy or restricted-energy feeding, prepartum overfeeding energy in form of NFC feeds either 
during entire dry period (Douglas et al., 2006; Janovick et al., 2011) or in close-up period 
(Richards et al., 2009) increased concentrations of blood insulin and glucose prepartum and 
increased concentrations of blood NEFA and BHBA, hepatic lipid accumulation and occurancy 
of metabolic disorders postpartum. Such symptoms indicated overfed cows experienced reduced 
insulin efficiency in stimulating peripheral glucose utilization prepartum and increased body fat 
mobilization postpartum. Similar responses were typically observed in cases of obesity induced 
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type II diabetes in non-ruminant subjects (McGarry, 2002; Jin et al., 2005). In these diabeteic 
subjects, AT is refractory to insulin‘s effects, which contributes to hyperglycemia and 
dyslipidemia. More recent evidence suggested that AT of obese individuals release more pro-
inflammatory cytokines to blood, which result in the low grade inflammation in other organs, 
especially in liver, and induce the hepatic dysfunction and fatty liver disease (Tilg and Moschen, 
2008). In non-ruminant animals, visceral AT has been reported to be different from SAT as 
compose of greater proportion of immune cells, higher lipolytic activity and more active in 
endocrine functions (Lionetti et al., 2009). However, how prepartum plane of dietary energy 
regulates AT metabolism of transition dairy cows and whether visceral AT respond differently to 
energy overfeeding compared with SAT in dairy cows is still largely unclear. Based on the 
evidences from other species, we hypothesize that prepartum overfeeding dietary energy increase 
preparturient BCS and exacerbated insulin resistance of AT in transition dairy cow, which is 
responsible for dramaticly increased lipolysis when concentration of blood insulin was reduced 
postpartum. Compared with SAT, visceral AT may secret more pro-inflammatory cytokines in 
response to energy overfeeding, which drains directly to liver from portal vein and compromise 
liver function postpartum.          
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CHAPTER 2 
 
OVERFEEDING ENERGY UPREGULATES PPARγ-CONTROLLED ADIPOGENIC 
NETWORKS AND INDUCIBLE ADIPOCYTOKINES IN VISCERAL AND 
SUBCUTANEOUS ADIPOSE DEPOTS OF HOLSTEIN COWS 
 
ABSTRACT 
This experiment was conducted to study the effects of energy overfeeding on gene 
expression in mesenteric (MAT), omental (OAT), and subcutaneous (SAT) adipose tissue from 
nonpregnant and nonlactating Holstein cows. Eighteen cows were randomly assigned to either a 
control (CON, NEL= 1.35 Mcal/kg DM) or energy-overfed group (OVE, NEL= 1.62 Mcal/kg 
DM) for 8 wk. Cows then were euthanized and subsamples of MAT, OAT, and SAT were 
harvested for transcript profiling via quantitative PCR (qPCR) of 29 genes involved in 
lipogenesis, triglyceride (TAG) synthesis, lipolysis, transcriptional regulation of lipogenesis, and 
immune response.   The interaction of dietary energy and AT depot was not significant for any 
gene analyzed. Here, we report differences in gene expression pattern due to energy overfeeding. 
Overfeeding energy increased (P < 0.05) mRNA expression of genes related with de novo fatty 
acid (FA) synthesis (ACLY, ACACA, FASN, THRSP), long-chain FA elongation, desaturation, 
and intracellular trafficking (ELOVL6, SCD, and FABP4), and TAG synthesis (GPAM and 
LPIN1). The transcription regulator PPARG was up-regulated (P < 0.05) by overfeeding, 
whereas SREBF1 was down-regulated (P < 0.05). The mRNA expression of LEP and CCL2 was 
increased in cows overfed energy (P < 0.05), while IL6R was higher in CON cows (P < 0.05). 
Overall, results indicate that overfeeding energy increases AT mass through stimulation of 
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transcription of the network encompassing de novo FA synthesis and esterification processes. In 
contrast to other species, PPARγ rather than SREBF1 appears essential for both adipogenesis and 
lipid filling due to energy overfeeding.  
 
INTRODUCTION 
A feature of most mammalian species is their ability to accrete lipid when in positive 
energy balance. Adipogenesis induced by overfeeding energy can occur via cell proliferation 
(hyperplasia) or by differentiation of preadipocytes through lipid filling (hypertrophy) (Hausman 
et al., 2009). Age, physiological status of the animal, and potential limitation of adipocyte size 
seems to be crucial factors in determining the major pathways driving adipogenesis (Hood and 
Allen, 1973; Robelin, 1981). In dairy cows there is an obvious trend for greater adipocyte 
proliferation (i.e,. increase in cells/g tissue) between early and mid-lactation (McNamara et al, 
1995). Pre-adipocyte markers such as delta-like 1 homolog (DLK1) as well as markers of 
differentiated adipocytes [e.g., fatty acid binding protein 4 (FABP4)] and lipogenic enzymes [e.g., 
acetyl-CoA carboxylase (ACACA), fatty acid synthase (FASN)] can be used to evaluate 
adipogenesis as related to lipid accretion and tissue mass in response to dietary energy intake. 
A previous study from our laboratory observed up-regulation of genes involved in FA 
import (e.g., CD36), de novo FA synthesis (e.g., ACACA, FASN, SREBF1), and TAG synthesis 
(e.g., LPIN1, SCD) in MacT cells treated with rosiglitazone, which is a potent PPARγ agonist 
(Kadegowda et al., 2009). In rodents, nuclear (activated) SREBP1c transcriptionally activates 
lipogenic genes through binding to SREs as well as E-boxes in target gene promoters. Its central 
role in hepatic lipogenesis has been firmly established in rodents and humans (Horton et al., 
2002). Moreover, SREBP1c was identified as a pro-adipogenic basic helix–loop–helix (bHLH) 
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transcription factor that can induce PPARγ expression and possibly generate an as-yet unknown 
PPARγ ligand (Kim and Spiegelman, 1996; Kim et al., 1998). It remains unclear whether 
SREBF1 has a role in bovine adipogenesis or whether it is responsive to dietary energy. 
Linear increases in lipogenic activity (greater incorporation rate of acetate) in SAT of 
hybrid steers (Greathead et al., 2001) and in SAT, MAT, and OAT from growing steers (Baldwin 
et al., 2007) were observed with increasing metabolizable energy (ME) intake. The stimulatory 
effect of high carbohydrate intake on lipogenesis is possibly due to (1) increased substrate supply 
for lipogenesis (e.g., acetate, β-hydroxybutyrate, glucose, and lactate), which in the presence of 
glucose increases acetate incorporation rate in adipose tissue in vitro (Whitehurst et al., 1978); 
and (2) elevated blood glucose and insulin concentration potentially mediating the induction of 
lipogenic transcription regulators, e.g. insulin-response elements have been detected in both the 
promoter regions of ACACA and FASN in ovine and murine adipocytes  (Sul et al., 2000; Travers 
et al., 2001).   
During the dry period pregnant dairy cows can readily over-consume dietary energy and 
become over-conditioned, which at parturition results in greater susceptibility to fatty liver or 
ketosis due to the greater amount of non-esterified fatty acids (NEFA) in the circulation (Dann et 
al., 2006, Douglas et al., 2006, Janovick and Drackley, 2010). Visceral obesity leads to chronic 
low-grade inflammation due to increased secretion of proinflammatory cytokines from adipose 
and resident immune cells in human and rodents (Gastaldelli et al., 2002, Shoelson et al., 2006). 
Whether fat deposition in response to overfeeding energy in dairy cows results in transcriptional 
changes and a pro-inflammatory status has not been established.  The underlying mechanisms 
whereby dietary energy overfeeding to ruminants regulates lipid metabolism and immune 
response in visceral and subcutaneous AT are unknown. Our hypothesis was that overfeeding a 
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moderate-energy diet to dairy cows would enhance fat deposition at least in part through changes 
in gene expression. Furthermore, different depots possess unique transcriptional signatures, 
which would make them more susceptible to varied dietary energy intake.  
 
MATERIALS AND METHODS 
Experimental Design, Animals, Diets, and Sampling 
Experimental Design. Eighteen nonpregnant, nonlactating Holstein cows [body weight 
(BW) = 656  29; body condition score (BCS) = 3.04 ± 0.25] were randomly assigned to either a 
moderate-energy diet (OVE; NEL = 1.62 Mcal/kg DM) or controlled-energy diet (CON; NEL = 
1.35 Mcal/kg DM) provided as a TMR for ad libitum intake. The OVE diet contained 73.8% 
forage without straw and 13.8% ground shelled corn (DM basis); whereas, the CON diet 
contained 81.7% forage with 40.5% wheat straw and 3.5% ground shelled corn. The TMR were 
mixed and processed in a Keenan Klassik 140 mixer wagon (Richard Keenan & Co., Ltd., Borris, 
County Carlow, Ireland) and offered once daily at 0800 h. Straw was not pre-processed before 
being added to the TMR mixer.  Cows had free access to water. Initial and final BW was 
recorded at the start of wk 1 and end of wk 8. The experiment was conducted in an indoor free-
stall barn equipped with Calan gates to monitor individual feed intake. Experimental procedures 
were approved by the Institutional Animal Care and Use Committee at the University of Illinois 
(protocol 06194). 
DMI, Body Composition, Visceral Adipose Tissue Mass, and Blood Metabolites. These 
data were collected and analyzed by Nikkhah et al. (unpublished data) and are shown in Table 
2.1. Feed intake were recorded daily; feed and TMR samples were collected bi-weekly and 
composited into 3 pooled samples for nutrient analysis. Blood was sampled at wk 2, 4, and 7 and 
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serum was obtained by centrifugation at 1800×g for analysis of non-esterified fatty acid (NEFA), 
β-hydroxybutyrate (BHBA), cholesterol, glucose, and insulin concentrations. Body condition 
scores (BCS) were assigned at wk 1, 4 and 7. After the 8-wk experiment, cows were euthanized 
at the University of Illinois College of Veterinary Medicine diagnostic facilities. The weights of 
visceral organs and visceral AT were recorded on site.   
Tissue Sampling. All AT samples were harvested within 20 min of euthanasia and snap-
frozen in liquid N2 until RNA extraction.  Subcutaneous AT (SAT) was harvested from the tail-
head region on the left side of each cow.  Mesenteric, omental, and perirenal AT depots were 
carefully dissected, weighed, and a subsample collected for RNA extraction.   
RNA Extraction and Quality Assessment, Primer Design and Evaluation, Internal Control 
Gene (ICG) Selection, and Quantitative RT-PCR (qPCR) 
RNA Extraction, Quality Assessment, and cDNA Preparation. Adipose tissue was 
weighted (~2.0 g) and immediately placed into ice-cold TRIzol
®
 Reagent (~15 mL) (Invitrogen, 
Carlsbad, CA) with 1 µL linear acrylamide (Ambion, Inc., Austin, TX) for extraction of total 
RNA as previously described (Loor et al., 2005). Total RNA was cleaned using RNeasy mini kit 
columns and genomic DNA was removed using the RNase-Free DNase Set (Qiagen, Valencia, 
CA). The RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies). The purity of RNA was assessed by ratio of optical density 
OD260/280, which were above 1.9 for all samples. Integrity of RNA (RIN) was tested by 
electrophoretic analysis of 28S and 18S rRNA subunits using a 2100 Bioanalyzer (Agilent 
Technologies), and values were >7.0 for all samples. A portion of the RNA was diluted to 100 
ng/µL with DNase-RNase free water prior to RT for cDNA synthesis. The cDNA were 
synthesized using 100 ng RNA, 1 µg dT18 (Operon Biotechnologies, AL), 1 µL 10 mM dNTP 
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mix (Invitrogen Corp., CA), 1 µL Random Primers (Invitrogen Corp., CA), and 10 µL 
DNase/RNase free water. The mixture was incubated at 65°C for 5 min and kept on ice for 3 min. 
A total of 6 µL of master mix composed of 4.5 µL 5X First-Strand Buffer, 1 µL 0.1 M DTT, 
0.25 µL (50 U) of SuperScript
TM
 III RT (Invitrogen Corp.,CA), and 0.25 µL of RNase Inhibitor 
(10 U, Promega, WI) was added. The reaction was performed in an Eppendorf Mastercycler
®
 
Gradient with the following temperature program: 25°C for 5 min, 50°C for 60 min, and 70°C 
for 15 min. The cDNA was then diluted 1:4 with DNase/RNase free water.  
Primer Design and Evaluation. Primers were designed and evaluated as previously 
described (Bionaz and Loor, 2008). The details of primer sequences and the description of genes 
are shown in Table 2.3 and Supplemental Table S2.1 and S2.2. Primers were designed using 
Primer Express 3.0 with minimum amplicon size of 80 bp (amplicons of 100 -120 bp were 
superior, if possible) and limited 3‘ G + C percentage (Applied Biosystems, CA). Primer sets 
were intentionally designed to fall across exon-exon junctions. Then, primers were aligned 
against NCBI database through BLASTN and UCSC‘s COW (Bos taurus) Genome Browser 
Gateway to determine the compatibility of primers with already annotated sequences of the 
corresponding gene in both databases. Prior to qPCR, primers were verified through a 20 µL-
PCR reaction, which followed the same procedures of qPCR described below except the 
dissociation step. A universal reference cDNA amplified from 3 bovine adipose tissues (SAT, 
mesenteric, and omental AT) was utilized to ensure the identification of genes. Five µL of PCR 
product was run in a 2% agarose gel stained with ethidium bromide, and the remaining 15 µL 
were cleaned with a QIAquick
®
 PCR Purification Kit (QIAGEN) and sequenced at the Core 
DNA Sequencing Facility of the Roy J. Carver Biotechnology Center at the University of Illinois, 
Urbana (in Supplement Table S2.2). The sequencing product was confirmed through BLASTN at 
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the National Center for Biotechnology Information (NCBI) database. Only primers that 
presented a single band of the expected size and the right amplification product were used for 
qPCR. The accuracy of a pair of primers was evaluated by the presence of a unique peak during 
the dissociation step at the end of qPCR. 
Genes evaluated included: acetyl-Coenzyme A carboxylase alpha (ACACA), ATP citrate 
lyase (ACLY), acyl-CoA synthetase long-chain (ACSL1), adipose differentiation-related protein 
(ADFP or PLIN2), thrombospondin receptor (CD36), elongation of long chain fatty acids family 
member 6 (ELOVL6), adipocyte fatty acid binding protein 4 (FABP4), fatty acid synthase 
(FASN), mitochondrial glycerol-3-phosphate acyltransferase (GPAM), hormone-sensitive lipase 
(LIPE), lipin 1 (LPIN1), lipoprotein lipase (LPL), stearoyl-CoA desaturase (SCD), MLX 
interacting protein-like (MLXIPL), peroxisome proliferator-activated receptor gamma (PPARG), 
sterol regulatory element binding transcription factor 1 (SREBF1), thyroid hormone responsive 
SPOT 14 (THRSP), adiponectin (ADIPOQ), chemokine (C-C motif) ligand 2 (CCL2), chemokine 
(C-C motif) ligand 5 (CCL5), interleukin-1 beta (IL1B), interleukin-6 (IL6), interleukin-6 
receptor (IL6R), leptin (LEP), acute-phase serum amyloid A1 (SAA1), toll-like receptor 4 (TLR4), 
and tumor necrosis factor alpha (TNF). 
Quantitative PCR (qPCR). qPCR was performed in a MicroAmp
TM
 Optical 384-Well 
Reaction Plate (Applied Biosystems, CA). Within each well, 4 µL diluted cDNA combined with 
6 µL of mixture composed of 5 µL 1×SYBR Green master mix (Applied Biosystems, CA), 0.4 
µL each of 10 µM forward and reverse primers, and 0.2 µL DNase/RNase free water were added. 
Three replicates and a 6 point standard curve plus the non-template control (NTC) were run for 
each sample to test the relative expression level (User Bulletin #2, Applied Biosystems, CA). 
qPCR was conducted in ABI Prism 7900 HT SDS instrument (Applied Biosystems, CA) 
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following these conditions: 2 min at 50 °C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C 
(denaturation), and 1 min at 60 °C (annealing + extension). The presence of a single PCR 
product was verified by the dissociation protocol using incremental temperatures to 95 °C for 15 
s, then 65 °C for 15 s. 
Internal Control Gene (ICG) Selection and Evaluation. A detailed description for the 
selection criteria of ICG for qPCR has been described previously (Mukesh et al., 2009). Briefly, 
ICGs are genes that are not coregulated and whose expression does not vary with physiological 
state or nutritional status (Bionaz and Loor, 2007). Based on previous microarray data for 
visceral and subcutaneous AT, 11 most stably expressed genes were identified as the candidate 
ICGs via GeneSpring GX7. The potential co-regulation among these genes was tested using 
Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Inc., Walnut Creek, CA, USA; released 
January 7, 2009). Then, all candidate ICGs were tested for expression using the same samples 
and standard curve samples used in current study. The expression values of candidate ICGs were 
uploaded into geNorm software to evaluate expression ratio stability (M value), of which the 
higher stability (expressed as lower M value) between any 2 non-coregulated genes indicates the 
greater suitability as ICGs. In addition, the optimal number of ICG that should be employed for 
normalization was determined via geNorm by calculating the pairwise variation (V value) 
between the normalization factor (NF) obtained using n ICGs and the NF from (n+1) ICGs. The 
decreased V value in (n+1) ICGs vs. n ICGs indicates the improvement of normalization effect. 
However, V value below 0.1 should be acceptable for normalization. The geometric mean of the 
finally selected ICGs was calculated and used as NF for normalization of mRNA expression of 
the tested genes (Vandesompele et al., 2002). 
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Data Processing and Statistical Analysis 
The threshold cycle (Ct) data were analyzed and transformed using the standard curve 
with the 7900 HT Sequence Detection System Software (version 2.2.1, Applied Biosystems, CA). 
Data were then normalized with the geometric mean of the three most stable ICG (Mukesh et al., 
2009).  Analysis (Supplemental Figure S2.1) revealed that genes encoding kelch-like ECH-
associated protein 1 (KEAP1), tripartite motif-containing 41 (TRIM41), and mitochondrial 
ribosomal protein 63 (MRP63) were the most appropriate to calculate a normalization factor to 
normalize gene expression data.  
The normalized PCR data (relative mRNA expression) were subjected to log 
transformation in SAS (SAS Inst. Release 8.0) to ensure a normal distribution of residuals. This 
transformed dataset was analyzed as a 2×3 factorial arrangement (diet and tissue source as the 
two factors) with the PROC GLM procedure in SAS. No significant interaction between the two 
factors was detected in the initial analysis; therefore, we excluded the interaction and re-analyzed 
data simply on main effects. The PDIFF statement of SAS was utilized to evaluate differences 
with significance declared at P ≤ 0.05.  
Relative mRNA Abundance of Genes within Adipose Tissue 
 Efficiency of qPCR amplification for each gene was calculated using the standard curve 
method (Efficiency = 10
(-1/slope)
) (See Supplement Table S2.3). Relative mRNA abundance 
among measured genes was calculated as previously reported (Bionaz and Loor, 2008), using the 
inverse of PCR efficiency raised to Ct (gene abundance = 1/ECt, where Ct = Ct of tested gene 
– geometric mean Ct of 3 internal control genes). Overall mRNA abundance for each gene 
among all samples of the same adipose tissue was calculated using the median Ct, and overall 
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percentage relative mRNA abundance was computed from the equation: 100 × mRNA 
abundance of individual gene / sum of mRNA abundance of all genes tested (See Table 2.4).     
Gene Network Analysis 
Ingenuity Pathway Analysis
®
 software (IPA; Redwood City, CA) was utilized to explore 
networks among the genes analyzed. This web-based software enables the reconstruction of 
networks and interactions among genes based on current knowledge (i.e., published literature) 
among human, mouse and rat genes/proteins. Thus, the software allows for easier interpretation 
and understanding of the underlying relationships in a biologically relevant context. Prior to 
uploading data into IPA, relative expression levels of genes in mesenteric and omental adipose 
from SAS results were transformed to fold-change relative to that in subcutaneous adipose; the 
same transformation was performed on data from moderate dietary energy to obtain fold-changes 
compared with data from low dietary energy. One-fold change was set as threshold to depict 
changes (i.e., genes marked black indicates up-regulation and white for down-regulation) in gene 
expression between the tissues or treatments. 
 
RESULTS AND DISCUSSION 
Except for a tendency for LPL (P = 0.085), no statistically significant (P < 0.05) 
interactions were detected between level of dietary energy and fat depot site. Therefore, our data 
indicate that both VAT and SAT of dairy cows respond in the same fashion to overfeeding 
energy. In work with beef cattle, Faulconnier et al. (2007) reported a lack of interaction between 
diet (grass-based or maize silage-based diets) and fat depot (intermuscular, subcutaneous, and 
perirenal AT) for lipogenic enzymes (glucose-6-phosphate dehydrogenase, malic enzyme, FASN, 
and glycerol-3-phosphate dehydrogenase) and LPL enzymatic activity. In the subsequent 
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sections only the main effect of dietary energy level will be discussed. The main effect of 
adipose depot on transcript profiles is presented in chapter 3.       
de novo Fatty Acid Synthesis  
Adipose tissues rather than liver are the major site of lipogenesis in non-lactating 
ruminants (Hood et al., 1980; Bergen and Mersmann, 2005). Expression of 3 genes encoding 
enzymes that participate in DNS was examined. ATP citrate lyase (ACLY) converts citrate to 
acetyl-CoA in the cytosol and allows glucose and lactate carbon to serve as substrates for DNS. 
Acetyl-CoA carboxylase (ACACA) synthesizes malonyl-CoA from acetyl-CoA derived from 
either ruminal acetate or glucose, and FASN uses malonyl-CoA to initiate a series of elongation 
reactions leading to the formation of palmitic acid (Vernon, 1980). Overfeeding dietary energy 
resulted in significantly greater (P < 0.01) mRNA expression levels of these 3 genes regardless 
of fat depot (Figure 2.1). Fold changes in OVE/CON were 1.7, 1.5 and 2.1 (based on mRNA 
expression of back-transformed data) for ACLY, ACACA, and FASN, respectively. These three 
genes accounted for ~0.1%, 0.7%, and 4.1% of total genes examined in OVE group, and for 
~0.1%, 0.6% and 0.28% in CON (See Table 2.4).  
Although acetate, glucose, and lactate could serve as substrates for lipogenesis, acetate 
has been shown to be the predominant precursor in ruminant adipose (Hanson and Ballard, 1967; 
Hood et al., 1972; Whitehurst et al., 1978, 1981). Despite the low enzymatic activity of ACLY in 
growing calf adipose tissues (perirenal, omental, and epididymal) (Ingle et al., 1972b), which 
may be the same in mature dairy cows as reflected by its low mRNA abundance (~0.1% of all 
genes tested in both treatment groups), an adaptation of this enzyme to substrate availability has 
been reported, i.e. there was a substantial increase in lipogenic enzyme activity and glucose-
carbon incorporation into fatty acids of dairy cows after infusion of glucose post-ruminally or 
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intravenously (Bauman, 1976). In a more recent study, activities of ACLY (P < 0.01), FASN (P 
< 0.05), and NADP-malate dehydrogenase (P < 0.01) were increased in SAT of ad libitum-fed vs. 
limit-fed steers (Schoonmaker et al., 2004).   
A linear increase in lipogenic activity (greater incorporation rate of [1-
14
C] acetate) in 
SAT of hybrid steers was observed with increasing metabolizable energy (ME) intake 
(Greathead et al., 2001), thus confirming that positive energy balance promotes the lipogenic 
process. The observed up-regulation of ACLY by overfeeding energy in the present study may 
have been due to a sustained increase in the availability of blood glucose and lactate due to 
greater dietary ground corn grain (13.8% vs. 3.5% of diet DM) and corn silage (50% vs. 28% of 
DM). The greater expression of ACACA and FASN in OVE cows indicated that excess energy 
intake altered adipose lipogenic capacity at least in part through gene transcription. Previous 
work from our laboratory also found that prepartal energy overfeeding up-regulated lipogenic 
genes (ACACA and FASN) and cytosolic isocitrate dehydrogenase 1 (IDH1) in SAT (Janovick et 
al., 2009). IDH1 converts cytoplasmic isocitrate to α-ketoglutarate with the production of 
NADPH, which is a critical pathway of reducing equivalent supply for DNS in ruminant adipose 
tissue (Ingle et al., 1972b).  
Greater mRNA abundance of lipogenic genes by energy overfeeding in the present study 
may have been induced by a combination of greater substrate supply and insulin, which is a well-
described lipogenic hormone (Sul et al., 2000; Travers et al., 2001). The inclusion of ground corn 
and easily fermentable corn silage (compared with wheat straw in the CON diet)  potentially 
provided greater amounts of substrates (acetate and glucose derived from either gluconeogenesis 
or absorbed post-ruminally) for lipogenesis even though no difference in blood glucose 
concentration was observed between treatments (66.1 and 66.7 mg/dL for CON and OVE) . 
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Moreover, serum insulin concentration was greater in OVE (23.5 and 29.6 µIU/mL for CON and 
OVE; Nikkhah et al., 2008).  
Long-chain Fatty Acid Uptake, Activation, and Intracellular Trafficking  
Gastrointestinal absorption of preformed lipid is relatively small in ruminants as a result 
of low dietary fat intake, and ruminant liver has limited capability to synthesize and secrete 
VLDL compared with non-ruminants (Drackley et al., 1999).  However, the uptake of preformed 
LCFA contributes to the intracellular FA pool of AT. In the present study, dietary fat content was 
nearly doubled in OVE cows due to the inclusion of whole cottonseeds at 5% of dietary DM 
(Table 2.2). The relative % mRNA abundance of LPL accounted for 8.3% and 14.6% in CON 
and OVE (Table 2.4), which indicated that uptake of LCFA is an important contributor to the 
intracellular FA pool.  
Lipoprotein lipase hydrolyzes LCFA from TAG in chylomicrons or VLDL (Weinstock et 
al., 1997), and is considered a suitable indicator of energy status in cows (McNamara et al., 
1987). The plasma membrane protein CD36 mediates LCFA translocation into the cytosol after 
their release via LPL (see reviews Hajri and Abumrad, 2002; Thompson et al., 2010). Long-
chain acyl-CoA synthases (ACSL) are localized in various subcellular sites including plasma 
membrane and cytosol and activate FA to acyl-CoA prior to entry into different metabolic 
pathways (Gargiulo et al., 1999). It was reported that ACSL1 is the predominant isoform in 
bovine mammary tissue (Bionaz and Loor, 2008) and AT (Janovick et al., 2009). A study in non-
pregnant beef heifers showed that high dietary energy increased LPL activity in SAT (Sprinkle et 
al., 1998). Bonnet et al. (2000) observed a parallel increase in both LPL activity and mRNA 
expression in perirenal AT of ewes, which also had greater plasma insulin concentration.  
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In non-ruminants, insulin regulates LPL and CD36 at the transcriptional level (Thompson 
et al., 2010) but in our study excess dietary energy consumption (which resulted in greater blood 
insulin; Nikkhah et al., 2008) did not affect the mRNA expression of these genes (P > 0.05, 
Figure 2.1). We did observe a lower serum glucose:insulin ratio in OVE cows, which may 
indicate a compromised insulin response by peripherial tissues. Therefore, it is possible that the 
lack of response of LPL and CD36 to dietary energy overfeeding was the result of impaired 
insulin sensitivity in AT. This idea is supported by the lower expression of the transcription 
regulator SREBF1, which is a well-established driver of the insulin-induced lipogenic response 
in non-ruminants (Foufelle and Ferre, 2002). Further discussion of transcription regulators is 
presented below. 
Adipocyte fatty acid-binding protein (encoded by the FABP4 gene) functions as 
intracellular LCFA transport protein and helps regulate lipid storage (Hertzel and Bemlohr, 
2000). FABP4 is the best described target gene of the nuclear receptor PPARγ (Lefterova et al., 
2008) and is an accepted marker of adipocyte differentiation due to its strikingly increased 
expression (Hertzel and Bernlohr, 2000). In this study, overfeeding energy significantly 
increased FABP4 expression (P < 0.05, Figure 2.1), which may be indicative of a sustained 
degree of adipocyte differentiation. Moreover, FABP4 accounted for up to ~24% and ~28% of 
total mRNA abundance in OVE or CON cows, which made it  the second most abundant gene in 
OVE and the most abundant in CON. These data implicate FABP4 as a crucial enzyme in bovine 
adipocytes. Paradoxically, in non-ruminants this protein was reported to be involved in lipolysis 
by directly interacting with LIPE (Shen et al., 1999; Smith et al., 2004). Adipocytes obtained 
from FABP4-null mice had markedly reduced efficiency of lipolysis in vivo and in vitro (Coe et 
al., 1999; Scheja et al., 1999). However, our results do not seem to support such an effect 
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because no differences were observed in plasma NEFA (0.11 mmol/L for both OVE and CON 
cows, Nikkhah et al., 2008) or LIPE mRNA expression. Macrophages express FABP4 and its 
reduced expression resulted in decreased production of a cluster of pro-inflammatory cytokines 
(Hertzel et al., 2009). Furthermore, disruption of FABP4 expression alone resulted in alleviation 
of insulin resistance associated with diet-induced obesity (Hotamisligil et al., 1996). The greater 
expression of FABP4 in adipose tissue of OVE cows may have predisposed the animal to insulin 
insensitivity and a pro-inflammatory state. 
Elongation and Desaturation of LCFA 
In rodents, isomers of the ELOVL family exhibit tissue- and substrate-specific activity 
(Ntambi and Miyazaki, 2004). In fact, both ELOVL and SCD are localized in the ER and 
cooperate during synthesis of 18:0 and cis9-18:1 in mice (see review Guillou et al., 2010). 
ELOVL6 is primarily involved at the ER in the elongation of saturated and monounsaturated FA 
with 16-carbons, without capacity for elongation beyond 18-carbons (Jakobsson et al., 2006).   
Janovick et al. (2009) reported that ELOVL6 was up-regulated together with other lipogenic-
related genes (ACACA, FASN, and SCD) in SAT of prepartal dairy cows overfed dietary energy, 
which may represent a previously-unrecognized step in fatty acid synthesis in bovine AT (Loor, 
2010). Loor (2010) proposed that ELOVL6 activity is a ‗necessary step‘ in endogenous 
formation of 18:0 in adipose, which is then converted to cis9-18:1 by SCD. Stearic acid rather 
than 16:0 is the preferred substrate for SCD in mice, and oleic acid is the predominant isomer of 
18:1 in bovine AT (Rukkwamsuk et al., 2000, Webb et al., 1998) and plasma (Loor et al., 2005; 
Douglas et al., 2007).  
In the present study, energy overfeeding markedly increased (P < 0.01, Figure 2.1) 
expression of both ELOVL6 (1.8 fold-change) and SCD (3.5 fold-change) regardless of adipose 
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depot. Furthermore, the parallel up-regulation of ELOVL6 and SCD and lipogenic genes (ACACA 
and FASN), as observed previously in overfed prepartal dairy cows (Janovick et al., 2009), 
suggests that the lipogenic pathway in ruminant adipose involves elongation of 16:0 and a 
subsequent desaturation to cis9-18:1 and, thus, these joint pathways possibly constitute (as in 
non-ruminants) the major source of LCFA in bovine AT. More importantly, the expression of 
these lipogenic enzymes may be subject to the same transcriptional regulators as the ‗classical‘ 
lipogenic genes. In OVE cows, SCD mRNA abundance accounted for ~38.8% of total mRNA 
compared with ~18% in CON (Table 2.4), which underscores its essential role in the overall 
process of lipogenesis and esterification in bovine adipocytes as shown in bovine mammary 
tissue (Bionaz and Loor, 2008). 
ELOVL6 was identified as target gene of SREBF1 in rodent liver (Moon et al., 2001; 
Wang et al., 2005); however, in the present study ELOVL6 together with other well-established 
SREBF1 target genes in rodent liver (ACACA, FASN and SCD) were up-regulated by 
overfeeding energy despite decreased expression of SREBF1, which suggests that they may not 
be regulated by SREBF1 in bovine AT. Results from previous studies also have challenged a 
putative central role of SREBF1 in lipogenesis in bovine mammary gland (Bionaz and Loor, 
2008) and in rat AT (Sekiya et al., 2007).   
TAG Synthesis, Lipid Droplet Formation, and Lipolysis  
Glycerol-3-phosphate acyltransferase (GPAT) esterifies FA to the sn-1 position of 
glycerol-3-phosphate, which is the first and presumed rate-limiting step of TAG biosynthesis 
(Takeuchi and Reue, 2009). GPAM is the isoform of GPAT localized on the outer membrane of 
mitochondria, and the only identified and characterized GPAT in bovine species (see NCBI 
webpage: http://www.ncbi.nlm.nih.gov/gene/497202). The high mRNA expression in liver and 
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AT in rodents (Lewin et al., 2001) and in AT in humans (Cao et al., 2006) underscores its critical 
role in TAG synthesis.  
Lipins function as phosphatidate phosphatases (PAP) that convert phosphatidic acid (PA) 
to diacylglycerol (DAG) during TAG synthesis. LPIN1 was previously shown to be the most 
highly-expressed isoform in bovine mammary gland during lactation (Bionaz and Loor, 2008). In 
the present study, excess dietary energy intake up-regulated both GPAM and LPIN1 (P < 0.01, 
Figure 2.1) and also ADFP expression (P = 0.06). The latter protein, currently defined as 
perilipin 2 (NCBI databse), is a lipid droplet membrane protein that functions to protect TAG 
from basal lipolysis but (paradoxically) also seems to be required for maximal β-adrenergic-
stimulated lipolysis (Tansey et al., 2001) (Figure 2.1). Although we did not measure other 
enzymes (e.g., AGPAT and DGAT isomers) participating in the step-wise pathway of TAG 
synthesis, the enhanced expression of GPAM, LPIN1, and ADFP was indicative of an increase in 
FA channeling towards TAG synthesis. In addition to its PAP activity, LPIN1 expression is 
required for induction of PPARγ and C/EBPα expression; both are key transcription factors 
regulating adipogenesis in non-ruminants (Phan et al., 2004). We found no change in LIPE 
(formerly known as hormone-sensitive lipase; NCBI) expression between the two treatment 
groups and its % mRNA abundance was lower in OVE than CON (~2.7% vs. ~5.2%, Table 2.3). 
Such responses seem to be in line with the positive energy balance status of cows even in CON 
group. However, we cannot exclude posttranslational effects on HSL, which is a demonstrated 
regulatory point of hormone-stimulated lipolysis (Duncan et al., 2007).  
In summary, over consumption of dietary energy increased expression of genes related 
with FA biosynthesis, elongation and desaturation, and TAG synthesis in a concerted fashion. 
Thus, the transcriptional changes in these genes partly explain the significant increase in total 
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visceral fat weight of cows overfed energy (visceral AT weight of OVE vs. CON = 59 kg vs. 35 
kg; Nikkhah et al., 2008). 
Transcriptional Regulation of Lipogenesis  
Adipogenesis induced by overfeeding energy can occur via cell proliferation (hyperplasia) 
and/or by differentiation of preadipocytes through lipid filling (hypertrophy) (Hausman et al., 
2009). Previous work (McNamara et al, 1995) has shown that adipocyte proliferation in SAT 
(i.e., increase in cells/g tissue) increases between early to mid-lactation, corresponding to the 
gradual increase in energy balance and the decrease in growth hormone to insulin (Herbein et al., 
1985). Although we did not evaluate cell number or cell size in the present study, expression of 
delta-like 1 homolog (DLK1), which is highly-expressed in preadipocytes and functions to 
inhibit differentiation through suppressing C/EBPδ expression (Smas and Sul, 1993; Sul, 2009), 
was barely detectable in many of our samples (data not shown), which indicated the presence of 
few preadipocytes.  In other words, differentiation was the predominant event driving 
adipogenesis and lipid accretion, regardless of diet (Nikkhah et al., 2008). Further, our data 
underscore that energy overfeeding promoted differentiation and lipid filling, i.e., greater mass 
deposition (Nikkhah et al., 2008). 
Terminal differentiation leads to increased adipocyte size through lipid filling and 
transformation into a mature adipocyte (Sethi and Vidal-Puig, 2007). The best characterized 
aspect of differentiation is the sequential cascade regulated by transcription factors that converge 
at PPARγ and C/EBPα to coordinate expression of adipogenic genes [(e.g. FABP4 and insulin-
induced glucose transporter (SLC2A4)] (Spiegelman and Flier, 2001; Lefterova and Lazar, 2009). 
PPARγ is both necessary and sufficient for differentiation (Rosen and MacDougald, 2006). 
Ligand activated PPARγ heterodimerizes with retinoid X receptor (RXR) to induce the 
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expression of adipogenic genes by binding to PPAR response elements (PPRE) (Palmer et al., 
1995). In our study PPARG expression was up-regulated in AT due to energy overfeeding (P < 
0.05, Figure 2.2), which was indicative of greater differentiation activity. This also was 
supported by increased expression of FABP4, which is a well-defined PPARγ target gene 
(Lefterova et al., 2008). Recently, a novel zinc-finger protein encoded by the Zfp423 gene was 
identified as a putative transcription regulator that determines differentiation of preadipocytes 
through control of PPARG expression (Gupta et al., 2010). Whether dietary energy level changes 
PPARG expression through the action of this protein needs further investigation. 
Interestingly, except for FABP4, other coordinately up-regulated genes are well-
established non-ruminant SREBF1 target genes, e.g. ACACA, FASN, ELOVL6, and SCD (P < 
0.05); however, SREBF1 mRNA expression was significantly lower (P < 0.05, Figure 2.2) in 
cows overfed energy than in CON. Direct transcriptional activation of those genes by PPARγ 
was the most likely mechanism driving the observed responses, i.e., bovine preadipocytes may 
be able to differentiate without direct involvement of SREBF1. The murine promoter region of 
SCD contains both SRE (SREBF1 binding site) and a PPAR RE (PPRE; Miller and Ntambi, 
1996). Recent studies utilizing chromatin immunoprecipitation (ChIP) coupled with either deep 
sequencing or whole genome tiling arrays in rodent adipocytes unveiled thousands of 
PPARγ:RXR binding sites, which are particularly abundant in the vicinity of genes involved in 
lipid and glucose metabolism (Lefterova et al., 2008; Nielsen et al., 2008).   
The opposite expression pattern of SREBF1 between the treatment groups (lower in OVE 
than CON) challenges the notion of a central role for SREBF1 in bovine adipocyte lipogenesis. 
Our results are in accordance with a previous mouse study in which mice deficient in SREBP-1 
did not have a significant decrease in the amount of AT (Shimano et al., 1997). Recently, Sekiya 
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et al. (2007) also reported that SREBP1c did not bind to the functional SRE/E-box site on the 
FASN promoter in adipocytes. Nevertheless, these previous findings do not explain the lower 
expression of SREBF1 due to overfeeding energy in our study. SREBF1 expression was shown to 
be positively regulated by insulin in vivo and in primary rodent hepatocyte cultures (Shimomura 
et al., 1999; Azzout-Marniche et al., 2000). Inhibitors of PI3 kinase, an intracellular transducer of 
insulin- signalling, decreased nuclear and precursor SREBP-1c protein in rodent hepatocytes 
(Hasty et al., 2000). Thus, the impairment in insulin sensitivity that we inferred from reduced 
glucose/insulin ratio could be a cause of decreased transcription of SREBF1 in OVE cows. 
Because the above-mentioned evidence is from rodent models or hepatocyte culture studies our 
deduction for bovine AT will have to be confirmed with further studies. 
Thyroid hormone (TH) is critical in regulation of energy homeostasis. THRSP encodes a 
nuclear protein that was identified due to its rapid response to thyroid hormone (Kinlaw et al., 
1995). It has been implicated in transcriptional regulation of the major lipogenic genes in 
mammals via an unknown mechanism (Cunningham et al., 1998). THRSP is highly expressed in 
major lipogenic tissues in rodents including liver, AT, and lactating mammary gland (Jump and 
Oppenheimer, 1985). In lactating bovine mammary gland, however, expression of THRSP 
accounted for only 0.01% of total mRNA abundance and its expression increased modestly after 
parturition (Bionaz and Loor, 2008). A significant correlation between mRNA of THRSP and 
FASN was observed in rat liver (Clarke et al., 1990). Direct evidence of THRSP in regulation of 
lipogenesis comes from studies with rat hepatocytes, where transfection with THRSP antisense 
oligonucleotide prevented expression of lipogenic enzymes (Kinlaw et al., 1995; Brown et al., 
1997).  
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In our study, the up-regulation of THRSP (P < 0.05) paralleled the increase in expression 
of lipogenic genes in AT of OVE cows. Blood TH is correlated with energy balance of dairy 
cows (Kunz et al., 1985; Capuco et al., 2001), thus, higher TH secretion may be expected in 
cows overfed energy with the consequent increase in the transcription of THRSP (Cunningham et 
al., 1998). In the present study, THRSP mRNA expression in VAT depots (Chapter 3) was 
positively correlated with net energy intake in the last 3 wk (shown in Table 2.5). Besides TH, 
THRSP is potentially transcriptionally activated by SREBPs and carbohydrate response element 
binding protein (formerly-known as ChREBP; encoded by MLXIPL) due to the existence of SRE 
and ChoRE (carbohydrate response element) motifs in its promoter (Jacoby et al., 1989; Jump et 
al., 2001).  It is noteworthy that the % mRNA abundance of THRSP in mammary tissue of dairy 
cows is quite low (0.01% among 45 genes tested, Bionaz and Loor, 2008) compared with other 
lipogenesis-related genes, but we showed that it was comparatively high in adipose tissue (~4% 
to 6% mRNA abundance among investigated genes).  Together the data clearly indicate a more 
important role of THRSP in bovine AT than mammary tissue. Graugnard et al. (2009) reported a 
positive correlation between PPARG and THRSP in longissimus lumborum of fattening beef 
cattle, which we observed in the present study by overfeeding energy. Whether PPARγ targets 
THRSP, which then could play as a secondary transcription regulator of lipogenic genes or 
whether they exert a synergistic function needs further study.  
At the beginning of this decade, Yamashita et al. (2001) uncovered MLXIPL as a 
transcription factor regulated via a metabolite produced during glucose oxidation. This discovery 
was crucial in clarifying earlier observations: (1) besides insulin, glucose is another potent factor 
inducing transcription of major enzymes in the glycolytic and lipogenic pathways; and (2) 
several lipogenic genes (including ACACA and FASN) contain carbohydrate response elements 
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(ChoRE; Towle et al., 1997) as does THRSP, which in rodents was previously reported to be 
transcriptionally activated by high-carbohydrate diets (Shih et al., 1995). Despite abundant 
expression of MLXIPL in most lipogenic organs including liver, brown AT, and white AT 
(Iizuka et al., 2004), most studies have focused on rodent liver, which is the most important 
organ for lipid and glucose metabolism in non-ruminants. Hence, its function in adipose tissue is 
still unclear.  
Other than a study reporting the expression of MLXIPL in growing steers (Graugnard et 
al., 2010), to our knowledge there is no other documentation of MLXIPL expression and/or 
activity in bovine tissues. In the present study, MLXIPL expression was not affected (P > 0.05) 
by dietary energy level. The low relative % mRNA abundance compared to other TF (PPARG 
and THRSP) suggests minor importance of MLXIPL in bovine AT, which does not rely on 
glucose as the primary lipogenic substrate. Activity of MLXIPL appears to be primarily 
regulated at the post-translational level (phosphorylation/dephosphorylation) (Iizuka and 
Horikawa, 2008). Liver X receptor (LXR), which was identified as a glucose sensor in non-
ruminants (Metro et al., 2007) can regulate transcription of MLXIPL in rodent liver (Cha and 
Repa, 2007). However, only high glucose led to an increase in MLXIPL mRNA expression in 
HepG2 cells (Metro et al., 2007) and 3T3-L adipocytes (Li et al., 2003). Whether MLXIPL is 
less active in bovine AT or it is only activated trancriptionally during the post-prandial state, i.e. 
as a result of a transient rise in blood glucose, remains to be determined. Ruminants maintain 
much lower and less variable blood glucose concentrations thannon-ruminants, which may also 
challenge its function in ruminants.  
In summary,   our results highlighted a central role of PPARγ in the transcriptional 
regulation of adipogenesis and lipid filling process and challengesthe importance of SREBF1 in 
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bovine AT. The relatively low mRNA abundance of MLXIPL in bovine AT was suggestive of a 
minor involvement in regulation of lipogenic gene expression.   
Adipokine Expression  
The capability of expressing and secreting various cytokines implicated AT as an active 
endocrine organ in regulating systemic inflammatory and metabolic disease (Rosen and 
Spiegelman, 2006). In addition, AT also responds to these cytokines and inflammatory ligands 
by expressing a wide-variety of receptors (e.g., IL-6R and TLR4), which reflects the autocrine 
and paracrine characteristics of AT (Schäffler and Schölmerich, 2010). These cytokines include 
well-defined pro-inflammatory factors, acute-phase proteins, adipocytokines, and chemotactic 
proteins as signals for immune cell recruitment.  
In comparison with non-ruminants, the relationship between AT cytokine expression and 
excess energy intake has not been documented. Our results (see Figure 2.3) showed that 
overfeeding energy increased (P < 0.05) mRNA expression of LEP and CCL2, but reduced (P < 
0.05) expression of IL6R. Leptin is mainly produced by white AT and can regulate food intake 
and energy homeostasis in rodents by binding to specific receptors in the hypothalamus 
(Friedman and Halaas, 1998). Plasma LEP concentration was reported to be positively related 
with dietary energy intake (Holtenius et al., 2003) and body fatness (Chilliard et al., 2001), but 
neither plasma LEP concentration nor mRNA expression of LEP receptor and LEP in SAT 
seemed to be associated with macronutrient composition of the diet or BCS in dairy cows (Duske 
et al., 2009). As reviewed by Chilliard et al. (2001), insulin increases expression of LEP mRNA 
in bovine AT in vitro. Block et al. (2003) observed a significant increase in plasma LEP after 96 
h of hyperinsulinemia/euglycemia clamp in mid-lactating dairy cows.  More direct evidence 
obtained from previous study of our lab (Janovick et al., 2011) showed that, compared with 
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controlled-energy feeding, overfeeding energy during entire dry period significantly increased 
plasm insulin concentration prepartum, which was paralleled with higher plasma LEP. In the 
present study, a numerical increase of blood insulin concentration was found in OVE than CON 
cows (29.6 vs. 23.5 µIU/mL). Although it is tempting to speculate that insulin may have 
contributed to the greater LEP expression in our study, the fact remains that both SREBF1 
expression and the blood glucose/insulin ratio were lower in OVE cows.  
CCL2 encodes a protein that is a member of the C-C motif chemokine family, identified 
as chemoattractants, which increase macrophage infiltration in AT during obesity and are 
associated with inflammation and insulin resistance (Kanda et al., 2006).  Adipocyte hypertrophy 
increases CCL2 expression (Kamei et al., 2006). In the present study, increased CCL2 expression 
due to energy overfeeding may be partly explained by greater numbers of differentiated 
adipocytes, which also was reflected by the greater expression of lipogenic genes (e.g. ACACA 
and FASN) and the adipocyte differentiation marker FABP4. Enhanced chemotaxis via CCL2 
potentially promotes macrophage infiltration and could exacerbate inflammation by promoting 
the secretion of more pro-inflammatory cytokines. However, mRNA for pro-inflammatory 
cytokines (TNF, IL1B and IL6) were not differentially expressed between treatments possibly 
due to the greater PPARG expression as PPARγ activity inhibits NFκB, which is the major TF of 
pro-inflammatory cytokines (Ruan and Pownall, 2009). Despite the lack of difference in IL6 
mRNA expression between dietary treatments, IL6 receptor (IL6R) expression was lower due to 
overfeeding (P < 0.05) but the potential mechanisms behind this response are unknown.  
Although dietary energy intake in the current study did not affect expression profiles of 
most adipokines and pro-inflammatory cytokines, overfeeding energy drastically increased fat 
accumulation in visceral AT depots (Nikkhaha et al., 2008), which had greater expression of 
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these adipokines and inflammatory mediators, especially in MAT (Ji et al., 2011). Thus, long-
term excessive energy intake may indirectly increase production of cytokines by inducing 
visceral obesity. Drackley and Andersen (2006) proposed that cytokine produced in visceral 
depots draining directly into liver through the portal vein may induce inflammation and liver 
dysfunction. However, it remains to be determined whether the higher capacity for cytokine 
expression is a natural characteristic of adipocytes or whether immune cell infiltration is the 
primary source of these immune mediators. 
 
SUMMARY AND CONCLUSIONS 
Overfeeding energy potentially stimulated lipogenesis to the same extent in both VAT 
and SAT of dairy cows, which was reflected by the significant up-regulation in expression of 
genes related with DNS (ACLY, ACACA, and FASN), FA elongation and desaturation (ELOVL6 
and SCD), and FA trafficking and TAG synthesis (FABP4, GPAM, and LPIN1). PPARG and 
THRSP rather than SREBF1 were responsive to dietary energy intake and may play more crucial 
roles in transcriptional regulation of adipogenesis and lipogenesis in bovine AT (see network of 
transcriptional control in Figure 2.4).  
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TABLES AND FIGURES 
Table 2.1. DMI, BW, BCS, visceral organ mass, visceral adipost tissue mass, and serum 
metabolites in cows either overfed energy (OVE, NEL = 1.62 Mcal/kg DM) or fed the controlled 
energy diet (CON, NEL = 1.35 Mcal/kg DM). (Data from Nikkhah et al, unpublished data) 
Organs OVE CON SEM Diet (P) 
DMI, kg/d 15.7 10.9 0.6 <0.0001 
NEL intake, Mcal/d 25.3 14.7 0.9 <0.0001 
Preharvest BW, kg 734.9 736.0 24.0 0.98 
Final live BW, kg 805.1 786.8 25.2 0.62 
BCS,
 
wk 1 3.26 3.18 0.12 0.66 
BCS,wk 4 3.20 3.00 0.13 0.30 
BCS, wk 7 3.62 3.55 0.11 0.68 
Omental fat, kg 28.07 17.49 1.31 <0.0001 
Mesenteric fat, kg 21.99 12.10 2.35 0.01 
Perirenal fat, kg 9.86 5.98 1.20 0.04 
Total visceral fat
1
, kg 59.53 35.57 3.87 0.001 
Kidney, kg 1.95 1.78 0.17 0.50 
Liver, kg 10.30 9.39 0.59 0.27 
Mammary gland, kg 17.40 18.79 1.87 0.61 
Carcass
2
, kg 511.05 521.0 17.6 0.70 
Digestive tract, kg 46.57 45.11 2.94 0.73 
Heart, kg 3.92 4.17 0.18 0.34 
Glucose, mg/dL  66.7 66.1 2.2 0.85 
Insulin, µIU/mL 29.6 23.5 3.2 0.2 
Glucose/insulin ratio 2.6 3.5 0.3 0.06 
NEFA, mmol/L 0.11 0.11 0.01 0.96 
BHBA, mmol/L 0.46 0.35 0.03 0.01 
Cholesterol, mmol/L 120.2 99.8 4.5 0.005 
1 
Sum of omental, mesenteric, and perirenal adipose tissue 
2
 Including carcass, head, hide, hooves and tail  
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Table 2.2. Ingredients and nutrient composition of diets (% of DM) 
Diet  
CON OVE Ingredient 
0101 17.9 Alfalfa silage     
3.5 6.0 Alfalfa hay 
0.01 50.0 Corn silage 
40.5 0.0 Wheat straw 
3.5 13.8 Ground shelled corn 
-- 5.0 Whole cottonseed 
11.5 4.3 Soybean meal 
001 001 Minerals and Vitamins 
  Nutrient composition 
52.0 50.0 DM, % 
1.35 1.62 NEL, Mcal/kg 
12.0 15.0 CP, % 
54.8 36.7 NDF, % 
50.1 33.0 Forage NDF, % 
36.6 25.8 ADF, % 
26.2 38.7 NFC, % 
2.2 3.7 Fat, % 
NFC, non-fiber carbohydrate = 100 – (%CP + %NDF + %Fat + %ash). 
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Table 2.3. GenBank accession number, hybridization position, sequence, and amplicon size of 
primers use to analyze gene expression by qPCR 
Accession # Gene Primers
1
 Primers (5’-3’)2 bp3 
AJ132890 ACACA F. 3709 CATCTTGTCCGAAACGTCGAT 101 
  R. 3809 CCCTTCGAACATACACCTCCA  
BC108138 ACLY F. 2287 GTTCTCCTCCGAGGTCCAGTT 104 
  R. 2390 CAAACACTCCAGCCTCCTTCA  
BC119914 ACSL1 F. 1929 GTGGGCTCCTTTGAAGAACTGT 120 
  R. 2047 ATAGATGCCTTTGACCTGTTCAAAT  
BC102211 ADFP F. 139 TGGTCTCCTCGGCTTACATCA 81 
  R. 219 TCATGCCCTTCTCTGCCATC  
BC140488 ADIPOQ F. 211 GATCCAGGTCTTGTTGGTCCTAA 109 
  R. 319 GAGCGGTATACATAGGCACTTTCTC  
BC103112.1 CD36 F. 1196 TGATATTTGCAGGTCCATCTATGC 103 
  R. 1298 TGGAGATGCAAAAGCAAAGGA  
BC148954.1 ELOVL6 F. 439 AGCACCCGAACTAGGAGATACAAT 120 
  R. 540 TACCAGGAGTACAGAAGCACAGTGA  
CR552737 FASN F. 6383 ACCTCGTGAAGGCTGTGACTCA 92 
  R. 6474 TGAGTCGAGGCCAAGGTCTGAA  
AY515690 GPAM F. 1963 GCAGGTTTATCCAGTATGGCATT 63 
  R. 2026 GGACTGATATCTTCCTGATCATCTTG  
BT020625 LEP F. 79 GGCTTTGGCCCTATCTGTCTTA 124 
  R. 202 GAGACGGACTGCGTGTGTGA  
EF140760.1 LIPE F. 1674 TCAGTGTCCAAGACAGAGCCAAT 106 
  R. 1779 CATGCAGCTTCAGGCTTTTG  
DV797268 LPIN1 F. 147 TGGCCACCAGAATAAAGCATG 101 
  R. 247 GCTGACGCTGGACAACAGG  
BC118091 LPL F. 327 ACACAGCTGAGGACACTTGCC 101 
  R. 427 GCCATGGATCACCACAAAGG  
XM001255565.2 MLXIPL F. 107 TGTCTGACATCTCTGACACACTCTTC 107 
  R. 213 TGGCTGGATCATGTCAGCAT  
NM181024 PPARG F. 135 CCAAATATCGGTGGGAGTCG 101 
  R. 235 ACAGCGAAGGGCTCACTCTC  
AY241933 SCD F. 665 TCCTGTTGTTGTGCTTCATCC 101 
  R. 765 GGCATAACGGAATAAGGTGGC  
XM001790600.1 SREBF1 F. 1638 GTGCTGAGGGCAGAGATGGT 106 
  R. 1743 ACAAAGAGAAGTGCCAAGGAGAA  
AY656814 THRSP F. 631 CTACCTTCCTCTGAGCACCAGTTC 151 
  R. 781 ACACACTGACCAGGTGACAGACA  
1 Primer direction (F: forward; R: reverse) and hybridization position on the sequence 
2 Exon-exon junctions are underlined 
3 Amplicon size in base pair (bp) 
 
96 
 
Table 2.4. Gene symbol, name, and percentage of mRNA abundance among all genes 
investigated in each treatment 
Gene Symbol Gene Name in NCBI 
% mRNA in 
OVE 
% mRNA in 
CON 
Fatty acid and triglyceride metabolism 
ACACA 
acetyl-Coenzyme A carboxylase alpha 0.67 0.63 
ACLY 
ATP citrate lyase 0.09 0.10 
ACSL1 
acyl-CoA synthetase long-chain 0.38 0.90 
ADFP (PLIN2) 
adipose differentiation-related protein 2.13 2.74 
CD36 
thrombospondin receptor 5.61 9.80 
ELOVL6 
elongation of long chain fatty acids 0.63 0.51 
FABP4 
adipocyte fatty acid binding protein 4 24.07 28.09 
FASN 
fatty acid synthase 4.14 2.81 
GPAM 
glycerol-3-phosphate acyltransferase 0.39 0.50 
LIPE 
hormone-sensitive lipase 2.67 5.24 
LPIN1 
lipin 1 0.48 0.40 
LPL 
lipoprotein lipase 8.33 14.57 
SCD 
stearoyl-CoA desaturase 38.84 17.99 
Transcription regulators 
MLXIPL 
MLX interacting protein-like 0.02 0.03 
PPARG peroxisome proliferator-activated receptor 
gamma 
1.02 1.53 
SREBF1 sterol regulatory element binding 
transcription factor 1 
0.28 0.69 
THRSP 
thyroid hormone responsive SPOT 14 5.80 4.78 
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Table 2.4. (cont.) 
Gene Symbol Gene Name in NCBI 
% mRNA in 
OVE 
% mRNA in 
CON 
Adipokine and proinflammatory cytokines 
ADIPOQ 
adiponectin 3.38 6.65 
CCL2 
chemokine (C-C motif) ligand 2 0.05 0.04 
CCL5 
chemokine (C-C motif) ligand 5 0.03 0.03 
IL1B 
interleukin-1 beta < 0.01 < 0.01 
IL6 
interleukin-6 0.02 0.03 
IL6R 
Interleukin-6 receptor 0.58 1.39 
LEP 
leptin 0.33 0.41 
SAA3 
acute-phase serum amyloid A3 0.02 0.04 
TLR4 
toll-like receptor 4 0.03 0.07 
TNF 
tumor necrosis factor alpha 0.01 0.02 
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Table 2.5. Correlation analysis of SCD and THRSP mRNA level with net energy intake. 
Regardless of treatment assignment, the relative mRNA expression level of SCD in both MAT 
and OAT was positively correlated with NEL intake at wk 5 and 6 (P < 0.05), and tended to be 
positively correlated with NEL intake at wk 7 (P < 0.1).   
Y-variable X-variable Correlation coefficient P-value 
NEL intake at wk5 SCD mRNA in MAT 0.50 0.041 
 SCD mRNA in OAT 0.61 0.012 
 THRSP mRNA in MAT 0.49 0.046 
 THRSP mRNA in OAT 0.52 0.039 
NEL intake at wk6 SCD mRNA in MAT 0.49 0.043 
 SCD mRNA in OAT 0.52 0.040 
 THRSP mRNA in MAT 0.48 0.049 
 THRSP mRNA in OAT 0.44 0.087 
NEL intake at wk7 SCD mRNA in MAT 0.43 0.086 
 SCD mRNA in OAT 0.48 0.061 
 THRSP mRNA in MAT 0.46 0.061 
 THRSP mRNA in OAT 0.49 0.055 
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Table S2.1. Sequencing results using BLASTN from NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against nucleotide collection (nr/nt). 
Gene Best hit in NCBI Score 
CCL5 Bos taurus chemokine (C-C motif) ligand 5 96.9 
CD36 Bos taurus CD36 molecule (thrombospondin receptor)  64.4 
ELOVL6 Bos taurus hypothetical LOC533333 107 
IL6R Bos taurus interleukin 6 receptor (IL6R) 111 
LIPE Bos taurus lipase, hormone-sensitive (LIPE) 114 
MLXIPL Bos taurus similar to Mlx interactor zeta; Mio zeta 63.9 
SREBF1 PREDICTED: Bos taurus sterol regulatory element binding transcription 
factor 1 (SREBF1) 
113 
TNF Bos taurus tumor necrosis factor (TNF superfamily, member 2) 93.3 
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Table S2.2. Sequencing results obtained from PCR products. 
Gene Sequence 
CCL5 AGAAGAAGTGGGTGCGAGAGTACATCAACGCTTTGGAGTTGAGCTAGGGTGGAC
CC 
CD36 AAGGAATCCCTGTGTGATAGATTTATTCGTTCCATCCTGTGTGCTGTTTGCATCTC
CAAAG 
ELOVL6 CAGAAGCTGATCTTCCTGCACTGGTACCACCACATCACTGTGCTTCTGTACTCCT
GGTAAA 
IL6R AGGTCGGGAACAAGTCCAGCAACCCCCTAGGATTTGACGGCTACAAACTCCTAC
AGCCCGACCCAA 
LIPE AGCAGCCCTGACCCGGCCGGAGGGCTCACTGGGAACCGACTCCCTCAAAAGCCT
GAAGCTGCATGAA 
MLXIPL AGGATGCCCTACGTGGGCAATGCTGACATGATCCAGCCAAA 
SREBF1 CGTCGTCCCCCACTGGTCTGGCTGATGAATGGGCTGCTGGTGCTCTTCTCCTTGG
CACTTCTCTTTGTAAA 
TNF TCACTCTCCGGGGCAGCTCCGGTGGTGGGACTCGTATGCCAATGCCCTCATGGAA 
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Table S2.3. qPCR performances among 29 genes measured in adipose tissues. 
Gene Median Ct
1
 Median ΔCt2 Slope3 (R2)4 Efficiency5 
ACACA 21.9 -3.2 -3.23 0.996 2.04 
ACLY 24.5 -0.5 -3.29 0.995 2.01 
ACSL1 21.9 -3.1 -3.27 0.998 2.02 
ADFP 19.8 -5.4 -3.42 0.995 1.96 
ADIPOQ 18.6 -6.4 -3.47 0.995 1.94 
CCL2 25.6 0.5 -3.68 0.992 1.87 
CCL5 26.4 1.2 -3.64 0.994 1.88 
CD36 17.8 -7.4 -3.57 0.996 1.90 
ELOVL6 21.5 -3.6 -3.61 0.998 1.89 
FABP4 16.2 -9.1 -3.47 0.991 1.94 
FASN 18.2 -6.8 -3.71 0.998 1.86 
GPAM 22.0 -3.1 -3.74 1.000 1.85 
IL1B 29.3 4.2 -3.34 0.986 1.99 
IL6 26.6 1.5 -3.22 0.993 2.04 
IL6R 21.5 -3.7 -3.36 0.994 1.98 
LEP 22.6 -2.6 -3.40 0.997 1.97 
LIPE 18.9 -6.2 -3.52 0.998 1.93 
LPIN1 22.4 -2.9 -3.30 0.998 2.01 
LPL 17.2 -7.9 -3.55 0.992 1.91 
MLXIPL 26.4 1.3 -3.08 0.977 2.11 
PPARG 20.7 -4.5 -3.44 0.998 1.95 
SAA3 26.7 1.4 -3.33 0.995 2.00 
SCD 16.5 -8.6 -3.09 0.993 2.11 
SREBF1 22.4 -2.7 -3.18 0.995 2.07 
THRSP 18.5 -6.7 -3.45 0.999 1.95 
TLR4 25.7 0.5 -3.76 0.995 1.84 
TNF 27.7 2.5 -3.51 0.986 1.93 
1
 The median Ct is the result of Ct values of all samples. 
2
 ΔCt = Ct of gene – geometrical mean of Ct of ICGs, and the medianΔCt is calculated from 
ΔCt of all samples. 
3
 Slope of the standard curve. 
4
 R
2
 means the coefficient of determination of the standard curve. 
5
 Efficiency = 10
(-1/slope)
. 
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Figure 2.1. Main effect of dietary energy intake on mRNA expression of genes involved in 
lipid metabolism. Genes marked with asterisk were significantly differentially expressed 
between treatments (P < 0.05). X-axis: official gene symbol from NCBI website. Y-axis: relative 
mRNA expression value from natural logarithmic transformed data. Black column indicates 
CON; grey column indicates OVE treatment. 
  
A
C
L
Y
A
C
A
C
A
F
A
S
N
E
L
O
V
L
6
S
C
D
L
P
L
C
D
3
6
A
C
S
L
1
F
A
B
P
4
G
P
A
M
L
P
IN
1
A
D
F
P
L
IP
E
R
e
la
ti
v
e
 m
R
N
A
 E
x
p
re
s
s
io
n
 L
e
v
e
l
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
Control
Overfed
*
** * *
*
* *
103 
 
 
 
 
Figure 2.2. Main effect of dietary energy intakeon mRNA expression of transcriptional 
regulator genes. Genes marked with different letter means significantly differentially expressed 
among adipose sites (P < 0.05). X-axis: official gene symbol from NCBI website. Y-axis: 
relative mRNA expression value from natural logarithmic transformed data. Black column 
indicates CON; grey column indicates OVE treatment.  
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Figure 2.3. Main effect of dietary energy intake on mRNA expression of cytokines. Genes 
marked with asterisk were significantly differentially expressed between treatments (P < 0.05). 
X-axis: official gene symbol from NCBI website. Y-axis: relative mRNA expression value from 
natural logarithmic transformed data. Black column indicates CON; grey column indicates OVE 
treatment. 
 
  
Gene Symbol
A
D
IP
O
Q
L
E
P
T
N
F
IL
1
B
IL
6
IL
6
R
C
C
L
2
C
C
L
5
T
L
R
4
S
A
A
3
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 l
e
v
e
l
2.0
2.5
3.0
3.5
4.0
4.5
5.0
Control
Overfed
*
*
*
105 
 
 
Figure 2.4. 
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Figure 2.4. (cont.) Putative network and changes in transcription profile of genes in OVE vs. CON cows. Network was 
constructed with Ingenuity Pathway Analysis
®
 (IPA) based on IPA knowledge base that derived from published literature of non-
ruminant species. Several putative relationships were edited according to recently published literature, which includes LCFA (palmitic 
and stearic acid) as endogenous ligands of TLR4 (Shi et al., 2006) and PPARγ (Kadegowda et al., 2009). Two hormones (insulin and 
thyroid hormone) were incorporated due to their potential role in regulation of gene expression. Although not measured, NFκB was 
included in the network as it has a well-characterized role in regulating transcription of inflammation-related genes. Genes marked in 
black denote up-regulation and white down-regulation (P < 0.05; OVE vs. CON); genes in gray had no statistical change in mRNA 
expression between treatments. Letters along the edges denote effects on activity (A), expression (E), regulation of binding (RB), 
protein-DNA binding (PD), and transcription (T). 
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A. Average expression stability values of remaining control genes 
 
B. Determination of the optimal number of control genes for normalization 
Figure S2.1. Panel A, average expression stability M of remaining genes tested in the pairwise 
comparison. M was calculated by stepwise exclusion of the least stable gene. KEAP1, TRIM41, 
and MRP63 were the most stable ones; whereas, LGALS4, UQCRC2, and CREB3 were the least 
stable genes. Panel B, optimal number of ICG for normalization. Y-axis, variation between 
normalization factor by using n ICG (NFn) and the NF from (n + 1) ICG (NFn+1); X-axis, 
pairwise comparison using (n + 1) ICG replacing n ICG. Although the analysis indicated that 9 
ICG was optimal in our study (panel B), it was evident that using fewer than 9 ICG would still 
result in a threshold <0.10 which was deemed optimal (Bionaz and Loor, 2007). Thus, on 
practical grounds we elected to use the geometric mean of the 3 most stable genes, i.e., KEAP1, 
TRIM41, and MRP63 as ICG.     
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CHAPTER 3 
 
INFLAMMATION- AND LIPID METABOLISM-RELATED GENE NETWORK 
SIGNATURES IN VISCERAL AND SUBCUTANEOUS ADIPOSE DEPOTS OF DAIRY 
COWS 
 
ABSTRACT 
We examined mRNA expression of 27 genes in mesenteric (MAT), omental (OAT), and 
subcutaneous (SAT) adipose tissue from nonpregnant and nonlactating Holstein cows in 
response to control (CON, NEL= 1.35 Mcal/kg DM) or overfeeding energy (OVE, NEL= 1.62/kg 
DM). Eighteen cows were randomly assigned to one of the two treatment groups. After an 8-wk 
feeding period, AT were harvested, weighed, and subsamples for RNA extraction were collected 
from depots immediately after euthanasia. Genes involved in lipogenesis, triglyceride (TAG) 
synthesis, lipolysis, transcriptional regulation of lipogenesis, and adipose secreted proteins were 
analyzed via quantitative PCR (qPCR). The interaction of dietary energy and AT depot was not 
significant for any gene analyzed. In the present work, we report depot-specific differences in 
gene expression patterns. The mRNA expression of ACACA and FASN was significantly higher 
(P < 0.05) in SAT than MAT. Expression of SCD and ADFP was greatest in SAT, intermediate 
in MAT, and lowest in OAT. However, the two visceral depots had greater expression of THRSP, 
ACLY, LPL, FABP4, GPAM, and LPIN1 in comparison with SAT (P < 0.05).  The transcription 
factor SREBF1 had higher expression in MAT and SAT than OAT (P < 0.05). Among AT-
secreted proteins, visceral depots had higher (P < 0.05) expression of adipokines (leptin and 
adiponectin) and serum amyloid A3 (SAA3) compared with SAT.  However, MAT had higher 
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expression than SAT (P < 0.05) of pro-inflammatory cytokines (IL1B and IL6), IL6 receptor 
(IL6R) and chemokines (CCL2 and CCL5); whereas, TNF was higher in SAT than OAT, and 
intermediate in MAT (P < 0.05). Overall results suggested that visceral AT may be more active 
in uptake of preformed FA than SAT. In contrast, de novo FA synthesis could make a greater 
contribution to the intracellular FA pool in SAT than visceral AT. The visceral AT seemed to 
have a greater capacity for expressing and likely secreting pro-inflammatory cytokines than SAT; 
thus, visceral obesity due to overfeeding energy may be detrimental to liver health in dairy cows.  
Key words: adipose, gene expression, inflammation, lipogenesis, overfeeding energy, visceral  
 
INTRODUCTION 
Adipose tissue (AT) was first recognized to function as an ―energy reservoir‖ in the form 
of triacylglycerol (TAG) when there was a surplus of nutrients or as provider of energy in the 
form of long-chain fatty acids (LCFA) during periods of intense lipolysis as it occurs in negative 
energy balance (NEB). In non-lactating ruminants AT does not only take up preformed FA from 
blood but is the primary site of de novo FA synthesis (DNS) as well (Bergen and Mersmann, 
2005). In non-ruminant species (mainly human and rodents) it is well-established that 
metabolism of visceral AT (VAT) is different from subcutaneous AT (SAT) (Smith and 
Zachwieja, 1999), e.g., VAT is more sensitive to lipolytic stimuli (e.g. catecholamines) but less 
so to anti-lipolytic stimulation by insulin (Hellmer et al., 1992; Giorgino et al., 2005); Although, 
in dairy cows, the metabolic activity of SAT (McNamara, 1995) and VAT (Baldwin et al., 2004) 
changes with stage of lactation and availability of dietary energy, it is still unclear whether 
dietary energy intake differentially impacts the metabolism (lipogenesis and lipolysis) of VAT 
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and SAT. Hence, more research is necessary to further explore fundamental aspects of metabolic 
regulation in SAT and VAT in ruminants.  
The endocrine function of adipose tissue was not recognized until the discovery of leptin 
(LEP) in 1994, a protein that was initially identified as a feedback signal of AT to regulate food 
intake and energy expenditure in rodents (Zhang et al., 1994). Subsequent work identified a 
series of protein products secreted by AT including adiponectin (ADIPOQ), TNF, IL6, resistin, 
and chemokines (e.g. CCL2) (See review in Sethi and Vidal-Puig, 2007). Many of these products 
are classical pro-inflammatory cytokines. Studies in humans demonstrated that VAT had greater 
capability for secretion of these cytokines and is more susceptible to infiltration of macrophages 
than SAT (Weisberg et al., 2003; Pou et al., 2007). Furthermore, accumulating evidence 
indicated that obesity and insulin resistance are associated with a chronic proinflammatory 
response leading to increased cytokine production and activation of inflammatory signaling 
pathways (See review in Tilg and Moschen, 2008). Although the effect of dietary energy 
overfeeding on inflammatory status in dairy cows has not been well documented, a recent study 
provided evidence that SAT and VAT are immunoresponsive (Mukesh et al., 2009). Drackley et 
al. (2005) proposed that because of direct portal drainage of VAT, an increase in cytokine 
secretion by this depot might impact negatively the liver. 
Lipid metabolism pathways (DNS and TAG synthesis) are composed of multiple 
stepwise enzymatic reactions. In addition to well-established post-transcriptional and post-
translational regulation of enzymatic activity to coordinate AT metabolism (e.g., ACACA), 
transcriptional regulation represents a long-term mechanism of cellular metabolism (Desvergne 
et al., 2006). Proteins secreted by AT (e.g., ADIPOQ, LEP) are primarily regulated at the level of 
transcription (Berger and Moller, 2002).  Therefore, evaluation of mRNA expression of genes 
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encoding enzymes that participate in metabolic pathways, especially the ones catalyzing rate-
limiting steps, is of value (Bionaz and Loor, 2008). The objectives of this study were to 
investigate how overfeeding a moderate-energy diet impacts fat deposition in VAT, and to 
determine fat depot-specific adipogenic, lipogenic, and immune-related gene expression. Those 
data were related with blood metabolites and tissue mass in order to gain a more holistic view of 
the biological phenomena. 
 
MATERIALS AND METHODS 
Experimental Design, Animals, Diets, and Sampling 
Experimental Design. Eighteen nonpregnant, nonlactating Holstein cows [body weight 
(BW) = 656  29; body condition score (BCS) = 3.04 ± 0.25] were randomly assigned to either a 
moderate-energy diet (OVE; NEL = 1.62 Mcal/kg DM) or controlled-energy diet (CON; NEL = 
1.35 Mcal/kg DM) provided as a TMR for ad libitum intake. The OVE diet contained 73.8% 
forage (without wheat straw) and 13.8% ground shelled corn (DM basis); the CON diet 
contained 81.7% forage including 40.5% wheat straw and 3.5% ground shelled corn. The TMR 
was mixed and processed in a Keenan Klassik 140 mixer wagon (Richard Keenan & Co., Ltd., 
Borris, County Carlow, Ireland) and offered once daily at 0800 h. Cows had free access to water. 
Initial and final BW was recorded at the start of wk 1 and end of wk 8. The experiment was 
conducted in an indoor free-stall barn equipped with Calan gates to monitor individual feed 
intake. Experimental procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois (protocol 06194). 
Tissue Sampling. After the 8-wk experiment, cows were euthanized at the diagnostic 
facilities of the College of Veterinary Medicine, University of Illinois. .  All AT samples were 
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harvested within 20 min of euthanasia and were snap-frozen in liquid N2 until RNA extraction.  
Subcutaneous AT was harvested from the tail-head region on the left side of each cow.  
Mesenteric, omental, and perirenal AT depots were carefully dissected, weighed, and a 
subsample collected for RNA extraction.   
RNA Extraction and Quality Assessment, Primer Design and Evaluation, Internal Control 
Gene (ICG) Selection, and Quantitative RT-PCR (qPCR) 
RNA Extraction, Quality Assessment, and cDNA Preparation. Adipose tissue was 
weighed (~2.0 g) and immediately placed into ~15 mL ice-cold TRIzol
®
 Reagent (Invitrogen, 
Carlsbad, CA) with 1 µL linear acrylamide (Ambion, Inc., Austin, TX) for extraction of total 
RNA as previously described (Loor et al., 2005). Total RNA was cleaned using RNeasy mini kit 
columns and genomic DNA was removed using the RNase-Free DNase Set (Qiagen, Valencia, 
CA). The RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies). The purity of RNA was assessed by ratio of optical density 
OD260/280, which was above 1.9 for all samples. Integrity of RNA (RIN) was tested by 
electrophoretic analysis of 28S and 18S rRNA subunits using a 2100 Bioanalyzer (Agilent 
Technologies); values were >7.0 for all samples. A portion of the RNA was diluted to 100 ng/µL 
with DNase-RNase free water prior to RT for cDNA synthesis. The cDNA were synthesized 
using 100 ng RNA, 1 µg dT18 (Operon Biotechnologies, AL), 1 µL 10 mM dNTP mix 
(Invitrogen Corp., CA), 1 µL Random Primers (Invitrogen Corp., CA), and 10 µL DNase/RNase 
free water. The mixture was incubated at 65°C for 5 min and kept on ice for 3 min. A total of 6 
µL of master mix composed of 4.5 µL 5X First-Strand Buffer, 1 µL 0.1 M DTT, 0.25 µL (50 U) 
of SuperScript
TM
 III RT (Invitrogen Corp.,CA), and 0.25 µL of RNase Inhibitor (10 U, Promega, 
WI) was added. The reaction was performed in an Eppendorf Mastercycler
®
 Gradient with the 
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following temperature program: 25°C for 5 min, 50°C for 60 min, and 70°C for 15 min. The 
cDNA was then diluted 1:4 with DNase/RNase free water.  
Primer Design and Evaluation. Primers were designed and evaluated as previously 
described (Bionaz and Loor, 2008). The details of primer sequences and the description of genes 
are the same as shown in Table 2.2 and Supplemental Table S2.1 and S2.2. Primers were 
designed using Primer Express 3.0 with minimum amplicon size of 80 bp (amplicons of 100 -120 
bp were preferable, if possible) and limited 3‘ G + C percentage (Applied Biosystems, CA). 
Primer sets were intentionally designed to fall across exon-exon junctions. Then, primers were 
aligned against NCBI database through BLASTN and UCSC‘s COW (Bos taurus) Genome 
Browser Gateway to determine the compatibility of primers with already annotated sequence of 
the corresponding gene in both databases. Prior to qPCR, primers were verified through a 20 µL-
PCR reaction that followed the same procedures of qPCR described below except the 
dissociation step. A universal reference cDNA amplified from 3 bovine adipose tissues (SAT, 
mesenteric, and omental AT) was utilized to ensure the identification of genes. Five µL of PCR 
product was run in a 2% agarose gel stained with ethidium bromide, and the remaining 15 µL 
were cleaned with a QIAquick
®
 PCR Purification Kit (QIAGEN) and sequenced at the Core 
DNA Sequencing Facility of the Roy J. Carver Biotechnology Center at the University of Illinois, 
Urbana (the same as in Supplement Table S2.2). The sequencing product was confirmed through 
BLASTN at the National Center for Biotechnology Information (NCBI) database. Only primers 
that presented a single band of the expected size and the right amplification product were used 
for qPCR. The accuracy of a pair of primers was evaluated by the presence of a unique peak 
during the dissociation step at the end of qPCR. 
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Genes evaluated included: acetyl-Coenzyme A carboxylase alpha (ACACA), ATP citrate 
lyase (ACLY), acyl-CoA synthetase long-chain (ACSL1), adipose differentiation-related protein 
(ADFP or PLIN2), thrombospondin receptor (CD36), elongation of long chain fatty acids family 
member 6 (ELOVL6), adipocyte fatty acid binding protein 4 (FABP4), fatty acid synthase 
(FASN), mitochondrial glycerol-3-phosphate acyltransferase (GPAM), hormone-sensitive lipase 
(LIPE), lipin 1 (LPIN1), lipoprotein lipase (LPL), stearoyl-CoA desaturase (SCD), MLX 
interacting protein-like (MLXIPL), peroxisome proliferator-activated receptor gamma (PPARG), 
sterol regulatory element binding transcription factor 1 (SREBF1), thyroid hormone responsive 
SPOT 14 (THRSP), adiponectin (ADIPOQ), chemokine (C-C motif) ligand 2 (CCL2), chemokine 
(C-C motif) ligand 5 (CCL5), interleukin-1 beta (IL1B), interleukin-6 (IL6), interleukin-6 
receptor (IL6R), leptin (LEP), acute-phase serum amyloid A3 (SAA3), toll-like receptor 4 (TLR4), 
and tumor necrosis factor alpha (TNF). 
Quantitative PCR (qPCR). The qPCR analysis was performed in a MicroAmp
TM
 Optical 
384-Well Reaction Plate (Applied Biosystems, CA). Within each well, 4 µL diluted cDNA 
combined with 6 µL of mixture composed of 5 µL 1×SYBR Green master mix (Applied 
Biosystems, CA), 0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL DNase/RNase 
free water were added. Three replicates and a 6-point standard curve plus the non-template 
control (NTC) were run for each sample to test the relative expression level (User Bulletin #2, 
Applied Biosystems, CA). The qPCR reactions were conducted in an ABI Prism 7900 HT SDS 
instrument (Applied Biosystems, CA) with the following conditions: 2 min at 50 °C, 10 min at 
95 °C, 40 cycles of 15 s at 95 °C (denaturation), and 1 min at 60 °C (annealing + extension). The 
presence of a single PCR product was verified by the dissociation protocol using incremental 
temperatures to 95 °C for 15 s, then 65 °C for 15 s. 
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Internal Control Gene (ICG) Selection and Evaluation. A detailed description for the 
selection criteria of ICG for qPCR has been provided previously (Mukesh et al., 2009).  
Data Processing and Statistical Analysis 
The threshold cycle (Ct) data were analyzed and transformed using the standard curve 
with the 7900 HT Sequence Detection System Software (version 2.2.1, Applied Biosystems, CA). 
Data were then normalized with the geometric mean of the three most stable ICG (Mukesh et al., 
2009).  Analysis (Supplemental Figure S2.1) revealed that genes encoding kelch-like ECH-
associated protein 1 (KEAP1), tripartite motif-containing 41 (TRIM41), and mitochondrial 
ribosomal protein 63 (MRP63) were the most appropriate to calculate a normalization factor to 
normalized gene expression data.  
The normalized PCR data (relative mRNA expression) were subjected to log 
transformation in SAS (SAS Inst. Release 8.0) to ensure a normal distribution of residuals. This 
transformed dataset was analyzed as a 2 × 3 factorial arrangement (diet and tissue source as as 
the two factors) with the PROC GLM procedure in SAS. No significant interactions between the 
two factors were detected in the initial analysis; we excluded the interaction and re-analyzed data 
with only the main effects. The PDIFF statement of SAS was utilized to evaluate differences 
with significance declared at P ≤ 0.05.  
Relative mRNA Abundance of Genes within Adipose Tissue 
  Efficiency of qPCR amplification for each gene (see Table S2.3) was calculated using the 
standard curve method (Efficiency = 10
(-1/slope)
). Relative mRNA abundance among measured 
genes was calculated as previously reported (Bionaz and Loor, 2008), using the inverse of PCR 
efficiency raised to Ct (gene abundance = 1/ECt, where Ct = Ct of tested gene – geometric 
mean Ct of 3 internal control genes). Overall mRNA abundance for each gene among all samples 
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of the same adipose tissue was calculated using the median Ct, and overall percentage relative 
mRNA abundance was computed from the equation: 100 × mRNA abundance of individual gene 
/ sum of mRNA abundance of all genes tested (Table 3.2).     
 
RESULTS AND DISCUSSION 
In the present study, dietary energy intake exerted a consistent impact on gene expression 
in both VAT and SAT depots (chapter 2). Except for a tendency for LPL (P = 0.085), no 
interactions were detected (P > 0.10) between level of dietary energy and AT depot. Therefore, 
our data indicate that differential expression of genes among depots was due to unique 
characteristics of each depot examined. The depot-specific expression pattern of metabolic gene 
networks in ruminant species has not been documented previously. This manuscript deals 
exclusively with differences observed between depots. Our results clearly showed that AT from 
various anatomical sites exhibit different patterns of genes expression. 
Lipogenesis, Elongation, and Desaturation 
 Compared with the two VAT sites, SAT had the highest mRNA expression and % 
mRNA abundance of the classical lipogenic genes ACACA, FASN and SCD (Figure 3.1). The 
differences between SAT and MAT for were significant ACACA and FASN (P < 0.01), and 
among all sites for SCD with intermediate response in OAT (P < 0.02). However, ACLY 
exhibited the opposite expression pattern with higher mRNA abundance in VAT depots than 
SAT (P < 0.05). Expression of ELOVL6 was consistent in the three depots (P > 0.05). Baldwin et 
al. (2007) showed that the pattern of acetate incorporation into intracellular FA and TAG was 
generally greater for SAT as compared with VAT (OAT and MAT). Furthermore, Eguinoa et al. 
(2003) reported that the activity of glycerol-3-phosphate dehydrogenase and FASN was greater 
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in SAT than VAT. Because transcriptional regulation is the primary determinant of protein 
abundance (and likely function) of these genes (Foufelle and Ferre, 2002; Postic et al., 2007), 
together, our results indicate a potentially greater capacity for de novo FA synthesis in SAT than 
VAT depots.  
 Studies in humans and rodents have revealed transcriptional differences in a depot-
specific manner. In a human study, mRNA expression of FASN was 1.7-fold higher in VAT than 
SAT and these differences corresponded with differences in protein level (Berndt et al., 2007). 
Higher FASN and SREBF1 expression was found in inguinal AT than in MAT in rats (Palou et 
al., 2009). Furthermore, Bertile and Raclot (2004) showed delayed and smaller transcriptional 
changes for lipogenic genes (FASN and ACLY) in SAT compared with retroperitoneal AT in 
response to refeeding underfed rats. Despite the above differences among AT depots, in humans 
and rodents liver rather than AT is the major lipogenic organ (Bergen and Mersmann, 2005) and 
glucose absorbed from the gastrointestinal (GI) tract is the major substrate for de novo 
lipogenesis. Therefore, glucose delivery to the VAT prior to reaching SAT may result in 
enhanced transcription of lipogenic genes in VAT. Obvious physiological differences between 
species make it difficult to compare our data with non-ruminant studies.  
 Two classical studies at the University of Illinois shed light on site-specific lipogenic 
activity in ruminants. Ingle et al. (1972a) found that the rate of FA biosynthesis from acetate was 
higher in internal fat (perirenal and OAT) than in SAT (from rump, abdominal, and backfat) in 
lambs. However, a shift in lipogenic capacity between the two sites was uncovered in mature 
animals (sheep and market steers; (Ingle et al., 1972b). Our results supported these early findings 
at the transcriptional level. We speculate that the opposite expression pattern of ACLY between 
VAT and SAT may have been induced by the relatively greater glucose or lactate carbon 
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utilization rate through the citrate cleavage pathway, likely for FA synthesis and provision of 
NADPH. The closer anatomical location of VAT to the GI tract could facilitate absorption of any 
intestinal glucose and lactate, thus, providing more substrate for lipogenesis. 
 Correlation analysis revealed significant (P < 0.05) positive relationships regardless of 
dietary treatment between SCD expression in SAT and the average pre-harvest cow BCS. Martin 
et al. (1999) observed that the peak of SCD mRNA expression preceded a significant rise in 
lipogenesis and lipid filling in SAT of yearling steers, and concluded that the level of SCD 
expression was indicative of the extent of terminal differentiation in bovine tail-head SAT. In our 
study, SCD mRNA expression in MAT and OAT was positively correlated with tissue weight. 
Moreover, SCD mRNA expression in VAT was positively correlated (P < 0.05) with intake of 
net energy for lactation (NEL) at wk 5 and 6, and that relationship also tended (P < 0.10) to be 
significant at wk 7, i.e. prior to slaughter. Hence, overall our results indicate that mRNA 
expression of SCD could be a suitable marker of fat storage in subcutaneous and visceral depots, 
e.g., the transcriptional change of SCD in VAT was more responsive to dietary energy intake 
than SAT (Ji et al., 2009). A key role of SCD in bovine milk fat synthesis has been underscored 
previously (Bionaz and Loor, 2008).  
 The SAT exhibited higher expression of ADFP than the two VAT depots, with the lowest 
value in MAT. Thus, lipid droplet synthesis may differ among fat depots. 
Long-chain Fatty Acid Uptake, Activation, and Esterification 
 Interestingly, LPL, GPAM, and LPIN1 were more abundant in both VAT depots than in 
SAT (P < 0.01). Expression of ACSL1 was greater in MAT than in the other two fat depots (P < 
0.05), while it was numerically higher in OAT than SAT. It appears that VAT has greater 
capacity for utilizing preformed FA for TAG synthesis than SAT. Such a result is in accordance 
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with previous studies. For example, Hocquette et al. (1998) reported that both LPL mRNA 
expression and its enzymatic activity were greater in internal fat (perirenal AT and OAT) than in 
SAT of male calves. Together with our results, this evidence indicates that breed, maturity, and 
physiological status may influence fat deposition through regulation of major enzymes not only 
via the provision of substrate but also transcriptionally.  
 Despite the extensive number of genes we analyzed, it is difficult to make sweeping 
conclusions about priority for AT deposition among depots studied. For example, despite greater 
SAT expression of genes for de novo FA synthesis (ACACA, FASN, and SCD), VAT could 
possibly accumulate more lipid through incorporation of preformed FA due to greater expression 
of LPL, ACSL1, GPAM, and LPIN1. We found no difference in expression of CD36 and LIPE 
among fat depots (P > 0.05). The most abundant transcripts among all genes examined were 
SCD, FABP4, and LPL, which together accounted for ~63.2%, 69.9%, and 71.5% mRNA 
abundance in MAT, OAT, and SAT, respectively (See Table 3.2). Within lipid metabolic-related 
genes SCD had the greatest fold-change across fat depots; the relative mRNA expression in SAT 
was 3-fold that in MAT. The different expression patterns of these genes could be indicative of 
different enrichments of biological processes within AT depots.  
Transcriptional Regulation of Lipogenesis 
As shown in Figure 3.2, SREBF1 was more highly expressed in SAT and MAT than in 
OAT (P < 0.05), whereas PPARG and MLXIPL were consistently expressed among AT depots.  
The transcription factor MLXIPL was reported to control ca. 50% of hepatic lipogenesis in 
rodent liver by regulating glycolytic and lipogenic gene expression (Iizuka and Horikawa, 2008) 
through binding to the carbohydrate response element (ChoRE) in the promoter region of its 
target genes (Yamashita et al., 2001) including THRSP (Shih et al., 1995), ACACA, and FASN 
120 
 
(Towle et al., 1997). The relative % mRNA abundance of MLXIPL (0.02-0.03% of total genes) 
was much less than that of SREBF1 (0.3-0.5%) or PPARG (0.9-1.5%, shown in Table 3.2) across 
the three AT depots, from which we deduced that MLXIPL likely plays a minor role in the 
regulation of lipogenesis in ruminant AT. The consistent mRNA expression level of PPARG 
among all AT sites and its relatively higher mRNA abundance indicated that it may be the key 
transcription regulator driving adipogenesis and lipid filling (see Table 3.2). We speculate that 
PPARG activation via dietary LCFA (e.g., saturated and marine PUFA; Kadegowda et al., 2009) 
could aid in manipulating AT deposition or insulin sensitivity during the transition from 
pregnancy into lactation, i.e., when insulin sensitivity is markedly impaired (Bauman and 
Griinari, 2003). 
Expression of THRSP differed among fat depots with greater values in VAT than in SAT 
(P < 0.05), which underscored its importance in association with other lipogenic genes and 
potentially the adipocyte differentiation status among depots. This depot-specific expression 
pattern is possibly induced by differing numbers of thyroid hormone (TH) receptors (TR) and 
ratios of TR isomers among fat depots, which are required for transcriptional activation of 
THRSP (Cunningham et al., 1998). A recent study revealed a difference in expression of TRα (an 
isomer of TR) and THRSP between SAT and OAT in humans, and a significant correlation of 
THRSP expression with TRα mRNA abundance and with the TRα1/TRα2 ratio (Ortega et al., 
2009). However, contrary to our study, they found higher expression of these genes in SAT than 
in OAT, which could be associated with inherent species differences.  
Adipokines and Immune-related Genes 
Most of the adipocytokines tested exhibited depot-specific expression patterns (figure 
3.3). Adiponectin and SAA3 mRNA expression was higher in both VAT depots than in SAT (P < 
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0.05), with no statistical difference between MAT and OAT. Leptin was differentially expressed 
among the three depots (P < 0.05), with the highest mRNA abundance in OAT and the lowest in 
SAT. The MAT had greater mRNA expression of IL1B and IL6R than the other two depots (P < 
0.05), while there was no difference between OAT and SAT. A similar expression pattern was 
detected for IL6, CCL2, and CCL5 of which the mRNA expression profiles were markedly 
higher in MAT than in SAT (P < 0.05) and intermediate in OAT, with no statistical significance 
between OAT and the other two depots.  Expression of TNF mRNA was greater in SAT than in 
OAT (P < 0.05) and intermediate in MAT, but differences between MAT and the other two 
depots were not significant. Visceral AT depots, especially MAT, appear to have greater capacity 
than SAT to express these adipocytokines, with the exception of TNF. Strong evidence of 
correlative and causative relationships among visceral obesity, systemic low-grade chronic 
inflammation, hepatic disease, and insulin resistance has been found in human and rodent models 
and linked to secretion of adipocytokines (Lionetti et al., 2009). 
Expression of TLR4 was did not differ (P = 0.30) between SAT and the 2 VAT. Recent 
evidence seems to support a causative relationship between metabolic phenotype and immune 
responses of visceral fat, and TLR4 (at least in non-ruminants) appears to be a key molecular link 
(Song et al., 2006; Davis et al., 2008; Kopp et al., 2009). This receptor is the best-characterized 
endogenous sensor for lipopolysaccharide (LPS). Upon binding of LPS to TLR4 and its co-
receptors CD14 and MD-2, the adaptor protein myeloid differentiation factor 88 (MyD88) is 
recruited to the Toll/IL-1 receptor (TIR) domain of the receptor. Interaction of the TIR domain of 
TLR4 and MyD88 triggers a downstream signaling cascade, leading to activation of the NFκB 
pathway, which then activates the transcription of many genes encoding pro-inflammatory 
cytokines, chemokines, and other effectors of the innate immune response (Zuany-Amorim et al., 
122 
 
2002). In non-ruminant AT, both adipocytes and adipose-resident macrophages express TLR4 
(Lin et al., 2000). Stimulation of non-ruminant adipocytes by LPS induces the release of TNF-a, 
IL-6, IL-1β, IL-8, and CCL2 (Kopp et al., 2010). Despite the lack of effect of a 2-h in vitro LPS 
challenge on TLR4 expression in MAT and SAT from nonlactating cows, Mukesh et al. (2009) 
observed higher SAA3, CCL5, and CCL2 mRNA expression in MAT than in SAT, coupled with 
markedly increased expression of TNF and IL6 in both sites after LPS challenge; IL-6 increased 
more prominently in MAT. Therefore, CCL2 rather than TLR4 expression may be a more reliable 
marker of tissue inflammation. Our data for CCL2 (along with IL1B and IL6) seem to support a 
more prominent proinflammatory potential in MAT than SAT. 
  
SUMMARY AND CONCLUSIONS 
Endeavors to decipher the regulatory mechanisms driving metabolism in different AT 
depots have been largely conducted in human and rodent models. The current study established 
the different expression patterns of genes that may control lipid accretion between two visceral 
AT depots and subcutaneous adipose in dairy cows. Thus we have obtained a more holistic 
evaluation of fundamental differences in dairy cows relative to other species. As suggested by 
the greater mRNA expression of pro-inflammatory cytokines (IL1B and IL6), acute phase 
proteins (SAA3), and chemokines (CCL2 and CCL5), our data support the view that increased 
visceral adiposity may predispose dairy cows to more adverse pathophysiological states (e.g., 
inflammation and liver damage). Despite the limitations of deducing physiological changes by 
focusing on transcript profiles, the clear implication of our results supports the hypothesis 
visceral fat metabolism may impact liver health due to the direct portal drainage, and this may be 
much more prominent during the transition from late pregnancy to lactation.  Future research on 
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how nutritional management affects the visceral AT metabolism and its endocrine functions 
during the transition period is warranted. 
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TABLES AND FIGURES 
 
Table 3.1. Ingredients and nutrient composition of diets (% of DM) 
Diet  
     CON  OVE  Ingredent 
0101 17.9 Alfalfa silage     
3.5 6.0 Alfalfa hay 
0.01 50.0 Corn silage 
40.5 0.0 Wheat straw 
3.5 13.8 Ground shelled corn 
-- 5.0 Whole cottonseed 
11.5 4.3 Soybean meal 
001 001 Minerals and Vitamins 
  Nutrient composition 
52.0 50.0 DM, % 
1.35 1.62 NEL, Mcal/kg 
12.0 15.0 CP, % 
54.8 36.7 NDF, % 
50.1 33.0 Forage NDF, % 
36.6 25.8 ADF, % 
26.2 38.7 NFC, % 
2.2 3.7 Fat, % 
NFC, non-fiber carbohydrate = 100 – (%CP + %NDF + %Fat + %ash). 
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Table 3.2. Gene symbol, name and percentage of mRNA abundance among all genes 
investigated in each adipose tissue site 
Gene 
Symbol 
Gene Name in NCBI 
% mRNA in 
MAT 
% mRNA in 
OAT 
% mRNA in 
SAT 
Fatty acid and triglyceride metabolism 
ACACA acetyl-Coenzyme A carboxylase alpha 0.41 0.58 0.77 
ACLY ATP citrate lyase 0.10 0.09 0.07 
ACSL1 acyl-CoA synthetase long-chain 0.94 0.41 0.41 
ADFP 
(PLIN2) 
adipose differentiation-related protein 2.15 2.37 2.44 
CD36 thrombospondin receptor 8.54 5.89 6.97 
ELOVL6 elongation of long chain fatty acids 0.51 0.58 0.59 
FABP4 adipocyte fatty acid binding protein 4 33.44 22.84 18.90 
FASN fatty acid synthase 2.73 4.29 4.25 
GPAM glycerol-3-phosphate acyltransferase 0.52 0.41 0.28 
LIPE hormone-sensitive lipase 4.37 2.91 3.27 
LPIN1 lipin 1 0.89 0.44 0.22 
LPL lipoprotein lipase 13.38 10.95 7.15 
SCD stearoyl-CoA desaturase 16.36 36.11 45.37 
Transcriptional regulation of lipogenesis 
MLXIPL MLX interacting protein-like 0.03 0.02 0.02 
PPARG 
peroxisome proliferator-activated 
receptor gamma 
1.50 1.10 0.93 
SREBF1 
sterol regulatory element binding 
transcription factor 1 
0.56 0.35 0.41 
THRSP thyroid hormone responsive SPOT 14 5.79 5.50 4.26 
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Table 3.2. (cont.) 
Gene 
Symbol 
Gene Name in NCBI 
% mRNA in 
MAT 
% mRNA in 
OAT 
% mRNA in 
SAT 
Adipokine and proinflammatory cytokines 
ADIPOQ adiponectin 6.04 3.85 2.67 
CCL2 chemokine (C-C motif) ligand 2 0.07 0.03 0.04 
CCL5 chemokine (C-C motif) ligand 5 0.04 0.03 0.02 
IL1B interleukin-1 beta 0.01 < 0.01 < 0.01 
IL6 interleukin-6 0.02 0.02 0.02 
IL6R Interleukin-6 receptor 1.11 0.64 0.66 
LEP leptin 0.38 0.50 0.26 
SAA3 acute-phase serum amyloid A3 0.03 0.03 < 0.01 
TLR4 toll-like receptor 4 0.06 0.04 0.03 
TNF tumor necrosis factor alpha 0.01 0.01 0.01 
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Table 3.3. Correlation analysis of SCD and LEP mRNA level with BCS and tissue weight.  
Y-variable X-variable 
Correlation 
coefficient 
P-value 
Ave. pre-harvest BCS SCD mRNA in SAT 0.571 0.021 
 LEP mRNA in SAT 0.57 0.022 
MAT weight SCD mRNA in MAT 0.503 0.047 
 LEP mRNA in MAT 0.52 0.038 
OAT weight SCD mRNA in OAT 0.607 0.013 
 LEP mRNA in OAT 0.44 0.085 
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Figure 3.1. Main effect of adipose site on mRNA expression of genes involved in lipid 
metabolism. Genes marked with different letter means significant differences in expression 
among adipose sites (P < 0.05). X-axis: official gene symbol from NCBI website. Y-axis: 
relative mRNA expression value from natural logarithmic transformed data. Black column stands 
for MAT; dark grey column stands for OAT; light grey column stands for SAT. 
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Figure 3.2. Main effect of adipose site on mRNA expression of transcriptional regulator 
genes. Genes marked with asterisk means significant differences in expression among adipose 
sites (P < 0.05). X-axis: official gene symbol from NCBI website. Y-axis: relative mRNA 
expression value from natural logarithmic transformed data. Black column stands for MAT; dark 
grey column stands for OAT; light grey column stands for SAT. 
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Figure 3.3. Main effect of adipose site on mRNA expression of cytokines. Genes marked with 
different letter means significant difference in expression among adipose sites (P < 0.05). X-axis: 
official gene symbol from NCBI website. Y-axis: relative mRNA expression value from natural 
logarithmic transformed data. Black column stands for MAT; dark grey column stands for OAT; 
light grey column stands for SAT.
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CHAPTER 4 
 
TRANSCRIPTIONAL CHANGES IN MESENTERIC AND SUBCUTANEOUS ADIPOSE 
TISSUE FROM HOLSTEIN COWS IN RESPONSE TO PLANE OF DIETARY ENERGY 
 
ABSTRACT 
The transcriptional machinery of cow adipose tissue depots and the role of dietary energy 
on gene networks remain poorly characterized. Effects of overfeeding (OVE) or controlled 
(CON) dietary energy on mesenteric (MAT) and subcutaneous (SAT) adipose tissue transcript 
profiles were assessed in 10 non-pregnant non-lactating cows  The RNA from SAT and MES 
were used for microarray analysis with a 13,000-sequence annotated bovine oligonucleotide 
microarray. Statistical analysis revealed 409 and 310 differentially expressed genes (DEG) due 
to tissue sites and diets. Data mining was conducted with GeneSpring GX7 and DAVID 
Bioinformatics Resources 6.7 for functional analysis (categorized based on Gene Ontology [GO] 
as biological process [Bp], cellular component [Cc], or molecular function [Mf]) and Dynamic 
Impact Approach (DIA) for pathway analysis based on KEGG PATHWAY Database. The most 
enriched functions and pathways were screened based on the DEG and secondary criteria of each 
analysis. FLUX and IMPACT indices were calculated in DIA analysis with balanced 
consideration of fold-change, P-value and number of DEG participating in the function and 
pathway. Visual-friendly chart-tables were composed to summarize the most-enriched functions 
and pathways. Functional analysis from both GeneSpring and DIA analysis revealed that the 
extracellular region (primarily relating to type I collagen) and cytoskeleton structure (relating to 
actin filaments) were overrepresented as the signature difference in Cc between SAT and MES 
depots. Vasculature development, regulation of protein metabolism, and carboxylic acid 
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metabolism were the most-enriched Bp in the comparison between fat depots, whereas 
overfeeding energy significantly upregulated the gene sets associated with Bp of cell-substrate 
and cell-matrix adhesion, response to extracellular stimuli, and Mitogen-activated protein kinase 
(MAPK) signaling. The most overrepresented and biologically relevant pathways in comparison 
of adipose sites were extracellular matrix (ECM)-receptor interaction, focal adhesion, 
adipocytokine signaling, butyrate metabolism, glycolysis/gluconeogenesis, sphingolipid 
metabolism, and amino acid metabolism. Excess energy consumption significantly impacted the 
following pathways in AT: immune cell trafficking and signaling, metabolism of xenobiotics by 
cytochrome P450, and MAPK signaling pathway (not in the list of ―top IMPACT‖, but 
biologically relevant). Our bioinformatics results unveiled the distinct DEG between 
subcutaneous and visceral AT, which from a transcriptional perspective may implicate different 
ECM and cytoskeleton structure, angiogenesis activity, and LCFA metabolism in MES vs. SAT. 
In addition to potentially increased lipogenesis activity, another prominent consequence in AT 
induced by long-term energy overfeeding is cell apoptosis, immune cell recruitment, and 
stimulation of local inflammation. Therefore, we conclude that adipocytes from SAT may 
respond to external stimuli differently than those from MES due to the distinct ECM and cell 
skeleton structure, and overfeeding energy may compromise animal health by stimulating local 
inflammation in AT and secondary systemic inflammation.   
 
 
INTRODUCTION  
 Dairy cows can readily overconsume dietary energy during most of the dry period. 
Studies conducted by different research groups found, in comparison with controlled or restricted 
energy feeding, excess prepartal energy intake (particularly from high NFC diet) induced higher 
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prepartal concentrations of insulin and glucose and was associated with greater peripartal 
lipolysis, which subsequently resulted in greater hepatic lipid accumulation at the onset of 
lactation and compromised animal health (Holtenius et al., 2003; Dann et al., 2006; Janovick et 
al., 2011). Obviously, adipose tissue metabolism was differentially regulated in overfed dairy 
cows in those studies. Furthermore, decreased AT responsiveness to insulin was proposed as the 
reason for negative effects on animal performance, which is analogous to obesity-induced Type 
II diabetes in humans and rodent models.  
 Adipose tissue is not simply a metabolic tissue active in regulating whole body energy 
homeostasis, but also plays an important endocrine function by secretion of a number of proteins 
with signaling properties that are involved in regulation of metabolism (e.g., adiponectin, leptin), 
feed intake (leptin), and immune function and inflammation (TNF-α, IL-1 et al.) (Rosen and 
MacDougald, 2006). A growing body of literature based on rodents or humans has demonstrated 
a causal connection between overnutrition-induced obesity (mainly excess energy consumption) 
and chronic low-grade inflammation, which triggers a variety of metabolic disorders, such as 
non-alcoholic fatty liver and Type II diabetes (Tilg and Moschen, 2008).  
 Despite the dominance of mature adipocytes, AT is also composed of immune cells (e.g., 
macrophages) and stromal-vascular cell fractions containing preadipocytes, endothelial cells, and 
mesenchymal stem cells, which may vary in their response to external stimuli (such as nutrient 
supply) and immune activation. Differences between VAT and SAT in proportion of cell types, 
capillary network, lipid storage capacity, endocrine activity, and responsiveness to lipolytic 
stimuli have been documented in humans and rodents (Ibrahim, 2010). Excessive visceral 
obesity was reported to be more detrimental to liver health due to the direct portal drainage of 
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metabolites and cytokines from VAT (Tiniakos et al., 2010). However, less information is 
available regarding AT depot-specific metabolism and endocrine traits in dairy cows.  
 Microarray techniques enable detection of changes in thousands of genes simultaneously, 
which enables a more holistic picture of tissue metabolic changes from a transcriptional 
perspective. More than that, the combined utilization of bioinformatics analysis (software and 
methodology) helps identify the most enriched biological functions, pathways, and physiological 
changes under certain metabolic states. As case in point, Weisberg et al. (2003) utilized 
microarray analysis to profile gene expression in perigonadal adipose from mice in which 
adiposity varied due to sex, diet, and obesity-related mutations. They identified 1304 transcripts 
that were significantly correlated with body mass. Among the top 100 correlated genes, 30% 
encode proteins of macrophages.  
 In the current study, we utilized GeneSpring, DAVID, and KEGG bioinformatics 
software and the dynamic impact approach (DIA) analysis developed by our group to identify the 
most enriched GO functions and pathways in MES and SAT of multiparous dairy cows in 
response to 8 wk of energy overfeeding.  
 
MATERIALS AND METHODS 
Animals and Tissue Sample Collection 
The study used a subset of 10 cows from a larger study (Nikkhah et al., 2008) consisting 
of 18 non-pregnant and non-lactating Holstein cows (BW = 656 ± 29; BCS = 3.04 ± 0.25) from 
the University of Illinois Dairy Research Unit.  Cows were fed diets containing either 1.35 
Mcal/kg NEL (DM basis) as a low energy group (CON) or 1.62 Mcal/kg NEL as a moderate 
energy group (OVE) for 8 wk before slaughter and tissue collection.  Subsamples of 
subcutaneous and mesenteric adipose were harvested immediately post-slaughter and snap-
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frozen in liquid-N until the RNA extraction. All live-animal experimental procedures were 
approved by the Institutional Animal Care and Use Committee at the University of Illinois. 
RNA Extraction 
Subsequently, tissue slices (~2 g) were transferred to a tube containing ice-cold Trizol 
(Invitrogen Corp., San Diego, CA) reagent and immediately subjected to RNA extraction as 
previously described in chapter 2 and using the method published by Loor et al.(2005).  Genomic 
DNA was removed from RNA with DNase (Qiagen, Valencia, CA) using RNeasy Mini Kit 
columns (Qiagen). Integrity of RNA (RIN) was assessed by electrophoretic analysis of 28S and 
18S rRNA subunits.  The RNA concentration was measured using a NanoDrop ND-1000 
spectrophotometer (www.nanodrop.com). The purity of RNA (A260/A280) was above 1.9.   
Microarray Protocol 
We used a 13,257 annotated bovine oligonucleotide microarray containing >10,000 
unique elements, which is publicly accessible in the National Center for Biotechnology 
Information (NCBI) Gene Expression Omnibus (GEO) database (GSE16426) (Loor et al., 2007). 
Hybridizations were performed in a dye-swap reference design. The reference sample was made 
by pooling RNA from several bovine adipose tissues (SAT, OAT, and MAT). The cDNA were 
obtained by reverse transcriptase in a 30 μL reaction containing 8 µg RNA, 2 µL of random 
hexamer primers (3 g/L; Invitrogen Corp., CA), 1 µg oligo dT18 (Operon Biotechnologies, 
Huntsville, AL), and DNase-RNase-free water to a volume of 17.78 μL. The mixture was 
incubated at 65°C for 5 min and kept on ice for 3 min. To the mixture were added 12.2 µL 
solution composed of 6 µL 5X First-Strand Buffer, 3 µL 0.1 M DTT, 0.6 µL 100 mM dNTP mix 
(Invitrogen Corp.), 0.12 μL of 50 mM 5-(3-aminoallyl)-dUTP (Ambion, CA), 2 µL (100 U) of 
SuperScriptTM III RT (Invitrogen Corp.), and 0.5 µL of RNase Inhibitor (Promega, Agora, WI). 
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The reaction was performed at 23 °C for 1 min and 46 °C for 9 h.  The cDNA obtained was then 
treated with 10 µL 1 M NaOH and incubated for 15 min at 65 °C to remove residual RNA. The 
solution was neutralized by adding 10 µL of 1 M HCl. The unincorporated 5-(3-aminoallyl)-
dUTP and free amines were removed using a Qiagen PCR Purification Kit (Qiagen). Clean 
cDNA was dried and resuspended in 4.5 µL of 0.1 M Na2CO3 buffer (pH 9.0) and 4.5 µL of 
Amersham CyDye™ fluorescent dyes diluted in 60 µL of DMSO (Cy3 or Cy5; GE Healthcare, 
Waukesha, WI, USA). Binding of Cy dyes with 5-(3-aminoallyl)-dUTP incorporated into cDNA 
was obtained by incubation at room temperature for 1 h. The unbound dyes were removed using 
a Qiagen PCR Purification Kit (Qiagen) and clean labelled cDNA was measured by means of a 
NanoDrop ND-1000 spectrophotometer. Sample and reference were then vacuum-dried in the 
dark.  
Microarray Hybridization and Image Acquisition  
Prior to hybridization, slides were re-hydrated, placed in an UV cross-linker, washed with 
0.2% SDS solution, thoroughly rinsed with purified water to remove un-bound oligonucleotide, 
and pre-hybridized using a solution containing 1% albumin, 5 × SCC, and 0.1% SDS at 42 C 
for ≥45 min with the aim of  decreasing background. After pre-hybridization, slides were rinsed 
with abundant purified water, immersed in isopropanol for ~10 s, and spin-dried. Dried slides 
were immediately hybridized in a dye-swap-reference design (i.e., each sample was labeled 
twice with each of the two dyes and hybridized in each slide with the reference labeled with the 
opposite dye). Labeled cDNA of the sample was re-hydrated with 80 µL of hybridization buffer 
#1 (Ambion, Austin, TX) and mixed thoroughly. This solution was used to re-suspend the 
reference sample labeled with the opposite dye and mixed thoroughly in order to obtain a 
homogenous solution of the two labeled cDNA. Before hybridization, the labeled cDNA 
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resuspension of the sample + reference was incubated at 90-95 C for ca. 3 min to allow for 
cDNA denaturation to increase the efficiency of binding of oligos to the slide. 
 Hybridizations were carried out using humidified slide chambers (Corning, Lowell, MA) 
with cover slips (LifterSlip; Thermo Scientific, Billerica, MA) at 42 C for ca. 40 hours in the 
dark. After hybridization, slides were removed from the chamber and washed for 5 min by 
agitation 3 times with wash buffers in the following order: 1 × SSC and 0.2% SDS solution 
preheated at 42 C, 0.1 × SSC and 0.2% SDS solution, and 0.1 × SSC solution. Lastly, slides 
were inserted into a 50-mL tube, spin-dried and gassed with Argon to preserve dye from 
bleaching. Arrays were scanned with a ScanArray 4000 (GSI-Lumonics, Billerica, MA) dual-
laser confocal scanner and images were processed and edited using GenePix 6.0 (Axon 
Instruments). Array quality was assessed using an in-house parser written in Perl language as 
previously described (Loor et al., 2007). Spots that received a -100 flag by GenePix 6.0 were 
removed from further analysis and background intensity was subtracted from the foreground 
intensity. Spots on the slide were considered ―good‖ if the median intensity was ≥ 3  standard 
deviations above median background for each channel (i.e., dye). Spots were flagged ―present‖ 
when both dyes passed the criteria, ―marginal‖ if only one dye passed the criteria, or ―absent‖ 
when both dyes failed to pass the criteria. Statistical analysis was conducted on oligos that were 
flagged as ―present‖ and ―marginal‖. 
Quantitative PCR for Microarray Verification  
The protocols for cDNA synthesis, real time RT-PCR, primer design, and testing have 
been previously described in detail (Bionaz and Loor, 2008; see chapter 4). The relative 
expression levels of 29 genes whose protein products associate with lipid metabolism, 
inflammation, and insulin signaling were determined through qPCR. Initial PCR data was 
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normalized with the geometric mean of 3 pre-determined internal control genes, namely TRIM41, 
KEAP1, and MRP63. Finally, the LSmean of relative gene expression levels of mesenteric 
adipose and samples from OVE were transformed to fold-difference relative to subcutaneous 
adipose and sample from CON group, respectively. Table 4.3 shows the fold change of 29 genes 
analyzed by qPCR and microarray.  
Statistical Analysis  
Data from a total of 20 microarrays were normalized for dye and array effects (i.e., 
Lowess normalization and array centering and scaling) and used for statistical analysis. A mixed 
effects model was then fitted to the adjusted ratios (adipose/reference) of each oligonucleotide 
using Proc MIXED (SAS Inst., Cary, NC). The model consisted of the classification factors 
tissue (SAT, MES), diet (CON, OVE), and dye (Cy3, Cy5) as fixed effects, and cow as a random 
variable. The overall effect of diet and tissue was computed. The mean of the two spots for each 
oligonucleotide within each array and between dye-swap arrays was not averaged prior to 
statistical analysis. Benjamini and Hochberg‘s false discovery rate (FDR) was used to adjust for 
the number of comparisons, and significance was declared at FDR ≤ 0.2 (adjusted P-value). For 
qPCR verification, a 2 × 2 factorial arrangement in GLM model was used with tissue and diet as 
the two factors. The significance due to main effects was declared at P ≤ 0.10.  
Data Mining  
Functional Analysis (Gene Ontology (GO)) via GeneSpring GX7:  
 The initial functional analysis was performed by means of GeneSpring GX7 with the 
annotation updated on March 3, 2009 by the automatic annotation feature in GeneSpring GX7 
using GeneBank accession numbers. Out of 13,257 total oligos, the updated GO had 7,710 
annotated oligos with a category of Biological process (Bp), 7,765 with a Cellular component 
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(Cc), and 8,327 with a Molecular function (Mf). The identification of significantly (P < 0.05) 
enriched GO categories was obtained by the calculation of a hypergeometric P-value without 
multiple testing correction, which is a measure of the statistical significance of the overlap 
between the number of genes in the selected list and all the genes on the array platform assigned 
to that category (i.e., the likelihood that it is a coincidence that genes in the list were in both the 
gene list and the category).  The statistical results of the microarray data were uploaded into the 
software and an FDR ≤ 0.2 was set as the criterion to identify the DEG. The following were used 
to uncover enriched Bp, Cc, and Mf among the DEG: main effect of diet (DEG = 310) and main 
effect of tissue (DEG = 409); up-regulated DEG in OVE (201) vs. CON (109); and up-regulated 
DEG in MAT (242) vs. SAT (167).  
Criteria Used to Interpret the GO Categories and Build GO Figures:  
The GO analysis in GeneSpring GX7 provided a P-value and the number of genes in 
each sub-category to highlight the Bp, Mf, or Cc that were significantly enriched by the genes in 
the list. A criterion of FDR ≤ 0.2 from the original SAS output was used to declare genes as 
being significant (DEG). Subsequently, a total of 6 gene lists were uploaded into GeneSpring 
GX7: the overall DEG in diet and tissue comparison; the up-regulated DEG due to either OVE or 
CON; and the up-regulated DEG in either MAT or SAT. The most representative list was the 
overall DEG, which included both up- and downregulated DEG in the comparison, and the final 
interpretation of the data was based on this. The list of GO categories with associated P-values 
allowed the evaluation of the enrichment of GO categories but did not facilitate the 
understanding of which tissue or diet contributes more to a biological response. The separate 
analysis of DEG in each diet and tissue overcame that limitation.  
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Using the Pivot Table function in Microsoft Excel software we clustered all the GO 
categories in the overall list and the upregulated DEG lists in separate tissues and diet 
simultaneously that were significantly enriched (P-value ≤ 0.05) and had more than one DEG. 
For example, we can conclude that the change in a Bp within the overall tissue effect was 
primarily due to MES if more DEG that participated in the biological process appeared in MES 
rather than SAT. We also used different colors to denote different degrees of significance.  
Functional Analysis via DIA Analysis Based on DAVID Bioinformatics Resources 6.7:  
See Supplemental materials and methods. 
Pathway Analysis via Dynamic Impact Approach (DIA) Using KEGG Database:  
Preparation of reference KEGG pathway dataset was according to the following steps:  
1. The KEGG pathway database for each Entrez gene ID of Bos taurus was downloaded 
from the KEGG website: http://www.genome.jp/kegg/download/.  
2. The total number of molecules present in each pathway and represented in the array 
platform was calculated. An input file that can work in keggarray.exe was prepared which has 
the entire list of genes present in the array.  
3. The main categories and sub-categories were downloaded from the KEGG website: 
http://www.genome.jp/kegg/pathway.htmland were Copied and pasted in a new Excel sheet. 
There were a total of 6 main categories, namely Metabolism, Genetic information processing, 
Environmental information processing, Cellular processes, Organismal systems, and Human 
diseases.  
DIA analysis of array data was according to the following steps:  
1. The original data were copied in separate columns for oligo ID, Entrez gene ID, fold 
change (FC), FDR, and P-value of each comparison into a new Excel file. FC was expressed in 
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the form of a ratio, which means all upregulated genes have FC >1 and all downregulated genes 
have FC < 1. We determined the DEG with FDR cut-off value of 0.2, so all the genes with FDR > 
0.2 were removed from dataset.  
2. The DEG were matched with KEGG path ID, so that each path ID  had a fold change 
and P-value for all DEGs with respect to each of the comparisons (fat depot or dietary energy) in 
the experiment.  
3. The FC and P-value were Log transformed. In order to prevent a bias from the original 
values while calculating FLUX and IMPACT, FC was subjected to transformation by log2(FC) 
and P-value was transformed via –ln(P-value), which will be used in the subsequent calculations.  
4. the percentage of number of molecules in each pathway, average FC of DEG in each 
pathway, and average P-value of DEGs in each pathway were calculated.  
5. The FLUX and IMPACT were calculated only for the pathways that were represented 
by at least 30% in our array platform. FLUX: refers to the overall direction in which a 
term/pathway is impacted after treatment or in the tissue comparison. IMPACT: refers to the 
absolute perturbation in a biological process or pathway. It gives the magnitude of changes that 
occur within a term/pathway in either direction weighted by the percentage of DEG that hit the 
term or pathway.  
6. The FLUX and IMPACT were graphed to easily visualize the direction and magnitude. 
FLUX was depicted with a gradient color change, of which green, yellow, and red were used to 
denote negative FLUX, 0, and positive FLUX, respectively. The color gradation changed based 
on the actual calculated value. The IMPACT was expressed with a data bar, of which the length 
of the bar indicates the magnitude of the perturbation. 
145 
 
 
Pathway analysis via Ingenuity Pathway Analysis (IPA): See Supplemental materials and 
methods.  
Approach for Interpretation and Discussion Among the Significantly Represented Results 
Due to the ubiquitous expression of many DEG in various tissues or organs, it is 
inevitable that the analysis conducted with different software gives obviously irrelevant results 
for the adipose tissues, such as the significantly impacted biological process of ―urinary bladder 
development‖ in the DIA analysis of tissue comparisons (MAT vs SAT) and ―positive regulation 
of insulin secretion‖ in the DIA analysis of diet comparison (OVE vs CON). Thus, only the most 
biologically relevant results will be interpreted and discussed. 
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RESULTS 
Differentially Expressed Gene (DEG) Induced by Main Effect of Diet and Fat Depot 
With the cut-off FDR value of 0.2, results revealed 310 DEGs (257 annotated with Entrez 
gene ID) affected by the main effect of treatment (OVE vs. CON), among which 201 (164 
annotated with Entrez gene ID) and 109 (94 annotated with Entrez gene ID) were up- and down-
regulated by overfeeding energy. Regarding tissue site, 409 genes (341 annotated) were 
differentially expressed between fat depots (MAT vs. SAT), of which 242 (208 annotated) and 
167 (133 annotated) were up- and down-regulated in MES vs. SAT. Fifteen DEGs in the 
comparison between OVE and CON and 45 DEGs in the comparison between MAT and SAT 
changed by more than 2 fold (as shown in Table 4.1 and 4.2).  
Functional Analysis via GeneSpring GX7 Reveals the Most Representative GO Term of Cc, 
Mf, and Bp  
Most Representative Cc: (Shown in Figure 4.1) The most relevant depot specific 
signature within Cc lies in the extracellular region (GO:5576 extracellular region, P < 0.05; 
GO:31012 extracellular matrix, P < 0.05) and the composition of collagen (GO:5583 fibrillar 
collagen, P < 0.001; GO:5584 collagen type I, P < 0.05), which were primarily due to the higher 
expression of relevant genes in SAT than MAT. However, compared with SAT, MAT was 
characterized by having greater expression of genes associated with actin filaments (P < 0.05) 
and cytoskeleton formation (P < 0.05). Despite the high degree of significance within the overall 
tissue effect for immunological synapse (P < 0.05) and MHC class II protein complex (P < 0.05), 
no significant depot difference was uncovered. Within the overall diet effect we found that the cc 
ribosome (P < 0.05), ribosomal subunits (P < 0.05), and protein complex of 43S (P < 0.05) and 
48S (P < 0.01) were significantly impacted, which resulted from the greater expression of 
corresponding genes in CON vs. OVE. In addition, overfeeding energy negatively affected the 
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immunological synapse and MHC class I protein complex (P < 0.05), which was displayed as 
increased expression of the related genes within the CON treatment.  
Most Representative Mf: (Shown in Figure 4.2) A number of Mf were more highly 
represented in MAT than in SAT, such as cytoskeletal protein binding, magnesium and iron ion 
binding, signaling kinase activity, and phosphoric ester hydrolase activity. However, SAT had 
greater expression of genes related with extracellular matrix constituent and transcriptional 
activator activity. Overfeeding energy potentially enhanced the Mf of transcription coactivator 
activity, magnesium ion binding, nutrient transporter activity (amino acid and organic acid), and 
MAPKK kinase activity.  
Most Representative Bp: (Shown in Figure 4.3) Compared with SAT, visceral fat 
exhibited greater expression of genes involved in vasculature development, fatty acid β-oxidation, 
post-translational modification of protein amino acid residues, and carboxylic acid metabolism. 
Overconsumption of energy enhanced adipocyte response to external stimulus, nutrient transport 
(carboxylic acid, amine, and amino acid), and intracellular signaling transduction, such as 
MAPKKK cascade and protein kinase activity.  
KEGG Pathway Analysis via DIA Uncovered the Most Impacted Pathways Either Induced by 
Different Plane of Dietary Energy or due to the Uniqueness of Fat Depots 
DIA Analysis on Main Category and Sub-Category Regarding Adipose Depot 
Characteristics: (Shown in Figure 4.4) As described in the materials and methods section, only 
those pathways  represented by more than 30% of the genes in our array over the whole genome 
were eligible for use in calculations of FLUX and IMPACT. The FLUX and IMPACT for each 
sub-category is the calculated mean FLUX and IMPACT for all the pathways that belong to the 
same sub-category, based on which the FLUX and IMPACT of each category was calculated. 
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The most highlighted categories in the comparison between adipose sites were metabolism and 
organismal systems followed by environmental information processing. In comparison with SAT, 
the most differentially represented sub-categories within the main category of metabolism in 
MAT were greater FLUX of carbohydrate, lipid and terpenoids, and polyketides metabolism and 
lower FLUX of amino acid metabolism and glycan biosynthesis and metabolism.  
Xenobiotics biodegradation and metabolism was moderately impacted due to fat depot 
with greater FLUX in MAT vs. SAT. Regarding the impacted sub-category of organism system 
we were mainly interested in immune and endocrine system due to the endocrine function of 
adipocytes and the influence of adipocytokines on function of immune cells. The endocrine 
function of visceral fat appeared to differ markedly from SAT as indicated by a large IMPACT 
value, with moderate greater FLUX in MAT. The immune system exhibited the same FLUX 
pattern in MAT vs. SAT, but in a marginal manner. The most impacted sub-categories within 
environmental information processing due to tissue source were signaling molecules and 
interaction and membrane transport, with lower FLUX value in MAT compared with SAT. In 
addition, the sub-categories of transcription and cell communication were influenced between fat 
depots with marginally greater FLUX in MAT. Visceral fat is probably more associated with 
metabolic disease due to the positive value of FLUX compared with SAT.  
DIA Analysis on Main Category and Sub-Category Induced by Dietary Energy Level: 
(Shown in Figure 4.4) Greater plane of dietary energy drastically perturbed and increased FLUX 
of the main category of metabolism in KEGG. Genetic information processing, organismal 
system, and human diseases were moderately affected by dietary energy level. Among the most 
impacted sub-categories, overfeeding energy markedly increased FLUX of metabolism of 
cofactors and vitamins and xenobiotics biodegradation and metabolism, and moderately 
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increased FLUX of carbohydrate and lipid metabolism and transcription. Among the moderately 
impacted sub-categories, adipose from overfed cows exhibited lower FLUX in translation and 
immune system disease, and greater FLUX in amino acid metabolism and excretory system. 
DIA Analysis of the Most Over-represented Pathways Regarding the Fat Depot 
Characteristics: (Shown in Figure 4.5) There were141 out of the entire 210 KEGG pathways 
that were substantially represented (> 30%, as described before). However, only the pathways 
with a log2IMPACT value > [mean of (log2IMPACT value of all the pathways) + 1×SD of 
(log2IMPACT value of all the pathways)] were considered as ―most impacted‖ and used to focus 
the discussion. Among all 24 most-impacted pathways in the comparison between fat depots, 
butanoate metabolism, pentose phosphate pathway, glycolysis/gluconeogenesis, fatty acid 
elongation in mitochondria, lysine degradation, and limonene and pinene degradation had greater 
FLUX in MAT vs. SAT. In addition, MAT exhibited higher FLUX in adipocytokine and PPAR 
signaling pathways and Type II diabetes mellitus compared with SAT. In contrast, greater FLUX 
was observed in SAT vs. MAT for a number of amino acids metabolism, sphingolipid and ether 
lipid metabolism, glycosaminoglycan degradation, and ECM-receptor interaction and focal 
adhesion. Despite a larger IMPACT value, several pathways were deemed biologically 
meaningless in regard to adipose tissue, including phototransduction and amoebiasis, and will 
not be discussed here.  
DIA Analysis of the Most Over-represented Pathways Induced by Dietary Treatments: 
(Shown in Figure 4.6) A total of 12 out of 103 substantially represented pathways induced by 
plane of dietary energy were deemed as the most impacted based on our criteria. Pathways 
associated with ubiquinone and other terpenoid-quinone biosynthesis, metabolism of xenobiotics 
by cytochrome P450, sphingolipid and ether lipid metabolism, basal transcription factors, and 
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type II diabetes were highly enriched in OVE vs. CON due to the positive FLUX value. However, 
a negative FLUX value was observed for a number of immune function related pathways, such 
as FC gamma receptor mediated phagocytosis in OVE compared with CON.  
 
DISCUSSION 
The Signature Characteristics of Adipose Depots 
Physiological differences between visceral and subcutaneous fat depots have long 
attracted attention. Bioinformatic analysis of our transcriptomic data revealed distinct properties 
in cellular components, molecular functions, and biological processes between mesenteric and 
subcutaneous adipose of dairy cows. Such differences seem to underscore the different 
transcriptional control of genes involved in nutrient metabolism, response to external stimuli and 
intracellular signaling transduction, endocrine activity, and crosstalk with microenvironments. 
The SAT exhibited greater expression of genes involved in fibrillar collagen (type I and III) 
formation (COL1A1, COL1A2 and COL3A1). Collagen type I and III are major structural 
components of extracellular matrix (ECM) in AT (Divoux and Clément, 2011), therefore, the 
differentially expressed collagen-related genes significantly impacted the ECM-receptor 
interaction pathway as detected in DIA analysis. In adipose tissue, the ECM does not simply 
provide architecture for cell anchorage and mitigation, but plays a crucial role in orchestrating 
adipogenesis and tissue remodeling. Evidence from cellular studies showed that the 
differentiation of preadipocytes paralleled the increase in type I-VI collagens (Nakajima et al., 
2002). During differentiation, the ECM surrounding adipocytes was characterized by a process 
of degradation of old spiny fibrils and synthesis of thicker new networks (Taleb et al., 2006). The 
degradation of ECM structural component is mainly executed by metalloproteinases (MMPs) 
(Christiaens and Lijnen, 2006). The MMP-initiated proteolysis increases the space for cells to 
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migrate, and MMP-2 was found to release TGF-β, which functions to regulate cell motility and 
induce ECM expression of collagens (Bouloumie et al., 2001; Yan et al., 2009;).  In the current 
study, we observed greater expression of MMP-2 in SAT than MAT. Therefore, taken together 
with the greater expression of collagen genes, we speculate that SAT undergoes more active 
remodeling of ECM, which would preceed preadipocyte differentiation. Bovine adipocytes from 
SAT are bigger in size and had more differentiation potency than those from visceral depots 
(personal communication with Häussler S. from University of Bonn, Germany, in July, 2011).  
 Intriguingly, MAT was characterized by greater expression of gene sets involved in actin 
cytoskeleton formation (FGF2, FGF7, ACTN3, MYLK, MYL9, CYFIP2) (as shown in Figure 4.1. 
cellular component) and vasculature development and blood vessel morphogenesis (VEGFA, 
FGF2) (as shown in Figure 4.3. biological process). Besides the remodeling of ECM, the 
reorganization of cytoskeleton and integrin and the development of new capillary networks also 
are key events of adipocyte differentiation at least in non-ruminant species) (Hausman and 
Kauffman, 1986; Antras et al., 1989). FGF2 is reported to be a potent stimulator of adipocyte 
differentiation and proliferation of endothelial cells in mice (Kawaguchi et al., 1998). In the 
process of angiogenesis, FGF2 stimulates the synthesis of proteinases and integrins to form new 
capillary structures (Okamura et al., 1991). VEGFA is one of the major angiogenic factors 
produced and secreted by adipocytes, of which the expression level was believed to be positively 
correlated with the adipose tissue‘s angiogenic capacity (Zhang et al., 1997). It can stimulate the 
proliferation and migration of endothelial cells by binding to its surface VEGF receptor 1 and 2 
(VEGFR1 and VEGFR2) (Huusko et al., 2010). Furthermore, we also observed the greater 
mRNA expression of HIF-3α (HIF3A) in MAT vs. SAT. Hypoxia-inducible factor (HIF) is a 
transcription factor (TF) that plays a central role in oxygen homeostasis in mammalian cells by 
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stimulating expression of oxygen-regulated genes related to angiogenesis, glucose uptake, and 
glycolysis (Semenza, 1999). HIF-3α, one subunit of HIF, was demonstrated to be induced and 
highly-expressed during adipose differentiation and functions as a positive regulator of 
adipogenesis (Hatanaka et al., 2009).  
 In addition, MAT expressed higher levels of CEBPB and CEBPD than SAT, both of 
which encode the TF that are transiently expressed during early stages of preadipocyte 
differentiation to stimulate expression of CEBPα and PPARγ (Wu et al., 1995). Since adipose 
tissue rather than pure adipocytes were used in our study, which consists of mature adipocytes 
surrounded by a stromal-vascular cell fraction containing preadipocytes, endothelial cells, 
pericytes, fibroblasts, macrophages, and mesenchymal stem cells, our bioinformatic analysis 
sheds light on these signature genes and provides evidence that the differentiation process of 
adipocytes from different depots may follow distinct patterns. Taken together these results allow 
us to  speculate that differentiation of SAT may involve more drastic reconstruction of the ECM 
structure (collagen); whereas, in MAT adipocyte hypertrophy may require greater expansion of 
the capillary network to take up more oxygen. Focal adhesion, i.e., cell-matrix adhesion, serves 
as the mechanical linkage of cells to ECM, which is a process essential for triggering 
intracellular responses to external stimulus and is mediated by integrins (Zamir and Geiger, 
2001). Although the focal adhesion pathway was overrepresented due to a large IMPACT value 
(as shown in Figure 4.5) the FLUX value was around zero, which may be primarily due to the 
differentially regulated ECM signaling (higher collagen related gene expression in SAT, greater 
expression of genes associated with angiogenesis and actin formation in MAT). 
 The uniqueness of fat depots in terms of nutrient metabolism was also overrepresented in 
our DIA analysis of KEGG pathways (as shown in Figure 4.5). Sphingolipid metabolism was 
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one of the pathways altered between MAT and SAT, which was primarily due to differential 
expression of sphingosine phosphate lyase 1 (SGPL1, higher in MAT), sphingosine kinase 
(SPHK2, higher in MAT), sialidase 1 (NEU1, higher in SAT), and acid ceramidase 1 (ASAH1, 
higher in SAT). ASAH1 converts ceramides to sphingosine (SP), which is phosphorylated to 
sphingosine-1-phosphate (S1P) by SPHK2. SGPL1‘s cleavage of S1P leads to irreversible 
breakdown of the SP backbone (Spiegel and Milstien, 2003). Ceramides are composed of 
sphingosine and a fatty acid and serve as one of the major lipids in the lipid bilayer of cell 
membranes. However, accumulating evidence has demonstrated that ceramides and sphingosine 
act as important signaling molecules in the regulation of cell proliferation, differentiation, and 
apoptosis in many cell types (Hannun and Obeid, 2008). In our study, the higher expression of 
ASAH1 indicates the potentially greater capacity to produce SP from ceramides. Previous 
research has demonstrated that SP is an active inducer of apoptosis in various cell types 
(Cuvillier et al., 2003; Lepine et al., 2004; Suzuki et al., 2004). Suzuki et al. (2004) found that 
deprivation of SP protects 3T3/A31 cells from apoptosis. Krown et al. (1996) observed that the 
addition of exogenous SP markedly increased apoptosis of rodent cardiomyocytes in vitro. Since 
SAT had higher expression of ASAH1 but lower expression of genes associate with catabolism of 
SP, we speculate that adipocyte from SAT may have greater activity of cell apoptosis compared 
with that of MAT, which has recently been confirmed by a German research group. They found a 
higher cell apoptotic rate in SAT than in visceral AT (retroperitoneal fat) of dairy heifers 
(Häussler et al., 2011).  
 The DIA pathway analysis revealed greater FLUX of butyrate metabolism and fatty acid 
elongation in MITO in MAT vs. SAT, which were primarily attributed to the higher mRNA 
expression of HADHA and ACSM1 in MAT. HADHA encodes the alpha subunit of long-chain 3-
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hydroxyacyl-CoA dehydrogenase (LCHAD), a part of the mitochondria (MITO) trifunctional 
protein, which catalyzes the last 3 steps of β-oxidation of long-chain fatty acids (LCFA). The 
enzyme complex is required for breakdown of the LCFA in MITO. Mutations of HADHA in 
human cause the LCHAD deficiency and result in the dysfunction of MITO to metabolize LCFA 
(Rinaldo et al., 2002). As we discussed in chapter 3, the MAT had higher expression of LPL and 
ACSL1 than SAT, together with greater ACSM1 mRNA in MAT as uncovered in microarray 
analysis, which indicated a greater uptake and activation of LCFA and medium-chain FA 
(MCFA) in visceral adipocytes. Thus, the greater FLUX value of these two pathways as 
represented by higher mRNA level HADHA may underscore an adaptive mechanism in MAT to 
allow for greater influx of preformed LCFA and MCFA for oxidation. 
Transcriptomic Modification in Adipose Induced by Energy Overfeeding 
 Functional analysis revealed that the gene sets associated with cell-substrate adhesion, 
cell-matrix adhesion, and response to (external) stimulus were the most highly enriched Bp in 
OVE vs. CON. Such results indicate that over-consumption of dietary energy increased substrate 
supply to adipose tissue and stimulated the communication between adipocytes and ECM. The 
altered external stimuli may cause the induction of intracellular signaling, which, as 
demonstrated in our functional analysis of Bp (shown in figure 4.3, GO analysis), resulted in the 
enrichment of (MAPK) signaling pathway. The MAPK activity is regulated through three-tiered 
protein kinase cascade consisted of MAPK, MAPK kinase (MAPKK or MAP2K) and MAPKK 
kinase (MAPKKK or MAP3K). MAP3K is the first being activated by extracellular stimuli and 
initiate intracellular signal transduction through phosphorylation of MAP2K (English et al., 
1999).  
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 The MAP2K signaling converge onto three subgroups of MAPK, p38, c-Jun N-terminal 
kinase (JNK), and Extracellular signal-Regulated Kinase (ERK) (Schaeffer and Weber, 1999; 
Chang and Karin, 2001). The ERK signaling pathways are activated by mitogenic stimuli, 
whereas JNK and p38 pathways are induced by anti-mitogenic stimuli or stress factors such as 
environmental or oxidative stress, TGF-β, and the inflammatory cytokines (e.g., IL-1, IL-6, 
TNF-α and TGF-β) (Ip and Davis, 1998) and free fatty acids (FFA) (Lee et al., 2003). The 
activation of JNK signaling, particularly in the absence of mitogenic stimuli, has been shown to 
induce cell apoptosis in many cell types (Chen et al., 1996; Tournier et al., 2001). In cultured 
adipocytes, the activation of JNK signaling induced by the addition of inflammatory cytokines, 
FFA or MITO oxidative stress resulted in reduced insulin-stimulated glucose uptake and 
impaired downstream insulin signaling pathways (Lee et al., 2003; Kim et al., 2009). Several 
studies demonstrated that the inhibitory effect of JNK on insulin signaling was caused by serine 
sites on IRS-1, which can blunt tyrosine phosphorylation of IRS-1 required for normal insulin 
signal transduction (Hirosumi et al., 2002; Sharfi and Eldar-Finkelman, 2008; Sabio et al., 2010). 
  In the current study, a set of genes involved in MAP3K signaling (MAP3K4, MAP3K5, 
TAOK2, and GADD45B) was overrepresented in OVE compared with CON. The growth arrest 
and DNA damage-inducible (GADD) 45 genes have been found to be induced under various 
stress conditions such as UV, osmotic and oxidative stress, and cytokines (IL-1, TNFα and TGF-
β) (See review in Yang et al., 2009). Their activation may cause growth arrest (Vairapandi et al., 
2002), DNA repair (Smith et al., 2000), cell survival or apoptosis (Sheikh et al., 1998), and 
modulation of the immune response (Lu et al., 2004). Myeloid leukemia cells were rescued from 
TGFβ-induced apoptosis by blocking the expression of GADD45B (Selvakumaran et al., 1994). 
The link between induced expression of GADD45 proteins by stress factors and stimulated cell 
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apoptosis was uncovered because all GADD45 proteins (GADD45-α, -β and -γ) activate 
MAP3K4, which functions exclusively to induce JNK and p38 pathways (Takekawa et al., 1997).  
 As shown by our results, the coordinated upregulation of GADD45B and MAP3K4 in AT 
of energy-overfed animals probably indicated the greater induction of JNK signaling in response 
to energy overfeeding, which may contribute to increased cell apoptosis or growth arrest and 
insulin resistance in adipocytes. However, we did not observe any difference in expression of 
pro-inflammatory cytokines (TNFA, IL1B, and IL6) between the two treatment groups using 
either our array or qPCR, which seems contrary to the suggestion that inflammation induced 
overexpression of GADD45B in AT of OVE cows.  
 Another in vitro study with adipocytes revealed that GADD45B is preferentially 
expressed in differentiated adipocytes and is a target gene of CEBPα, which is one of the major 
adipogenic transcriptional factors expressed in post-mitotic, differentiated adipocytes (Constance 
et al., 1996). Temporal mis-expression of CEBPα in undifferentiated adipoblasts leads to mitotic 
growth arrest, which is mediated by the increased abundance of GADD45 proteins (Constance et 
al., 1996). Hence, it could be hypothesized that the hypertrophy of adipocytes may be an inducer 
besides other extracellular stress factors to stimulate the apoptotic pathway .  
 Despite a lack of difference in mRNA expression of CEBPA between the two groups in 
our array, it does not exclude a greater activity in transcriptional regulation in response to OVE 
vs. CON. Results from qPCR confirmed that PPARG, the master TF of adipogenesis (Rosen and 
MacDougald, 2006), was highly expressed in OVE vs. CON and in previous studies has been 
shown to be activated by CEBPα both of which are markers of of the differentiation process 
(Rosen and MacDougald, 2006). The total visceral AT weight (including mesenteric, omental, 
and perirenal fat) in OVE cows almost doubled the size of that in the CON group (59.5 vs. 35.5 
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kg), which partly supports the notion of enhanced adipocyte differentiation. Therefore, our 
bioinformatics analysis implicated a GADD45-mediated apoptotic pathway (JNK pathway) as 
being induced in hypertrophic adipocytes by chronic energy overfeeding.  
 Thousand and one amino acid kinase 2 (TAOK2), which had greater mRNA expression in 
OVE vs. CON, was identified as a key intermediate to activate p38 MAPK cascades in response 
to DNA damage induced by detrimental stimuli, such as oxidative stress and UV injury (Chen et 
al., 1999; Raman et al., 2007). As we discussed above, the activation p38 pathway is highly 
involved in cell apoptosis. Together with the highlighted apoptotic-related genes, in our DIA 
pathway analysis metabolism of xenobiotics by cytochrome P450 was overrepresented due to the 
higher expression of CYP2S1 and GSTM3 genes in OVE vs. CON. As is well known, the 
endoplasmic reticulum (ER) contains the majority of cytochrome P450 enzymes involved in 
xenobiotic metabolism, as well as a number of conjugating enzymes. In addition to its function 
in bioactivation and detoxification of these cytotoxic compounds, the ER is subject to the 
damage from reactive intermediates as well, which may lead to cell death (Cribb et al., 2005). 
Several studies have shown an involvement of the ER stress in the death of hypertrophic 
adipocytes, leading to adipose insulin resistance (Zinszner et al., 1998; Özcan et al., 2004;  
Nakatani et al., 2005; Gregor and Hotamisligil, 2007). GSTM3 encodes a protein of the 
multigene family of the GST, which catalyzes the conjugation of glutathione with compounds 
containing an electrophilic center and functions as peroxidase and thiol transferase (Mannervik, 
1985). GSTM3 is an antioxidant enzyme involved in the degradation of cytotoxic products in the 
cell, and the enzyme product of CYP2S1 was reported to oxidize several carcinogens by using 
hydrogen peroxide, which is the major contributor to oxidative damage of cells (Bui et al., 2009). 
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The greater expression of these two genes indicated a greater detoxification activity, which may 
be a sign of higher risk of ER stress in adipocytes in response to long-term energy overfeeding.  
 It has been clearly demonstrated in vitro that hypertrophy per se promotes adipocyte 
death and macrophage recruitment and aggregation around individual adipocytes. Such increase 
in colonies of macrophages is primarily due to the chemoattractant property of adipokines (Cinti 
et al., 2005). As verified by qPCR, CCL2 mRNA expression was greater in cows fed OVE vs. 
CON. Monocyte chemotactic protein-1 (MCP-1), the protein product of CCL2, is a chemokine 
and plays a role in recruitment of monocytes and T lymphocytes to sites of inflammation or to 
apoptotic cells (Baggiolini, 1998). It is expressed by a number of cell types including endothelial 
cells (Rollins, 1997) and adipocytes (Gerhardt et al., 2001). Increased expression of MCP-1 has 
been reported in different adipose depots (visceral, SAT and epicardial fat) in obese patients 
(Bruun et al., 2005; Yu et al., 2006) with higher expression in visceral than SAT, and closely 
associated with the enrichment of macrophages (Bruun et al., 2005).  
 Skurk et al. (2007) clearly illustrated that the secretion of MCP-1 and other 
adipocytokines (e.g. IL-6, TNF-α) was positively correlated with adipocyte size. In vitro addition 
of MCP-1 to differentiated adipocytes decreased insulin-stimulated glucose uptake, which 
suggested a causal relationship between MCP-1 and insulin resistance (Sartipy and Loskutoff, 
2003). Parallel with greater CCL2 expression, we found several significantly enriched pathways 
associated with immune response of monocytes and lymphocytes in response to OVE vs. CON, 
e.g., natural killer cell mediated cytotoxicity, Fc-gamma receptor-mediated phagocytosis, and T 
cell receptor signaling. All these enriched pathways underscored the importance of nuclear factor 
of activated T cells calcineurin-dependent 3 (NFATC3), which is a TF central to transactivate 
TNF expression upon B and T cell receptor engagement (Oh-hora and Rao, 2008).  A 
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recent in vitro study showed that the nuclear localization of NFATC3 is also required for TLR-
initiated innate immune responses in bone marrow-derived macrophages including TNF 
expression (Minematsu et al., 2011). The higher expression of CCL2 and NFATC3 in AT of 
cows fed OVE than CON indicated an increase  in residency of immune cells in AT of OVE–fed 
animals, thus, increasing the likelihood of communication between immune cells and adipocytes 
to induce an immune response and produce the pro-inflammatory cytokines.  
 Adipocyte death was reported to be remarkably greater in obese mice 
ob/ob
 and human 
individuals (expressed as necrosis rather than apoptosis), and more than 90% of all macrophages 
(infiltrated and resident) in WAT of these obese subjects were localized to dead adipocytes (Cinti 
et al., 2005). In addition, accumulating evidence from studies of obese rodent models and 
humans has demonstrated that macrophages are the predominant source of proinflammatory 
cytokines (e.g., TNF-α and IL-6) (Weisberg et al., 2003; Fain et al., 2004). As a result, chronic 
low-grade inflammation has been closely related to subsequent development of insulin resistance 
in WAT (Xu et al., 2003; see review in Tilg and Moschen, 2008). In the current study, we 
observed an increase in insulin to glucose ratio, which may indicate lower efficiency of insulin-
stimulated glucose uptake in peripheral tissues. Taken together, our results and the evidence 
from rodent and humans allow us to hypothesize that a series of events may be induced 
sequentially in response to energy overfeeding. Overfeeding energy increased adipocytes 
differentiation and apoptotic gene expression, which may result in ER-stress, adipocyte death, 
and subsequently increase the recruitment of immune cells. The increased infiltration of 
macrophages augments the production of proinflammatory cytokines, which may finally trigger 
the insulin resistance in WAT of overfed animals.  
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 In conclusion, the transcriptomics results highlighted a depot-specific regulation of 
cytoskeleton formation, ECM structure, and blood vessel morphology, which potentially induces 
different responses to extracellular stimuli including substrate and oxygen supply in visceral vs. 
SAT adipocytes. Long-term overfeeding energy could stimulate adipocyte hypertrophy which 
may activate apoptosis through MAPK-JNK pathway and subsequently result in the recruitment 
of immune cells. The aggregation of immune cells on adipocytes may induce inflammation by 
promoting secretion of pro-inflammatory cytokines, and the drainage of cytokines either 
produced by adipocyte or immune cells via the circulation may cause inflammation of other 
organs such as the liver.    
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TABLES AND FIGURES 
Table 4.1. DEG (FDR  0.2) with expression difference ≥ 2-fold between dietary treatments (OVE vs. CON). Positive fold-difference 
means DEG were more highly expressed in OVE than CON, whereas negative fold-difference indicates DEG had lower expression in 
OVE than CON.  
Oligo ID GenBank Gene Symbol Gene Name Fold-Difference P-value FDR 
Up-regulated in OVE vs. CON      
OLIGO_11285 NM_005063 SCD stearoyl-CoA desaturase 3.50 0.0023 0.132 
OLIGO_00815 NM_000245 MET met proto-oncogene 2.52 0.0001 0.065 
OLIGO_05066 MGC143330 
endoplasmic reticulum-golgi intermediate 
compartment 
2.45 0.0032 0.187 
OLIGO_07313 NM_017986 GPR172B G protein-coupled receptor 172B 2.44 0.0011 0.124 
OLIGO_04905 XM_595298 LOC517135 
chromosome 22 open reading frame 13 
ortholog 
2.40 0.0042 0.196 
OLIGO_09862 NM_004521 KIF5B kinesin family member 5B 2.32 0.0043 0.196 
OLIGO_02993  CN439798 
 
2.31 0.0010 0.115 
OLIGO_10679 NM_002370 MAGOH 
mago-nashi homolog, proliferation-associated 
(Drosophila) 
2.25 0.0002 0.065 
OLIGO_00533 SERINC3 serine incorporator 3 2.24 0.0002 0.065 
OLIGO_01279 NM_001015892 TAF9 
TAF9 RNA polymerase II, TATA box binding 
protein (TBP)-associated factor 
2.21 0.0021 0.159 
OLIGO_00123 NM_003251 THRSP thyroid hormone responsive SPOT14 homolog 2.20 0.0025 0.132 
OLIGO_00906 NM_004291 CARTPT CART prepropeptide 2.17 0.0049 0.203 
OLIGO_02892 NM_001012669 FASN fatty acid synthase 2.10 0.0014 0.128 
Down-regulated in OVE vs. CON     
OLIGO_11220 NM_181689 NNAT neuronatin -2.73 2.1×10
-5
 0.040 
OLIGO_09664 NM_001014988 LAT linker for activation of T cells -2.00 0.0013 0.130 
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Table 4.2. DEG (FDR ≥ 0.2) with expression difference ≥ 2-fold between tissues (MAT vs. SAT). Positive fold-difference means 
DEG had higher expression in MAT than SAT, whereas negative fold-difference indicates DEG had lower expression in MAT than 
SAT.  
Oligo ID GenBank Gene Symbol Gene Name 
Fold-
Difference 
P-value FDR 
Up-regulated in MAT vs. SAT      
OLIGO_05586 NM_199161 SAA3 serum amyloid A 3 5.45 0.0025 0.170 
OLIGO_12174 NM_004797 ADIPOQ adiponectin 3.23 0.0021 0.127 
OLIGO_11220 NM_181689 NNAT neuronatin 2.95 9.2×10-6 0.011 
OLIGO_09217 NM_005252 FOS FBJ murine osteosarcoma viral oncogene homolog 2.81 0.0001 0.037 
OLIGO_09413 NM_145693 LPIN1 lipin 1 2.55 0.0023 0.144 
OLIGO_10000 DR749338 DR749338 
 
2.52 1.1×10-6 0.007 
OLIGO_06440 NM_005327 HADH hydroxyacyl-Coenzyme A dehydrogenase pseudogene 2.37 0.0003 0.058 
OLIGO_03834 NM_004040 RHOB ras homolog gene family, member B 2.27 3.9×10-6 0.007 
OLIGO_09127 NM_006744 RBP4 retinol binding protein 4, plasma 2.25 0.0022 0.127 
OLIGO_10552 NM_001063 TF transferrin 2.17 0.0026 0.138 
OLIGO_08595 NM_018100 EFHC1 EF-hand domain (C-terminal) containing 1 2.16 1.9×10-6 0.007 
OLIGO_12171 NM_002591 PCK1 phosphoenolpyruvate carboxykinase 1 2.15 0.0017 0.113 
OLIGO_06738 NM_002612 PDK4 pyruvate dehydrogenase kinase, isozyme 4 2.06 0.0044 0.169 
OLIGO_04502 NM_144641 PPM1M protein phosphatase 1M 2.06 2.9×10-5 0.020 
OLIGO_11884 NM_002006 FGF2 fibroblast growth factor 2 2.04 0.0002 0.054 
Down-regulated in MAT vs. SAT      
OLIGO_10483 NM_000089 COL1A2 collagen, type I, alpha 2 -4.53 2.9×10-5 0.020 
OLIGO_02891 NM_000071 CBS cystathionine-beta-synthase -3.17 6.8×10-6 0.010 
OLIGO_00934 NM_001075435 MGC143401 myosin binding protein H -2.97 0.0034 0.153 
OLIGO_07817 NM_017703 FBXL12 F-box and leucine-rich repeat protein 12 -2.95 0.0001 0.037 
OLIGO_13133 NM_001982 ERBB3 
v-erb-b2 erythroblastic leukemia viral oncogene 
homolog 3 
-2.87 0.0063 0.200 
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Table 4.2. (cont.) 
Oligo ID GenBank Gene Symbol Gene Name 
Fold-
Difference 
P-value FDR 
OLIGO_02728 NM_001005367 TTYH1 tweety homolog 1 (Drosophila) -2.76 0.0001 0.037 
OLIGO_11285 NM_005063 SCD stearoyl-CoA desaturase -2.72 0.0020 0.180 
OLIGO_00835 NM_003014 SFRP4 secreted frizzled-related protein 4 -2.66 0.0041 0.166 
OLIGO_09430 XM_614120 LOC534369 ATPase type 13A1 -2.66 0.0007 0.074 
OLIGO_04894 XM_001126181 MGC142346 aurora kinase A interacting protein 1 -2.64 0.0005 0.070 
OLIGO_02697 XM_172995 LOC255809 chromosome 19 open reading frame 38 -2.63 0.0002 0.047 
OLIGO_09832 NM_018250 RC74 integrator complex subunit 9 -2.57 0.0016 0.108 
OLIGO_06101 NM_024578 OCEL1 occludin/ELL domain containing 1 -2.53 0.0002 0.047 
OLIGO_06643 NM_005827 SLC35B1 solute carrier family 35, member B1 -2.51 0.0049 0.177 
OLIGO_09048 NM_000355 TCN2 transcobalamin II -2.45 0.0002 0.045 
OLIGO_12570 NM_015221 DNMBP dynamin binding protein -2.41 0.0010 0.087 
OLIGO_02864 NM_022716 PRRX1 paired related homeobox 1 -2.38 0.0001 0.025 
OLIGO_10599 NM_002046 GAPDH glyceraldehyde-3-phosphate dehydrogenase -2.31 0.0012 0.095 
OLIGO_04103 LOC519222 DIS3 mitotic control homolog (S. cerevisiae)-like 2 -2.30 0.0027 0.138 
OLIGO_07055 NM_002961 S100A4 S100 calcium binding protein A4 -2.29 0.0022 0.127 
OLIGO_10553 NM_000090 COL3A1 collagen, type III, alpha 1 -2.27 0.0040 0.163 
OLIGO_08952 NM_007159 SLMAP sarcolemma associated protein -2.22 0.0005 0.070 
OLIGO_07207 NM_004887 CXCL14 chemokine (C-X-C motif) ligand 14 -2.21 0.0001 0.024 
OLIGO_02231 XM_910489 2310004N24Rik RIKEN cDNA 2310004N24 gene -2.20 0.0018 0.116 
OLIGO_05794 NM_002009 FGF7 fibroblast growth factor 7 -2.18 0.0011 0.089 
OLIGO_02155 NM_014048 MKL2 MKL/myocardin-like 2 -2.12 0.0030 0.146 
OLIGO_11084 NM_000088 COL1A1 collagen, type I, alpha 1 -2.10 0.0001 0.024 
OLIGO_12335 NM_015429 ABI3BP ABI family, member 3 (NESH) binding protein -2.00 0.0002 0.047 
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Table 4.3. Fold change consistency of genes investigated in qPCR and microarray 
Gene Description 
Fold-Difference 
MAT vs SAT  OVE vs CON 
Microarray qPCR Microarray qPCR 
Lipid metabolism, fatty acid import 
ACLY ATP citrate lyase  1.11  1.52* 1.18 1.71** 
ACACA acetyl-Coenzyme A carboxylase alpha -1.09 -1.50* 1.51 1.52* 
FASN fatty acid synthase -1.10   -1.67** 1.90 2.10** 
ELOVL6 elongation of long chain fatty acids -1.08  1.17 1.55 1.78** 
SCD stearoyl-CoA desaturase -1.60   -2.72** 4.36 3.50** 
GPAM glycerol-3-phosphate acyltransferase  1.80 1.63** 1.48 1.33* 
LPL lipoprotein lipase  1.57 1.65** -1.09 1.04 
CD36 thrombospondin receptor  1.31 -1.04 -1.12 -1.01 
ACSL1 acyl-CoA synthetase long-chain  1.38 1.55* -1.27 -1.09 
ADFP adipose differentiation-related protein -1.06 -1.60** 1.22 1.13 
LPIN1 lipin 1  1.72 2.55** 1.09 1.79** 
LIPE hormone-sensitive lipase   1.50 1.04 1.17 -1.04 
LEP leptin  1.02 1.78** 1.14 1.39 
ADIPOQ adiponectin  3.23 1.82** -1.06 -1.01 
Transcription regulation 
THRSP thyroid hormone responsive SPOT 14 2.02 1.46* 2.53 2.20** 
PPARG peroxisome proliferator-activated 
receptor gamma 
1.21 1.13 1.19 1.15 
SREBF1 sterol regulatory element binding 
transcription factor 1 
1.13 -1.04 -1.07 -1.41** 
MLXIPL MLX interacting protein-like 1.01 1.08 1.07 1.11 
NR2F2 nuclear receptor 1.08 1.40** -1.20 -1.08 
Immune response, acute-phase response, inflammation and insulin sensitivity 
TNF tumor necrosis factor -1.11 -1.15 -1.52 -1.05 
IL-1B interleukin-1 beta 1.04 1.87** 1.15 1.33 
IL-6 interleukin-6 -1.11 1.20 -1.13 1.02 
IL-6R Interleukin-6 receptor 1.21 1.38** -1.08 -1.36** 
AKT2 thymoma viral proto-oncogene -1.18 1.25* -1.09 -1.27** 
SAA3 acute-phase serum amyloid A1 -1.29 5.45** 1.07 -1.48 
TLR4 toll-like receptor 4 -1.03 1.22 -1.20 -1.18 
CCL2 chemokine (C-C motif) ligand 2 1.22 1.83 1.09 1.78* 
CCL5 chemokine C-C motif ligand 5 -1.07 1.51 -1.03 1.08 
INSR insulin receptor 1.21 1.22 1.02 1.01 
**
 P ≤ 0.05; * P ≤ 0.10.
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Figure 4.1. Most representative cellular component (Cc) in GO analyses among DEG in either diet or tissue comparison.    
Most representative GO Cc among significantly impacted Cc with unadjusted P-value ≤ 0.05 in the 6 analyses (described in materials 
and methods). The Cc were grouped and shown by different background colors (grey or white). The color gradation in the left column 
of each analysis denotes the degree of reliability of this Cc being influenced or the range of the P-value (criteria shown on the top row 
of the figure), and no color means not significant in this analysis (P > 0.05); The number in the right column of each analysis means 
how many DEG (FDR ≤ 0.2) exerted an effect on this Cc. MAT: mesenteric adipose tissue; SAT: subcutaneous adipose tissue; OVE: 
moderate energy diet; Strw or CON: controlled energy diet. 
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Figure 4.2. Most representative molecular functions (Mf) in GO analyses among DEG in either diet or tissue comparison.    
Most representative GO Mf among significantly impacted Mf with unadjusted P-value ≤ 0.05 in the 6 analyses (described in materials 
and methods). The color gradation in the left column of each analysis denotes the degree of reliability of this Mf being influenced or 
the range of the P-value (criteria showed on the top row of the figure), and no color means not significant in this analysis (P > 0.05); 
The number in the right column of each analysis means how many DEG (FDR ≤ 0.2) participated in the Mf. MAT: mesenteric adipose 
tissue; SAT: subcutaneous adipose tissue; OVE: moderate energy diet; Strw or CON: controlled energy diet.
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GO:5342: organic acid transporter activity 4 4
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Figure 4.3. Most representative biological process (Bp) in GO analyses among DEG in either diet or tissue comparison.  
Most representative GO Bp among significantly impacted Bp with unadjusted P-value ≤ 0.05 in the 6 analyses (described in materials 
and methods). The Bp were grouped by the overall function that they belong to and showed by different background colors (grey or 
white). The color gradation in the left column of each analysis denotes the degree of reliability of this Bp being influenced or the range 
of the P-value (criteria showed on the top row of the figure), and no color means not significant in this analysis (P > 0.05); The 
number in the right column of each analysis means how many DEG (FDR ≤ 0.2) participated in this Bp. MAT: mesenteric adipose 
tissue; SAT: subcutaneous adipose tissue; OVE: moderate energy diet; Strw or CON: controlled energy diet. 
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GO:51128: regulation of cell organization and biogenesis 6 4
GO:51129: negative regulation of cell organization and biogenesis 4
GO:30835: negative regulation of actin filament depolymerization 3
GO:51016: barbed-end actin filament capping 3
GO:31589: cell-substrate adhesion 5 4
GO:7160: cell-matrix adhesion 4 3
GO:45860: positive regulation of protein kinase activity 7 7
GO:186: activation of MAPKK activity 2 4 4
GO:31324: negative regulation of cellular metabolism 10
GO:6665: sphingolipid metabolism 4 3 2
GO:46519: sphingoid metabolism 4 2 2
GO:6672: ceramide metabolism 3 2 2
GO:6635: fatty acid beta-oxidation 3 3
GO:51246: regulation of protein metabolism 13
GO:6470: protein amino acid dephosphorylation 7 6
GO:6479: protein amino acid methylation 3 3
GO:8213: protein amino acid alkylation 3 3
GO:51261: protein depolymerization 4
GO:19752: carboxylic acid metabolism 20 14
GO:6094: gluconeogenesis 3 3
GO:46165: alcohol biosynthesis 3 3
GO:6090: pyruvate metabolism 3 3
GO:9308: amine metabolism 11 9
GO:50896: response to stimulus 43 29
GO:9605: response to external stimulus 17 13
GO:9991: response to extracellular stimulus 3 2
GO:165: MAPKKK cascade 7 6
GO:15698: inorganic anion transport 9 5
GO:15674: di-, tri-valent inorganic cation transport 7 5
GO:6826: iron ion transport 3
GO:6817: phosphate transport 7 4
GO:46942: carboxylic acid transport 4 4
GO:15837: amine transport 4 4
GO:6865: amino acid transport 3 3
GO:16197: endosome transport 3 3
GO:6826: iron ion transport 3
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Figure 4.4. The FLUX and IMPACT of main- and sub-categories of KEGG PATHWAY 
database due to main effects of fat depots (SAT vs. MAT) or dietary energy plane (OVE vs. 
CON). The FLUX value ranges from -25.9 (greenest, pathway: Metabolism of other amino acids) 
to 26.5 (reddest, pathway: Metabolism of terpenoids and polyketides) for fat depot comparison, 
and -6.7 to 14.6 for diet comparison. IMPACT bar length ranges from 2 to 10+ for all 
comparison, which means any IMPACT value that is more than 10 will be expressed as the same 
full bar length (Maximum for fat depot comparison: 35.4, Metabolism of other amino acids; 
Maximum for diet comparison: 19.9, Metabolism of cofactor and vitamins).  
FLUX IMPACT FLUX IMPACT
1. Metabolism
0.1 Metabolic pathways
1.1 Carbohydrate Metabolism
1.11 Xenobiotics Biodegradation and Metabolism
1.2 Energy Metabolism
1.3 Lipid Metabolism
1.4 Nucleotide Metabolism
1.5 Amino Acid Metabolism
1.6 Metabolism of Other Amino Acids
1.7 Glycan Biosynthesis and Metabolism
1.8 Metabolism of Cofactors and Vitamins
1.9 Metabolism of Terpenoids and Polyketides
2. Genetic Information Processing
2.1 Transcription
2.2 Translation
2.3 Folding, Sorting and Degradation
3. Environmental Information Processing
3.1 Membrane Transport
3.2 Signal Transduction
3.3 Signaling Molecules and Interaction
4. Cellular Processes
4.1 Transport and Catabolism
4.2 Cell Motility
4.3 Cell Growth and Death
4.4 Cell Communication
5. Organismal Systems
5.1 Immune System
5.2 Endocrine System
5.3 Circulatory System
5.4 Digestive System
5.5 Excretory System
5.6 Nervous System
5.7 Sensory System
5.8 Development
5.9 Environmental Adaptation
6. Human Diseases
6.1 Cancers
6.2 Immune System Diseases
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Diseases
6.5 Metabolic Diseases
6.6 Infectious Diseases
SUB-CATEGORY
OVE vs CONMAT vs. SAT
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Figure 4.5. The FLUX, IMPACT and the DEGs for the most over-represented KEGG pathway in comparison of fat depots (MAT vs. 
SAT). The most over-represented pathways were screened from a complete list of over-represented pathways that is based on DEGs in 
comparison of fat depot and contains more than 30% of genes presented in genome as in our array. The threshold value for ―most 
over-represented pathway‖ has the Log2(IMPACT of this pathway) > [Mean of Log2(IMPACT of every pathway) + SD of (IMPACT 
of every pathway)]. The FLUX value ranges from -61.4 (the greenest, pathway: Selenoamino acid metabolism) to 33.1 (the reddest, 
pathway: phototransduction). The IMPACT bar length stands for the value that ranges from 16.7 (pathway: Gastric acid secretion) to 
30+ (Maximum is 61.4 for pathway: Selenoamino acid metabolism), which means any IMPACT value that more than 30 will be 
expressed as the same full bar length.   
FLUX IMPACT Up-regulated Down-regulated
Carbohydrate Metabolism Butanoate metabolism HADHA; ACSM1
Glycolysis / Gluconeogenesis PCK1; FBP1; PGM1 GAPDH
Pentose phosphate pathway FBP1; PGM1
Lipid Metabolism Ether lipid metabolism PAFAH1B1; PAFAH1B2; PLA2G7
Fatty acid elongation in mitochondria HADHA
Sphingolipid metabolism SGPL1; SPHK2 NEU1; ASAH1
Amino Acid Metabolism Cysteine and methionine metabolism CBS
Glycine, serine and threonine metabolism CBS; AGXT
Lysine degradation HADHA; PLOD2 SETD2
Metabolism of Other Amino Acids Selenoamino acid metabolism
Glycan Biosynthesis and Metabolism Glycosaminoglycan degradation GNS
Metabolism of Terpenoids and Polyketides Limonene and pinene degradation
Signal Transduction Phosphatidylinositol signaling system ITPR2; CALM1; CALM3; CDS2; INPP1; PIK3C2A
Signaling Molecules and Interaction ECM-receptor interaction COL1A1; COL1A2; COL3A1
Cell Communication Focal adhesion VEGFA; MYLK; MYL9; SHC1; ACTN3; PARVA COL1A1; COL1A2; COL3A1
Endocrine System Adipocytokine signaling pathway PCK1; ADIPOQ; RXRG CAMKK1; PRKAB2
PPAR signaling pathway PCK1; ADIPOQ; RXRG
Digestive System Gastric acid secretion MYLK; CALM1; CALM3; ITPR2
Excretory System Proximal tubule bicarbonate reclamation PCK1
Sensory System Phototransduction GNB1; GUCY2D; CALM1; CALM3
Cancers Bladder cancer VEGFA MMP2
Melanoma FGF2; FGF7 MITF
Metabolic Diseases Type II diabetes mellitus ADIPOQ
Infectious Diseases Amoebiasis CSF2; ACTN3 COL1A1; COL1A2; COL3A1
SUB-CATEGORY PATHWAY NAME
MAT vs SAT
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Figure 4.6. The FLUX, IMPACT and the DEGs for the most over-represented KEGG pathway in comparison of dietary energy plane 
(OVE vs. CON). The most over-represented pathways were screened  from a complete list of over-represented pathways that is based 
on DEGs in comparison of diets and contains more than 30% of genes presented in genome as in our array. The threshold value for 
―most over-represented pathway‖ has the Log2(IMPACT of this pathway) > [Mean of Log2(IMPACT of every pathway) + SD of 
(IMPACT of every pathway)]. The FLUX value ranges from -5.2 (the greenest, pathway: Fc epsilon RI signaling pathway) to 34.5 
(the reddest, pathway: Ubiquinone and other terpenoid-quinone biosynthesis). The IMPACT bar length stands for the value that ranges 
from 10.2 (pathway: T cell receptor signaling) to 20+ (Maximum is 34.5 for pathway: Ubiquinone and other terpenoid-quinone 
biosynthesis), which means any IMPACT value that more than 30 will be expressed as the same full bar length.   
FLUX IMPACT Up-regulated Down-regulated
Carbohydrate Metabolism Glyoxylate and dicarboxylate metabolism GLYCTK; 
Xenobiotics Biodegradation and MetabolismMetabolism of xenobiotics by cytochrome P450 CYP2S1; GSTM3
Lipid Metabolism Sphingolipid metabolism NEU1; PPAP2A ASAH1
Ether lipid metabolism PAFAH1B1; PPAP2A
Glycan Biosynthesis and Metabolism Other glycan degradation NEU1
Metabolism of Cofactors and Vitamins Ubiquinone and other terpenoid-quinone biosynthesis COQ3
Transcription Basal transcription factors TAF9
Immune System Fc gamma R-mediated phagocytosis PIK3R1; PPAP2A LAT; VAV3
Fc epsilon RI signaling pathway PIK3R1 LAT; VAV3
Natural killer cell mediated cytotoxicity PIK3R1; NFATC3 LAT; VAV3
T cell receptor signaling pathway PIK3R1; NFATC3 LAT; VAV3
Metabolic Diseases Type II diabetes mellitus PIK3R1 SOCS1
OVE vs CON
SUB-CATEGORY PATHWAY
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CHAPTER 5 
 
PREPARTAL PLANE OF DIETARY ENERGY CHANGED INSULIN SIGNALING 
TRANSDUCTION AND TRANSCRIPTIONAL ADAPTATION OF ADIPOSE TISSUE 
OF DAIRY COWS DURING THE TRANSITION PERIOD 
 
ABSTRACT 
Reduced peripheral insulin responsiveness is a hallmark of physiological adaptation in 
late pregnancy and early lactation in dairy cows. Previous studies demonstrated prepartum 
overfeeding dietary energy seemed to predispose animals to a more severe insulin-resistant state, 
which resulted in enhanced postpartum lipolysis of dairy cows. In an attempt to evaluate the 
mechanism for the effect of prepartum overfeeding in regulation of adipose metabolism and 
insulin sensitivity during transition period, 14 Holstein cows (≥ 2nd parity) were dried off at -50 d 
relative to expected parturition date and offered a controlled-energy diet (NEL = 1.24 Mcal/kg 
DM) that contained 36% of DM as wheat straw until -21 d. Then animals were randomly 
assigned to either the same controlled-energy diet (controlled or CON) or a moderate-energy diet 
(overfed or OVE, NEL = 1.47 Mcal/kg DM) during the close-up dry period (-21 d to parturition). 
Both groups were fed the same lactation diet (NEL = 1.65 Mcal/kg DM) after calving. Blood 
samples were collected before the morning feeding twice weekly from -21 to 30 d relative to 
parturition. Subcutaneous adipose tissue (AT) was biopsied from the tail-head region at -10, 7, 
and 21 d. Adipose explants from part of the AT collected at -10 and 7 d were used to determine 
the IRS1 tyrosine phosphorylation (IRS1-pY) level with or without insulin challenge in vitro. 
Total RNA was extracted from the rest of the AT from all 3 biopsies.  Quantitative RT-PCR was 
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utilized to analyze mRNA expression of 24 genes associated with lipid metabolism and insulin 
signaling. Overfeeding energy markedly increased DMI (P = 0.05), NEL intake (P < 0.01), and 
serum insulin concentration (P < 0.01) during the close-up period. Compared with OVE group, 
serum NEFA levels of CON cows were numerically higher and lower in close-up period and 
postpartum, respectively. However, OVE animals experienced a more drastic increase of 
circulating NEFA after calving than the CON group (P = 0.04) and tended to have higher serum 
BHBA postpartum (P = 0.06). As a consequence, postparturient hepatic lipid and triglyceride 
accumulation was significantly greater in OVE vs. CON cows. No difference in any aspect of  
performance was detected between the two groups, except the tendency for greater milk protein 
percentage (P = 0.10) in CON group. Adipose IRS1-pY, either without or with insulin challenge 
was significantly lower at 7 vs. -10 d for both groups. The AT biopsied at -10 d in OVE animals 
had greater IRS1-pY in response to insulin challenge than that in CON group. The mRNA 
expression of genes involved in fatty acid biosynthesis, fatty acid uptake and activation, NADPH 
production, and triglyceride synthesis were all up-regulated at -10 d by overfeeding energy 
compared with CON. However, the expression of these genes was remarkably suppressed post-
calving in both groups. Despite the decrease in both groups, genes encoding adipose triglyceride 
lipase (ATGL) and its activator protein (ABHD5) were more highly expressed in OVE vs. CON 
at -10 and +7 d. PPARG exhibited the same expression pattern as ATGL and ABHD5, whereas 
CEBPA showed the same change as those of lipogenic genes. In conclusion, the sharply 
increased postparturient lipolysis in OVE cows may not be the consequence of insulin resistance 
induced by preparturient overfeeding. Overfeeding increased lipolytic gene expression, which 
may contribute to the greater body fat mobilization in early lactation. Prepartum overfeeding 
regulates adipose tissue metabolism at least from the transcriptional level.   
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INTRODUCTION 
Insulin is a major anabolic hormone in ruminants as in human and rodents. The classic 
mechanism of insulin action on adipose tissue includes stimulation of adipogenesis and glucose 
utilization and inhibition of lipolysis. ―Insulin resistance‖ has been defined as either decreased 
sensitivity (the insulin concentration to induce half-maximal response) or responsiveness (the 
maximal response) of insulin-sensitive tissues (primarily adipose and skeletal muscle) to insulin 
(Kahn, 1978).  
The periparturient period in ruminants has long been thought to represent a physiological 
state of increased peripheral insulin resistance (IR), which was considered an important 
homeorhetic adaptation to shift energy from peripheral tissues to the fetus and mammary gland 
(Bauman and Currie, 1980). Measurements of glucose utilization in vivo revealed that late-
pregnant ewes exhibit reduced insulin sensitivity (Petterson et al., 1993), and also had 
compromised responsiveness to insulin‘s antilipolytic effect (Petterson et al., 1994). In vitro 
insulin-stimulated glucose and acetate uptake were almost completely suppressed in 
subcutaneous adipose tissue from early lactating ewes (Vernon and Taylor, 1988). However, the 
underlying molecular mechanism for peripartal IR remains unclear. Vernon and Taylor (1988) 
were unable to attribute the apparent IR to changes in receptor number or insulin-receptor 
binding affinity, and they suggested the possibility of ―post-receptor‖ defects, which have not 
been evaluated in ruminants so far.  
With regard to insulin‘s antilipolytic effect, besides the hypoinsulinemia during early 
lactation (Bell, 1995), the apparent IR in adipose during the transition period is linked with the 
sharp increase in circulating NEFA around parturition. Whereas intrajugular infusion of the 
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insulin-sensitizing drug thiazolidinedione (TZD) during the close-up dry period was found to 
decrease postpartal serum NEFA linearly with increased dose administered (Smith et al., 2009).  
The ―steam-up‖ dietary approach during the last few weeks of gestation, i.e., feeding a 
higher-energy diet primarly by increasing cereal grains, has been used in the field for a number 
of years. On the one hand such a management approach was designed to compensate for the 
normal reduction in voluntary feed intake as parturition approaches, and was thought to be useful 
in priming the cow for greater appetite postpartum (Grummer, 1995); on the other hand, the high 
level of non-fiber carbohydrate (NFC) in the steam-up approach was expected to stimulate 
ruminal propionate production and consequently hepatic gluconeogenesis, which would trigger 
insulin secretion and suppress adipose tissue lipolysis during the periparturient period 
(Ingvartsen and Andersen, 2000).  
However, studies from different research groups demonstrated that prepartal overfeeding 
of energy from grains with greater NFC has often resulted in prepartal hyperglycemia and 
hyperinsulinemia and marked adipose tissue mobilization (i.e., greater blood NEFA 
concentration) at the initiation of lactation (Rukkwamsuk et al., 1999; Holtenius et al., 2003; 
Dann et al., 2006; Douglas et al., 2006; Janovick et al., 2011). As a consequence of increased 
lipolysis, energy-overfed cows had greater hepatic lipid accumulation and were more subject to 
metabolic disorders postpartum (Dann et al., 2006; Janovick et al., 2011). The observed signs 
resemble those of obesity-induced Type II diabetes, which is primarily due to dysfunctional 
insulin signaling in adipose tissue and skeletal muscle metabolism (McGarry, 2002). In 
comparison with the steam-up approach, physical control of prepartal energy consumption to 
meet but not greatly exceed energy requirements by inclusion of bulky forages (e.g., wheat straw, 
low-quality hay) stabilizes DMI around parturition, and has resulted in more ―moderate‖ 
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increases in blood NEFA during early lactation (Janovick et al., 2010). Thus, uncovering the 
mechanisms whereby dry period energy nutrition affects adipose tissue metabolism is of great 
importance.  
The metabolic effects of insulin are initiated upon binding of the hormone to the α-
subunit on its receptor (INSR), which induces a conformational change and activates the tyrosine 
kinase activity of the β-subunit. This event stimulates recruitment of insulin receptor substrate 
(IRS) proteins causing phosphorylation on multiple tyrosine residues (IRS-p-Y). Those 
phosphorylated residues serve as docking sites for a number of downstream proteins (Virkamäki 
et al., 1999). The tyrosine phosphorylation of IRS1 is linked with activation of thymoma viral 
protooncogene (AKT), which finally triggers the translocation of insulin-sensitive glucose 
transporter (GLUT4) (Foran et al., 1999) and activation of phosphodiesterase 3B leading to the 
initiation of insulin‘s antilipolytic effect in adipocytes (Kitamura et al., 1999).  
Accumulating evidence from rodent and human studies has revealed that defects in IRS1 
tyrosine phosphorylation are causal of  peripheral insulin resistance either during late pregnancy 
(Sevillano et al., 2007) or in cases of obesity induced by Type II diabetes (Esposito et al., 2001; 
Sesti et al., 2001). Hence, IRS1-p-Y could be used as parameter to determine insulin 
responsiveness in adipose tissue of transition dairy cows. More importantly, linking 
phosphorylation with transcriptomics could be valuable in expanding our mechanistic knowledge 
of nutritional regulation of peripartal adipose tissue metabolism and. The study of longitudinal 
changes in gene expression as it relates to insulin signaling could shed light on the long-term 
dynamic metabolic adaptations to physiological and nutritional status. 
The hypotheses that we sought to test in the present research were that prepartal energy 
overfeeding 1) exacerbates subcutaneous adipose tissue IR by compromising the tyrosine 
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phosphorylation of IRS-1, and 2) changes adipose tissue metabolism through alterations in 
expression  of genes encoding the major functional enzymes involved in adipogenesis, 
lipogenesis, and lipolysis.  
 
MATERIALS AND METHODS 
Experimental Design, Diet, and Animals 
All procedures were conducted under protocols approved by the University of Illinois 
Institutional Animal Care and Use Committee. Fourteen multiparous Holstein cows were used in 
this study. All cows were dried off at d -50  relative to expected parturition and fed a controlled-
energy diet (NEL = 1.24 Mcal/kg DM; Table 5.1) containing  wheat straw at 36% of DM for ad 
libitum intake during the far-off period (i.e. d -50 to d -21). During the close-up period (i.e. d -21 
to parturition), cows were randomly assigned either to a moderate-energy diet (Overfed or 
OVER; NEL = 1.47 Mcal/kg DM) or continuously fed the same controlled-energy diet 
(Controlled or CON) for ad libitum intake. The same lactation diet (NEL = 1.65 Mcal/kg DM) 
was provided for all animals postpartum until 30 days in milk (DIM). 
Managements, Sampling, and Analyses  
Both pre- and postpartum diets were mixed daily and fed as TMR. All cows were 
individually fed once daily at 0630 h. Individual feed offered and feed refusals were recorded 
daily from the initiation of dry period through 30 d postpartum. Cows were housed in a free stall 
barn with Calan gates during the dry period (dry-off at -50 d relative to expected parturition). At 
3 d before expected parturition, cows were moved to individual maternity pens until parturition. 
After parturition, cows were housed in tie stall barn and milked 3 times daily and milk yields 
were recorded. When cows were > 6 DIM, milk samples were taken at each milking of the same 
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day once weekly and analyzed for fat, protein, lactose, and urea N, as well as SCC (Dairy Lab 
Services, Dubuque, IA). Cow BW was recorded once weekly for all cows after the morning 
milking and before the morning feeding. Additionally, cows were weighed after parturition and 
calf birth weight was recorded. Body condition score (BCS) (Wildman et al., 1982) was 
independently evaluated by 2 individuals once per week and the mean score was used for each 
cow. Individual feed ingredients were sampled weekly and DM content (AOAC, 1995) was 
determined for each component. Rations were adjusted for DM of ingredients on a weekly basis. 
Weekly feed ingredient samples were dried and frozen at −20°C and then composited monthly 
for analysis of DM, CP, NDF, and ADF by wet chemistry techniques at a commercial laboratory 
(Dairy One, Ithaca, NY). For energy calculations, Dairy One used the Ohio State summative 
energy equation to predict total digestible nutrients (TDN) at maintenance and the NRC (2001) 
equations to calculate NEL at 3× maintenance, with the Van Soest variable discount system used 
for forages. Blood was sampled from the coccygeal vein or artery every Monday and Thursday 
before morning feeding from -21 to 30 d. Samples were collected into evacuated serum tubes 
containing clot activator. Serum was obtained by centrifugation at 1,300 × g for 15 min and 
frozen at -20°C until later analysis. Serum insulin concentration was analyzed by a commercial 
bovine insulin ELISA kit (cat. #10-1201-01; Mercodia AB). Concentrations of BHBA and 
NEFA were analyzed using commercial kits at the Veterinary Diagnostics Laboratory, College 
of Veterinary Medicine, University of Illinois.     
AT Biopsy and Tissue Handling 
Adipose biopsies were collected from alternate sides of the tail-head region at -10, 7, and 
21 d before the morning feeding. The hair of the surgical area was cut closely with clippers and 
washed with an iodine disinfectant mixture. Lidocaine-HCl (5 ml; Agri Laboratories) was given 
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intramuscularly to anaesthetize the biopsy area 10 min before performing a ~2 cm incision. 
Adipose tissue was collected with scalpel and forceps. The incision was then closed with surgical 
staples (Multi-Shot Disposable Skin Stapler, Henry Schein) and iodine ointment was applied to 
the wound. The wound was carefully watched for the following 7 d, and treated accordingly if 
any inflammation or swelling were observed. A 2-4 g of tissue was harvested by blunt dissection. 
Half of the tissue was quickly blotted with sterile gauze to remove residual blood and snap-
frozen in liquid N2 until RNA extraction for gene expression analysis. The remaining ~2 g of 
tissue was prepped for culture (only conducted with samples from -10 and 7 d) by quickly 
rinsing in pre-warmed (~37°C) sterile 1× PBS solution and coarsely minced to minimize risk of 
hypoxia. Subsequently, tissue samples were quickly transported (within 30 min after biopsy) 
back to the laboratory in pre-warmed (~37°C) 1× Dulbecco's Modified Eagle Medium (DMEM; 
Cat. #12320-032, Invitrogen).  
AT Explants and Protein Assay 
All of the following procedures, except weighing, were carried out under a laminar flow 
hood using sterile techniques. Tissue was carefully processed to remove adjacent non-adipose 
tissue, and chopped into small pieces of ca. 10 mg. Evenly distributed pieces of tissue were 
placed into sterile petri dishes (Cat. #5662-7161, Fisher Scientific) and weighed to make sure 
each culture dish contained ~100 mg tissue. Subsequently, all samples were quickly washed with 
5 mL 37°C 1× DMEM to remove lipid released from tissue during cutting. Samples were then 
transferred into 12-well culture plate (Cat. #CLS3512, Sigma-Aldrich), which contained 1.5 mL 
37°C 1× DMEM in each well. Tissue was pre-incubated in a water-jacketed CO2 incubator (at 
37°C with 5% CO2) for 30 min for adaptation.  
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After 30-min adaptation, two samples were taken out and served as duplicate negative 
controls, i.e. the 0 min sample before insulin challenge. The remaining samples were transferred 
into a new culture plate, which contained 1.5 mL 37°C 1× DMEM in each well with or without 
addition of 1 µmol/L bovine insulin (Cat. #I0516, Sigma-Aldrich; 10 mg/mL bovine insulin in 
25 mM HEPES, pH 8.2, sterile-filtered). Culture plates were then incubated with the same 
conditions as listed above. Duplicate samples with or without insulin were removed from plates 
at 15, 30, and 60 min of incubation,.   
After removal tissue samples were immediately immersed into 1.5 mL ice-cold 1× cell 
lysis buffer (Cat. #9803, Cell Signaling Technology
®
) containing 1 mM phenylmethylsulfonyl 
fluoride (PMSF; protease inhibitor, Cat. #P7626, Sigma-Aldrich) and were quickly homogenized.   
After homogenization tissue was sonicated in an ice bath 2 times for ca. 10 sec/time right to 
break down the nuclear membrane. Samples were then centrifuged at 8984 × g at 4°C for 10 min 
and the supernant was carefully transferred into 1.5 mL tubes without disturbing lipid layer, and 
stored at -80°C until protein analysis.  
Total protein was analyzed with the BCA protein assay kit (Cat. #23227, Thermo 
Scientific). Total IRS-1 and IRS-1 pan-tyrosine phosphorylation (IRS1-pY) were analyzed with 
PathScan
®
 Total IRS-1 Sandwich ELISA kit (Cat. #7328, Cell Signaling Technology
®
) and 
PathScan
®
 Phospho-IRS-1(pan Tyr) Sandwich ELISA kit (Cat. #7133, Cell Signaling 
Technology
®) according to manufacturer‘s instructions. Phosphorylation level of IRS1 was 
calculated according to the manufacturer‘s protocol by dividing absorbance values of IRS1-pY at 
450 nm by absorbance values of total IRS1 at 450 nm.  
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RNA Extraction, Primer Design and Evaluation, Internal Control Gene (ICG) Selection, and 
Real-time RT-PCR (qRT-PCR) 
RNA extraction, cDNA synthesis, primer design and evaluation, and real-time PCR 
(qPCR) were conducted as presented previously (Bionaz and Loor, 2008; the same as described 
in chapter 3 materials and methods). The information for primers used in this study is listed in 
Table S5.2. The criteria for ICG selection was described in Bionaz and Loor, 2007. In this study, 
8 candidate ICGs were evaluated using GeNorm software (for detail see chapter 3 materials and 
methods). Analysis revealed that genes encoding beta actin (ACTB), ribosomal protein S9 (RPS9) 
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were the most stably expressed and 
were finally used as ICG. Relative mRNA abundance was calculated for each gene to 
demonstrate the proportion of mRNA expression level of each gene in total mRNA abundance of 
all genes tested (for detail information on calculation of mRNA abundance, see chapter 3 
materials and methods).   
Statistical Analysis 
To avoid problems with fitting covariance structure, pre and postpartal data for DMI, 
NEL intake, energy balance, serum concentration of insulin, BHBA, and NEFA were analyzed 
separately as a completely randomized design using the MIXED procedure of SAS (version 9.1, 
SAS Institute Inc.) The fixed effects in the model were close-up diet (Trt), day or week, and Trt 
× day (or week) for each variable analyzed. The REPEATED statement was used for variables 
measured over time (DMI, NEL intake, energy balance, milk yield, milk components, and serum 
insulin, BHBA and NEFA). Autoregressive covariance structure was the best fit for these data. 
Significance was declared when P < 0.05, and tendencies when P < 0.15. 
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Phosphorylation level of IRS1-pY from the negative control samples was analyzed as a 2 
× 2 factorial in CRD using PROC MIXED procedure of SAS to evaluate the effects of close-up 
diets (Trt) and day relative to parturition (Day) on IRS1 tyrosine phosphorylation. The data from 
samples after insulin challenge were analyzed as 2 × 2 × 3 in CRD with the same SAS program 
to evaluate the main effects of Trt, Day and insulin challenge time (Time) and all the interactions 
of IRS1-pY.   
The relative mRNA abundance data of the tested genes were normalized with the 
geometric mean of 3 ICGs. To ensure normal distribution of residuals, normalized data were 
subjected to square root transformation. This final dataset was analyzed as 2 (Trt) × 3 (Day) 
factorial in CRD using PROC MIXED model. Significant difference was declared at P ≤ 0.05, 
and tendency of significance at P ≤ 0.10. Contrasts were conducted for genes with significant 
interactions and declared significant at P < 0.05.   
 
RESULTS 
Performance, Serum Hormone and Metabolites, and Hepatic Lipid Accumulation 
As expected, compared with CON, OVE cows had greater DMI (P = 0.05), NEL intake (P 
< 0.01), energy balance (P < 0.01), serum insulin concentration (P < 0.01), and numercially 
lower serum NEFA concentration (P = 0.16) during the close-up period. In comparison with 
CON, close-up energy overfeeding had no effect on postpartal (within 30 DIM) DMI, NEL intake, 
energy balance, serum insulin concentration (P > 0.10). However, OVE animals had a tendency 
for greater circulating BHBA (P = 0.06) and numercially higher serum NEFA concentration 
post-calving (P = 0.15). When comparing serum NEFA changes postpartum vs. the close-up 
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period between the two groups, energy overfeeding resulted in significantly higher NEFA 
change post-calving (P = 0.04) (shown in Table 5.2, Figure 5.1-5.3 and 5.5).  
Close-up energy overfeeding did not affect milk production, fat-corrected milk yield (3.5% 
FCM), energy corrected milk yield (ECM), or any milk components either expressed as 
percentage or as yields (P > 0.10) . There was a tendency for lower milk protein percentage in 
OVE cows (P = 0.10). Both groups had greater hepatic lipid and TAG concentration postpartum 
(P < 0.01). However, prepartum energy overfeeding resulted in a more pronounced increase in 
both indices in early lactation. Particularly at 21 d post-calving, OVE cows still had greater TAG 
and lipid contents in liver compared to 7 d, whereas CON cows tended to decrease TAG and 
lipid between 7 and 21 d as expressed by  tendency and significance of interactions of treatment 
and day relative to parturition (Figure 5.4).  
Gene Expression 
Insulin Signaling Pathawy 
As shown in Figure 5.6, no treatment effect was detected for INSR mRNA expression (P 
= 0.77), perhaps due to the large variation observed. Overfeeding tended to increase IRS1 
expression (P = 0.08), which appeared to be due to the difference at 21 d post-calving. 
Expression of IRS1 mRNA increased markedly in both groups at 21 d compared with -10 and 7 d 
(P < 0.01). Cows fed OVE had greater mRNA expression of GLUT4 at -10 d (P < 0.05), but the 
expression was sharply downregulated postpartum in both groups (P < 0.05). In comparison with 
OVE cows, controlled energy feeding resulted in greater PDE3B expression primarily at -10 and 
7 d (P = 0.02). The mRNA expression of this gene was lower in late pregnancy in both groups, 
but increased at 7 d postpartum followed by a drastic decreased at 21 d of lactation (P < 0.01).    
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de novo Lipogenesis and Desaturation 
A coordinated upregulation was observed for genes involved in de novo FA synthesis and 
desaturation (ACLY, ACACA, FASN, and SCD), FA uptake and activation (LPL, ACSS2, and 
ACSL1), NADPH production and glyceroneogenesis (G6PD, IDH1, and PCK1), and TAG 
synthesis (GPAM and DGAT2) in response to close-up energy overfeeding at -10 d relative to 
expected parturition (P < 0.05). However, the mRNA expression of all these genes regardless of 
prepartal diet was drastically downregulated to the same expression at 7 d postpartum, and 
remained unchanged through 21 d of lactation (P < 0.05) (shown in Figure 5.7 and 5.8).  
Lipolysis 
Prepartal energy overfeeding led to greater mRNA expression of adipose triglyceride 
lipase (ATGL), and its activator protein ABHD5, at -10 and 7 d compared with controlled energy 
feeding (P < 0.05). At 21 d after calving, the expression profiles of these two genes were similar 
in both groups. The mRNA expression of the gene encoding the major β-adrenergic receptor in 
adipocyte, ADRB2, was increased at 21 d compared with its level at -10 d in both groups (P < 
0.01). A numerically higher expression of HSL and ADRB2 was found in OVE vs. CON cows at 
7 d (shown in Figure 5.9).  
Transcritpion Regulators, GHR and ANGPTL4 
As shown in Figure 5.10, a significant main effect of prepartal dietary energy level was 
detected for the mRNA expression of the major transcription factors (TF) regulating 
adipogenesis, CEBPA (P = 0.04) and PPARG (P = 0.03). However, this main effect was 
primarily due to the remarkably higher expression of CEBPA and PPARG at -10, and PPARG at 
7 d in cows fed OVE vs. CON. However, OVE cows had lower adipose SREBF1 mRNA 
expression at -10 d than CON group (P < 0.05). A significant interaction of prepartal dietary 
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level and day relative to parturition was observed for the mRNA expression of ANGPTL4 (P < 
0.05), recognized as fasting-induced adipose factor (Kersten et al., 2000). Controlled energy 
feeding during the close-up period led to greater mRNA expression in AT at -10 and 21 d 
relative to parturition compared with overfeeding energy; whereas, the expression of this gene 
was sharply increased to the similar level at 7 d postpartum in both groups. The mRNA of GHR 
displayed the same expression pattern as PPARG.  
IRS1 Tyrosine Phosphorylation  
In the absence of the insulin challenge in vitro, no significant difference of prepartal 
overfeeding on IRS1 phosphorylation level was observed. at -10 and 7 d was However, 
decreased IRS1-pY was observed for both groups at 7 vs. -10 d relative to parturition. In tissue 
challenged with supraphysiological amounts of bovine insulin across the different time points, 
phosphorylation level was significantly lower in postpartal than prepartal tissue. Furthermore, 
adipose from OVE or CON cows responded to the same in vitro insulin challenge differently in 
pre- and postpartum, i.e. IRS1-pY level was greater at -10 d and lower at 7 d in OVE vs. CON 
cows (shown in Figure 5.11).    
 
DISCUSSION 
Production Data 
Similar to what we found in previous studies (Janovick et al., 2010), CON  successfully 
controlled the DMI during the entire dry period and limited NEL intake close to predicted 
requirements. This was probably due to the bulkiness from wheat straw and the ensuing rumen 
fill response. Since OVE contained 9% more of ground shelled corn (GSC) than CON diet, those 
cows consumed ca. 1.4 kg more of GSC daily than CON animals, which may have resulted in 
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greater propionate production prepartum. Thus, it is reasonable to assume that hepatic 
gluconeogenesis was quantitatively greater in OVE animals, thus stimulating greater pancreatic 
insulin secretion as we found in OVE cows. Although we did not analyze serum glucose 
concentration in the current study, the repeatable data from two recently finished studies 
(Richards et al., 2009; Vasquez et al., unpublished data), which utilized the same dry period 
feeding strategy as the present study, showed that hyperinsulinemia due to close-up overfeeding 
energy was always paralleled with hyperglycemia. Regardless of treatment duration (either in 
far-off or close-up or the entire dry period), this and previous research from our laboratory (Dann 
et al., 2006; Janovick et al., 2011) and others (Holtenius et al., 2003; Rabelo et al., 2005) clearly 
showed that overfeeding energy by increasing NFC content resulted in higher blood 
concentrations of insulin and glucose level, which was analogous to the IR state found in patients 
with Type II diabetes.  
It is noteworthy that in all studies mentioned above, circulating insulin and glucose 
concentrations affected only by current feeding level, and no carryover effect was observed when 
cows were switched to another dietary energy plane. It has long been established that late-
pregnant dairy cows experience a state of peripheral insulin resistance as a mechanism to spare 
glucose for fetal growth (Bauman and Currie, 1980). Uterine tissues take up ca. 46% of maternal 
glucose supply in an insulin-independent manner in late-pregnant cows (Bell, 1995). Hence, the 
alternative explanation for this period of energy-overfeeding IR state is that an increase in 
gluconeogenesis may have exceeded the maximal disposal rate of glucose by peripheral tissues 
during the late pregnant period.  
The same pre- and postpartal patterns as in the current study with significant differences 
in circulating NEFA between OVE and CON cows have been observed in previous studies in 
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which overfeeding was implemented for the whole dry period (Janovick et al., 2011) or during 
the close-up period ( Vasquez et al., 2011; significant difference in pre- and numerical difference 
in postpartum from Richards et al., unpublished data). Relative to previous studies, the smaller 
number of animals (7 in each treatment) likely precluded us from detecting statistical 
significance in serum NEFA concentration between the two groups.  
Rukkwamsuk et al. (1998) reported that adipose tissue cows overfed energy during the 
entire dry period collected at -1 wk relative to parturition had lower basal lipolytic rate in vitro, 
but tended to have greater noradrenaline-stimulated lipolysis at -1 and 3 wk in comparison with 
energy restricted  animals. A second study from the same group demonstrated that adipose tissue 
from the same overfed cows had greater in vitro rates of basal esterification at -1 wk 
(Rukkwamsuk et al., 1999), which probably helped recycle mobilized NEFA into TAG and helps 
explain the lower prepartal adipose lipolytic rate in overfed cows. Thus, such responses also may 
partly explain the lower circulating prepartal NEFA in overfed cows in the current and previous 
studies (Dann et al., 2006; Janovick et al., 2010).  
The greater postpartal hepatic lipid and TAG concentration and greater serum BHBA in 
overfed animals provide indirect evidence of greater lipolytic activity after calving. Fasting has 
been linked with higher NEFA mobilization and reduced peripheral response to insulin and 
glucose uptake (Oikawa and Oetzel, 2006). However, even though the postparturient DMI and 
energy balance were not different between the two groups in the current study, OVE cows still 
experienced a more prominent increase of serum NEFA after calving. This phenomenon does not 
seem to be specific to the periparturient period. Dann et al. (2006) found that cows that 
overconsumed higher energy in the far-off dry period and were energy restricted in the close-up 
period had the highest close-up serum NEFA concentrations than groups receiving CON or ca. 
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80% of estimated NEL requirements in the far-off and were energy restricted in the close-up 
period. Thus, our data and those from previous studies indicated that prepartal plane of energy 
nutrition impacted the mechanisms controlling lipolysis or lipolytic activity, the sensitivity to 
lipolytic stimulation, or a combination of these aspects. 
Both prepartal dietary groups had relatively low  postpartal serum insulin concentrations, 
thus, as adipose tissue is subjected to antilipolytic regulation by insulin, it was of great 
importance to determine whether prepartal overfeeding of energy predisposes animals to an 
exacerbated IR state resulting in greater mobilization of body fat.  In the current study, close-up 
energy overfeeding had no benefit on milk production or component yields, yet resulted in 
greater postpartal NEFA which underscored the lower efficiency of such feeding strategy. Such 
results are consistent with the recent findings from two studies in our group, in which the same 
dietary treatments with larger groups of animals were employed (Richards et al., 2009; Vasquez 
et al., 2011).  
In ruminants, hepatic uptake of circulating NEFA is in proportion to its circulating 
concentrations (Bell, 1979) and, relative to other species, the cow has limited capacity to 
synthesize VLDL in liver (Emery et al., 1992; Bauchart et al., 1996). Hence, the increased 
accumulation of hepatic lipid is the consequence of uncontrolled increases in blood NEFA at the 
onset of lactation. This phenomenon is more pronounced when cows are fed with high-energy 
density, high-starch diets during the dry period (current study; Grum et al., 1996; Holtenius et al., 
2003; Janovick et al., 2011). Hepatic metabolic adaptations to periparturient nutritional plane 
was not the focus of current study, and readers are referred to recent reviews (Drackley et al., 
2001; Friggens et al., 2004) for more detailed information on that aspect.  
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IRS1 Tyrosine Phosphorylation and Expression of Insulin Signaling Genes 
The underlying mechanisms of IR during the transition period are still unclear. Using the 
euglycemic hyperinsulinemic clamp, Petterson et al. (1993) demonstrated that IR during late 
pregnancy was primarily due to impaired peripheral insulin sensitivity, which suggested that 
mechanisms involved reduction in INSR binding or defects in early post-receptor signal 
transduction. Early studies regarding alterations of INSR numbers and binding affinity were 
mainly conducted with ewes and failed to give conclusive results (Vernon et al., 1981; Vernon 
and Taylor, 1988; Guesnet et al., 1991). Guesnet et al. (1991) reported a 62% decrease of INSR 
accompanied by markedly decreased insulin-stimulated lipogenesis in omental AT of early 
lactating ewes. Vernon and Taylor (1988) showed that, compared with non-lactating controls, 
SAT from early lactation ewes had both reduced sensitivity and response to insulin stimulated 
glucose uptake and FA synthesis in vitro. However, neither number nor binding affinity of INSR 
differed between the two physiological states. Recently, a similar study showed that the mRNA 
expression of INSR in SAT of periparturient dairy cows remained unchanged from 8 wk pre- to 
5 wk postpartum (Sadri et al., 2010). In the current study, with greater degree of variation, INSR 
expression was not affected during the transition period, which seems to highlight a weak 
association with transition period IR.  
Vernon and Taylor (1988) attributed lactational IR to defects in intracellular insulin 
signaling transduction at the post-receptor level. At the molecular level, insulin receptor 
substrates (IRS) are the proteins that carry out the first intracellular step mediating insulin 
signaling. IRS1, rather than the other isoforms, is preferentially involved in insulin-induced 
metabolic actions including glucose uptake (Saltiel and Kahn, 2001). Phosphorylation of IRS1 
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on tyrosine residues is required for insulin stimulated glucose uptake. A substantial body of 
research demonstrated a causal relationship between compromised tyrosine phosphorylation of 
IRS1 (IRS1-pY) and adipose IR  in either late pregnant rodents (Sevillano et al., 2007) or in 
cases of obesity-induced Type II diabetis (Esposito et al., 2001; Sesti et al., 2001; Smith, 2002).  
IRS1-pY was shown to be relatively sustained due to less dephosphorylation by 
phosphatase (Ogihara et al., 1997), so we assume that the phosphorylation level of IRS1 in 
adipose tissue that adapted to the culture medium without bovine insulin for 30 min was still 
representative of its basal physiological state. As shown in Figure 5.11, IRS1-pY was 
significantly reduced at 7 d postpartum compared with 10 d before calving, which suggested a 
lower degree of insulin signaling postpartum. However, we do not believe that this result alone 
was indicative of exacerbated an IR state in early lactation because lower IRS1-pY also may be 
due to the postpartal hypoinsulinemia observed. Similarly, the numerically lower prepartal IRS1-
pY in cows fed CON may have resulted from lower serum insulin concentration in those animals.  
A supraphysiological challenge with bovine insulin should have elicited maximal 
response in IRS-pY, which was clearly reflected by the much higher phosphorylation level after 
insulin challenge. After insulin stimulation and regardless of prepartal diet, the IRS1-pY was still 
much lower in postpartal than prepartal tissue. Thus, we speculate that animals experienced more 
severe peripheral IR early post-calving to spare more glucose for milk synthesis. At the 
transcriptional level, no significant dietary treatment difference was observed in IRS1 mRNA 
expression between -10 and 7 d, which suggests that defects in posttranslational modification of 
IRS1 is likely the major mechanism exacerbating  IR at the initiation of lactation. The 
concomitant decrease of GLUT4 expression also represented a reduction in the capacity of 
glucose uptake by adipose during early lactation. If a similar scenario was prevailing in goats, it 
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may help to interpret the diminished whole-body glucose utilization in response to insulin in 
lactating vs. nonlactating goats (Debras et al., 1989). This may at least in part also be responsible 
for the loss of lipogenic activity in subcutaneous adipose tissue of early lactating cows 
(McNamara et al., 1995), as glucose is an important source of cytosolic NADPH required for FA 
biosynthesis (Bauman, 1976). The increase in mRNA expression of IRS1 in both groups from 7 
to 21 d postpartum suggests that transcriptional regulation may be involved in the process of 
restoration of insulin responsiveness after calving.  
Contrary to our hypothesis, OVE cows had higher insulin-stimulated IRS1-pY and 
GLUT4 mRNA expression than CON cows prepartum, and no significant difference was 
observed between the two groups postpartum, i.e., close-up energy overfeeding did not 
predispose animals to a more IR status but rather if anything seemed to have enhanced insulin 
sensitivity. Holtenius et al. (2003) reported a greater glucose clearance rate (GCR) after a 
glucose tolerance test (GTT) in overfed vs. underfed cows at 3 wk prior to calving. Therefore, 
the higher GCR may have reflected the real peripheral response to GTT in overfed cows. 
Ruminants have lower peripheral insulin responsiveness in terms of glucose utilization relative to 
humans and rodents (e.g. maximal insulin-stimulated glucose utilization rate for sheep or bovine 
was 50-75% and 15-20% of the rate for human and rats; Hocquette et al, 1996), and insulin had 
insufficient inhibitory effect on propionate-derived hepatic gluconeogenesis (Brockman, 1990; 
Donkin and Amentano, 1995).   The higher prepartal serum insulin and glucose concentration in 
overfed cows as observed in the current study (glucose was not measured) and other studies 
(Holtenius et al., 2003; Dann et al., 2006; Janovick et al., 2011) may be due to the fact that the 
increase in gluconeogenesis induced by energy overfeeding overwhelmed the mechanisms of 
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peripheral tissue glucose utilization in late pregnancy, rather than contributed to an exacerbated 
insulin resistance.  
Insulin antagonizes cAMP-mediated lipolytic signaling downstream of IRS signaling 
pathway through activation of PDE3B in an AKT-dependent manner (Kitamura et al., 1999; 
Degerman et al., 2003). Upon insulin-stimulated phosphorylation, PDE3B catalyzes metabolism 
of cAMP into AMP, which in turn reduces the activation of PKA and consequently blunts 
hormone-stimulated lipolysis in adipocytes. The lower prepartal serum NEFA in OVE cows may 
have been caused by higher circulating insulin and greater adipose insulin sensitivity. 
Interestingly, adipose from CON cows, which had greater prepartal NEFA level, also had greater 
mRNA expression of PDE3B at -10 and 7 d. Those responses suggested the existence of a 
feedback-regulating mechanism that was activated in response to a blunted anitlipolytic response 
by insulin (i.e., signaling may have been ―impaired‖) through upregulation of PDE3B expression. 
Such mechanism was more pronounced for both groups at 7 d and coincided with a marked 
increase in serum NEFA and exacerbated IR postpartum. Hence, the prolonged upregulation of 
PDE3B postpartum as a consequence of controlled energy feeding during the dry period may be 
one of the factor that contributes to lower postpartal lipolysis relative to OVE cows. 
Lipogenesis 
Recent studies in ruminants has provided compelling evidence that transcriptional 
regulation in response to different nutritional planes and physiological status is an important 
control mechanism of  lipid metabolism in mammary gland (Bauman et al., 2008; Bionaz and 
Loor, 2008), skeletal muscle (Graugnard et al., 2009), liver (Loor et al., 2005, 2006), and adipose 
tissue (Loor, 2010).  In non-lactating ruminants, adipose tissue is the principal site of lipogenesis 
(Bergen and Mersmann, 2005). Previous studies showed that cows overconsuming energy during 
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the dry period gained more weight and body condition before calving (Dann et al., 2006; 
Janovick et al., 2010). In the current study, expression of ACACA, FASN, and SCD, encoding the 
major enzymes involved in de novo fatty acid synthesis (DNS), was upregulated in OVE cows at 
-10 d likely as a result of excessively positive energy balance. As acetate is the major precursor 
for DNS in ruminant adipose tissue (Hood et al., 1972), the higher expression of ACSS2 
indicated that OVE cows had the potential to activate and channel more acetate from blood 
towards adipogenesis during the dry period. Although classic in vitro studies showed low activity 
of ATP-citrate lyase (ACLY) in ruminant adipose (Ingle et al., 1972a), which indicated  minimal 
contribution of glucose-derived carbon for lipogenesis, we still observed a more than 2-fold 
increase in mRNA expression of ACLY at -10 d in response to OVE vs. CON. Thus, data indicate 
potentially greater glucose use for lipogenesis in those cows and also that this enzyme is 
adaptable, at least at the transcriptional level, to nutrient availability and particularly dietary 
starch content as was observed previously in beef skeletal muscle (Graugnard et al., 2010).  
In ruminant adipose tissue, the cytosolic isocitrate dehydrogenase (IDH1) and pentose 
phosphate pathway were highlighted as the predominant sources for NADPH production to 
support DNS (Ingle et al., 1972b). Both IDH1 and G6PD, the rate limiting enzymes controlling 
each pathway, were coordinately upregulated along with the other lipogenic genes in OVE vs. 
CON cows in the prepartal period.  Those responses support the notion that lipogenesis was 
enhanced by energy overfeeding. In fact, not only was DNS apparently increased but the process 
of uptake of preformed FA also was probably enhanced prepartum by energy overfeeding as 
reflected by greater expression of LPL and ACSL1 in OVE vs. CON cows.  
Lastly, the greater expression of GPAM and DGAT2 in OVE vs. CON group at -10 d 
seems to be in agreement with the greater prepartal basal adipose esterification rates found 
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previously in energy-overfed vs. restricted-fed cows (Rukkwamsuk et al., 1999), which also 
supports our hypothesis that lower prepartal serum NEFA in OVE vs. CON cows may have 
partially resulted from greater recycling of NEFA within adipose tissue through re-esterification. 
Overall, the data discussed here strongly indicate that adipose lipogenesis was stimulated by 
enhanced plane of energy nutrition in late pregnancy and, at the transcriptional level, the entire 
process was synchronized, i.e., there was likely a strong degree of co-regulation via a 
transcription factor or nuclear receptor. 
In the current study, the remarkable and coordinated downregulation of lipogenic genes 
after calving explains the nearly complete loss of in vitro lipogenic enzyme activity in adipose 
tissue from early lactating dairy cows (McNamara et al. 1995). No carryover effects of prepartal 
plane of nutrition were detectable postpartum for any of these genes, indicating that the well-
established physiological changes (NEB, hormonal environment, stress) around parturition 
override the impact of dry period nutritional management on adipose lipogenesis.  
Insulin, the principal anabolic hormone that stimulates transcription of lipogenic genes in 
adipocytes, mediates parts of its response through activation of transcriptional regulators 
(Kersten, 2001; Griffin and Sul, 2004; Rosen and MacDougald, 2006). In the present study, the 
expression pattern of lipogenic genes during the transition period matched well the changes 
observed in serum insulin concentration and insulin sensitivity assessed by IRS1-pY, regardless 
of plane of nutrition prepartum. Therefore, we speculate that postparturient hypoinsulinemia and 
exaggerated IR directly cause the suppression of mRNA expression of lipogenic genes. 
Lipolysis 
The classic lipolytic pathway in response to β-adrenergic stimulation and HSL is well-
established. Not until recently has accumulating evidence indicated the existence of another 
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lipolytic enzyme, adipose triglyceride lipase (ATGL), that is highly expressed in white adipose 
tissue and is primarily responsible for basal and β-adrenergic-stimulated TAG hydrolysis 
(Miyoshi et al., 2007 and 2008). The complete activation of ATGL requires binding to its 
activator protein ABHD5 after it dissociates from perilipin following phosphorylation induced 
by β-adrenergic stimulation (see review by Zechner et al., 2009). Due to the specificity or 
preference of its substrate (triacylglycerol), ATGL is now considered the rate-limiting enzyme of 
lipolysis in mammals (Haemmerle et al., 2006). The anti-lipolytic effect of insulin reduces the 
activity of PKA by stimulating PDE3B, which increases catabolism of cytosolic cAMP, thereby 
preventing phosphorylation of PLIN and effectively reversing the dissociation of PLIN and 
ABHD5 (Subramanian et al., 2004).  
Based on the known roles of ATGL and ABDH5, it was interesting that OVE cows had 
both lower prepartal serum NEFA and higher mRNA expression of ATGL and ABHD5. Despite 
the well-characterized posttranslational modification of lipolytic enzyme activities, the amount 
of available enzyme, which is regulated at the transcriptional level, may also affect the 
magnitude of lipolytic reactions. As discussed previously OVE cows had higher prepartal serum 
insulin and likely undiminished insulin sensitivity compared with CON cows, i.e. lower lipolytic 
capacity. In addition, transcriptional adaptations in these cows likely resulted in greater potential 
for re-esterification of NEFA released from either basal or stimulated lipolysis. Thus, despite the 
greater mRNA expression of ATGL and ABHD5, it is possible that lipolysis was still tightly 
controlled in OVE cows prepartum.  
Postpartum, both ATGL and ABHD5 mRNA expression were decreased in both groups, 
which agrees with the reduced adipose ATGL protein expression in early lactating vs. late 
pregnant dairy cows observed recently (Koltes and Spurlock, 2011). Both mRNA and protein 
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expression of ATGL in AT were reduced in individuals with obesity-induced insulin resistance 
compared with insulin-sensitive subjects (Jocken et al., 2007). The parallel postpartal decrease of 
ATGL mRNA expression with IRS1-pY implicates that insulin sensitivity is required to maintain 
ATGL expression in bovine adipocytes. However, the carryover effect of close-up energy 
overfeeding was maintained because both genes were upregulated at 7 d postpartum in OVER 
cows compared with. CON cows. Interestingly, the mRNA expression of HSL and ADRB2 (the 
major isoform of β-adrenergic receptor in adipocytes, Table 5.3) also was greater in OVE than 
CON cows at 7 d. Such response indicated that OVE cow may have been more sensitive to 
lipolytic stimulation, e.g. via norepinephrine, postpartum. On the other hand, adipose insulin 
sensitivity and responsiveness (assessed by decreased IRS1-pY and GLUT4 mRNA expression) 
and esterification capacity (assessed by decreased mRNA of GPAM, DGAT2 and PCK1) 
appeared to have been depressed to the same extent in both dietary groups.  
The sympathetic nervous system in AT appears to be more active during early lactation 
(McNamara and Murray, 2001). Koltes and Spurlock (2010) found increased phosphorylation of 
HSL early post-calving compared with late pregnancy, despite unchanged HSL protein 
expression, which supported the notion of greater postparturient β-adrenergic stimulated lipolysis. 
Together, these data allow a better mechanistic explanation of the greater circulating NEFA in 
OVE cows early postpartum as has been repeatedly observed in recent studies (Holtenius et al., 
2003; Dann et al., 2006; Janovick et al., 2011). The greater expression of lipolytic genes (ATGL, 
HSL, and ADRB2) also provides answers for the greater in vitro noradrenaline-stimulated 
lipolysis in adipose tissue from cows that were overfed energy during the dry period compared 
with restricted-fed cows (Rukkwamsuk et al., 1998). In comparison with d -10, the mRNA 
expression of the major adipose β-adrenergic receptor ADRB2 was increased in both groups, 
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indicating that the increased lipolysis during early lactation is not simply a cause of decreased 
insulin responsivennes but also increased sensitivity to lipolytic stimulation.  
Transcriptional Regulation 
One of the well-established functions of insulin is to stimulate adipogenesis, the 
differentiation process of preadipocyte into lipid-loaded mature adipocytes. This process is 
initialized by activating the sequential expression of a series of transcription regulators; PPARγ 
and C/EBPα induced by ―early‖ transcription regulators (mainly C/EBPβ and C/EBPδ) are 
considered the ―master regulators‖ mediating insulin signals to activate transcription of most 
lipogenic genes (Rosen and MacDougald, 2006). In comparison with CON cows, the coordinated 
upregulation of lipogenic genes at -10 d in OVE-fed cows paralleled the greater expression of 
PPARG and CEBPA. Despite a lack of direct evidence in bovine adipocytes, Kadegowda et al. 
(2009) found increased mRNA expression of ACACA, FASN, DGAT1, LPIN1, and AGPAT6 in 
bovine mammary epithelial cells when the culture medium was supplemented with the PPARγ 
agonist rosiglitazone. Thus, we suggest from our data that expression of lipogenic genes was 
probably subject to PPARγ transcriptional regulation.  
The accumulating literature has defined multiple roles of C/EBPα in adipogenesis. First, 
the presence of C/EBPα was required for maintaining PPARγ expression during adipocyte 
differentiation in non-ruminants (Farmer, 2006). Furthermore, blunting CEBPA expression led to 
markedly lower expression of PPARG, FABP4, GLUT4 and DGAT2 in 3T3-L1 preadipocytes 
even after culture in differentiation-stimulating medium for 5 d (Payne et al., 2010). Mice 
deficient in C/EBPα have defective development of white AT (Linhart et al., 2001). Our data 
revealed an expression pattern of CEBPA identical to that of lipogenic genes in response to 
dietary treatment and the change in physiological state during transition period; whereas, despite 
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a moderate decrease after calving, PPARG expression was still significantly greater in AT of 
overfed vs. control cows at 7 d postpartum. Thus, our results seem to implicate that the presence 
of C/EBPα is required to sustain the expression of lipogenic genes. The presence of C/EBPα is 
also required for acquisition of insulinsensitivity in adipocytes. Differentiated C/EBPα(-/-) fat 
cells (induced by ectopic expression of PPARγ) completely lost insulin-stimulated glucose 
uptake, which is primarily due to reduced gene expression and tyrosine phosphorylation of INSR 
and IRS1 (Wu et al., 1999). Whether the reduced adipose IRS1-pY postpartum observed in the 
current study resulted from the decreased expression of CEBPA warrants further research.   
The transcription factor SREBF1c has well-documented importance in stimulating 
hepatic lipogenic gene expression in humans and rodents (Foufelle and Ferré, 2002). It also has 
been reported as another important pro-adipogenic transcription factor (Eberle et al., 2004), 
partly due to the production of an as-yet unknown endogenous PPARγ ligand in adipocytes (Kim 
and Spiegelman, 1996; Kim et al., 1998). However, in our study, SREBF1 expression was lower 
in energy-overfed vs. control cows at -10 d, which is the opposite of the expression of lipogenic 
genes and PPARG. Thus, our data do not support a key role of SREBF1 in lipogenesis of 
subcutaneous AT at least from a transcriptional standpoint.  
In the present study, we observed the same expression pattern of PPARG and ATGL in 
response to energy overfeeding. In fully-differentiated 3T3-L1 adipocytes, both ATGL mRNA 
and protein expression are induced by PPARγ agonists in a dose- and time-dependent manner 
(Kershaw et al., 2007). The same response of ATGL was observed in WAT of either lean or 
obese mice following oral treatment with the PPARγ agonist rosiglitazone (Kershaw et al., 2007).  
Such transcriptional regulation of ATGL by PPARγ was supported by another study as well (Kim 
et al., 2006). Therefore, we postulate that increased prepartal insulin in response to overfeeding 
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energy stimulated PPARG expression and its activity as a transcription factor, which. in turn 
increased transcription of ATGL. However, the carryover effect of overfeeding energy seems to 
have maintained a greater expression of PPARG (and probably its activity) only through the first 
few days post-calving. As a consequence, the ATGL mRNA expression remained higher in OVE 
cows in early lactation. That effect likely contributed to the greater magnitude of lipolysis in 
OVE cows. The transcriptional regulation of PPARγ on ATGL warrants further research. 
Other Factors Involved in the Regulation of Lipid Homeorhesis During the 
Periparturient Period 
Besides insulin, growth hormone (GH) also plays an important role in orchestrating the 
metabolic adaptation and nutrient partitioning (Bauman and Vernon, 1993). Growth hormone 
stimulates hepatic synthesis and secretion of IGF-1, which serves as feedback signal to control 
GH release (Le Roith et al., 2001). However, early lactation was characterized as a period of 
uncoupling of the GH – IGF-1 axis (Lucy, 2008). The plasma concentration of GH of dairy cows 
was increased during early lactation, when animals were experiencing NEB (Bell, 1995). Growth 
hormone targeting of AT functionally antagonizes insulin‘s effects by amplifying the lipolytic 
response to β-adrenergic signals and inhibiting lipogenesis (Etherton and Bauman, 1998). Thus, 
the greater circulating GH concentration contributes to increased lipolysis postpartum. Rhoads et 
al. (2004) reported that the abundance of GHR protein in AT of dairy cows fell in paralleled the 
decrease of plasma insulin concentration from late pregnancy (-28 d) to early lactation (10 d). 
Administration of exogenous insulin increased adipose GHR protein expression in both late 
pregnancy and early lactation (Rhoads et al., 2004). In the current study, close-up overfeeding 
increased adipose mRNA expression of GHR at -10 d, which may have been mediated by the 
increased plasma insulin concentration in OVE cows. Despite decreased postpartal expression in 
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both groups, the carryover effect of energy overfeeding maintained greater GHR mRNA in OVE 
cows vs. CON cows at 7 d postpartum. Hence, the OVE cows may be more responsive to 
increased GH postpartum and have greater lipolytic activity in AT.     
Adipose tissue also serves as an active endocrine organ to affect metabolic homeostasis 
by secreting an array of adipocytokines. Both mRNA and protein,of ANGPTL4 (fasting-induced 
adipose factor), are highly expressed in WAT and liver of rodents (Kersten et al., 2000) and 
humans (Kersten et al., 2009) as well as in cattle (Mamedova et al., 2010). A growing body of 
literature demonstrated that ANGPTL4 is upregulated in adipose tissue by fasting and inhibits 
LPL activity with a consequent increase in lipolysis (see reviews by Kersten, 2005 and Hato et 
al., 2008). Mice lacking ANGPTL4 (Angptl4
-/-
) have increased ability to gain weight (Bäckhed 
et al., 2004); whereas, mice overexpressing this protein in WAT have a remarkably limited 
capability for TAG accumulation and have increased concentrations of circulating TAG and 
NEFA (Mandard et al., 2006).  
In the present study, changes in adipose mRNA expression of ANGPTL4 during the 
periparturient period coincided with changes of circulating NEFA concentration in both groups. 
Particularly prepartum, the OVE cows had lower expression of ANGPTL4, greater LPL mRNA, 
and lower serum NEFA than CON cows. However, such a relationship did not seem to apply at 
21 d postpartum. Despite being identified as a target gene of PPARγ in preadipocytes in mice 
(Yoon et al., 2000), our study does not support such abrelationship at least from the PPARG 
standpoint. Further research is required to clarify the function of ANGPTL4 in the regulation of 
lipid homeostasis in peripartal cows.  
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CONCLUSIONS 
The results of the present study provide evidence that moderately overfeeding energy 
during the last 3 wk of the prepartal period facilitates rather than compromises the pathway of 
insulin signaling in subcutaneous adipose tissue of dairy cows. This may contribute to the 
increase in lipogenic gene expression and, potentially, lipid deposition in adipose tissue both in 
subcutaneous and internal depots. Adipose insulin resistance may be exacerbated postpartum vs. 
prepartum due to both reduced circulating insulin and increased lipolytic stimuli. Physiological 
adaptations around parturition overwhelmed the transcriptional adaptations of adipose lipogenic 
genes induced by prepartal energy overfeeding. However, the sustained higher expression of 
lipolytic-related genes including ATGL and ABHD5 and the lower mRNA expression of PDE3B 
may contribute to the parallel and remarkably increased rates of lipolysis that were apparent in 
overfed animals at the initiation of lactation. Our study highlighted the presumed pivotal role of 
PPARγ and CEBPα as the major transcriptional regulators of lipogenic gene expression during 
the preparturient period. In addition, we speculate that PPARγ may transcriptionally activate 
ATGL expression as well and serve as the link between lipogenesis (and adipogenesis) and 
lipolysis. 
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TABLES AND FIGURES 
Table 5.1. Ingredient and chemical composition of diets 
 Diet
1
 
Component CON OVE Lactation 
Ingredient, % of DM    
Alfalfa silage 12.00 8.20 5.00 
Alfalfa hay --- 3.50 4.00 
Corn silage 33.00 35.90 33.00 
Wheat straw 36.00 15.40 4.00 
Cottonseed --- --- 3.50 
Wet brewers grains --- 6.00 10.00 
Ground shelled corn 4.00 13.00 22.20 
Soy hulls 2.00 4.00 4.00 
Soybean meal, 48% CP 7.94 3.10 3.30 
Expeller soybean meal
2
 --- 2.00 6.20 
SoyChlor 0.15 3.80 --- 
Blood meal 85% 1.00 1.00 0.30 
Urea 0.45 0.30 0.14 
Rumen-inert fat
3
 --- --- 1.00 
Limestone 1.30 1.30 1.18 
Salt (plain) 0.32 0.30 0.27 
Sodium bicarbonate --- --- 0.75 
Potassium carbonate --- --- 0.10 
Calcium sulfate --- --- 0.10 
Dicalcium phosphate 0.12 0.18 0.27 
Magnesium oxide 0.21 0.08 0.14 
Magnesium sulfate 0.91 0.97 --- 
Mineral-vitamin mix
4
 0.20 0.20 0.20 
Vitamin A
5
 0.015 0.015 --- 
Vitamin D
6
 0.025 0.025 --- 
Vitamin E
7
  0.38 0.38 --- 
Biotin --- 0.35 0.35 
Chemical Analysis    
DM of diet, % 47.1 ± 2.0 46.6 ± 0.8 45.2 ± 1.5 
NEL, Mcal/kg 1.24 1.47 1.65 
CP, % DM 14.6 15.6 16.3 
ADF, % DM 36.2 30.2 24.1 
NDF, % DM 52.7 44.7 37.9 
1
 Controlled diet was provided for all animals during the far-off dry period (-50 d to -21 d 
relative to expected calving). During close-up dry period (-21 d to calving), one group of animals 
continued to be fed the controlled diet for ad libitum intake and another group was fed the 
overfed diet for ad libitum intake. After calving, all animals were fed the lactation diet for ad 
libitum intake. 
2
SoyPLUS (West Central Soy, Ralston, IA) 
3
Energy Booster 100
®
 (MSC, Carpentersville, IL) 
4
Contained a minimum of 5% Mg, 10% S, 7.5% K, 2.0% Fe, 3.0% Zn, 3.0% Mn, 5,000 mg/kg of Cu, 250 
mg/kg of I, 40 mg/kg of Co, 150 mg/kg of Se, 2,200 kIU/kg of vitamin A, 660 kIU/kg of vitamin D3, and 
7,700 IU/kg of vitamin E. 
5
Contained 30,000 kIU/kg. 
6
Contained 5,009 kIU/kg. 
7
Contained 44,000 IU/kg. 
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Table 5.2. Effect of close-up overfeeding energy on DMI, NELintake, blood metabolites, and 
production of dairy cows 
Variable CON OVE 
P-value 
Trt Week T×W 
DMI, kg/d
1
      
Close-up  12.6 ± 0.70 14.8 ± 0.72 0.05 0.02 0.53 
Postpartum, d 1 - 7 13.0 ± 1.84  15.3 ± 1.85 0.39 < 0.01 0.12 
Postpartum, d 1 - 28 16.7 ± 1.84 17.0 ± 1.84 0.92 < 0.01 0.02 
NEL intake, MJ/d
1
      
Close-up  65.4 ± 4.07 91.1 ± 4.070 < 0.01 < 0.01 0.22 
Postpartum 115.4 ± 12.5  117.8 ± 12.5 0.89 < 0.01 0.05 
Energy balance, % of req.      
Close-up  107.9 ± 4.60 139.9 ± 4.11 < 0.01 0.03 0.23 
Postpartum 63.7 ± 6.59 67.7 ± 6.56 0.67 < 0.01 0.13 
Serum insulin, µg/L       
Close-up  0.37 ± 0.04 0.58 ± 0.03 < 0.01 < 0.01 0.10 
Postpartum 0.14 ± 0.03 0.21 ± 0.03 0.12 0.09 0.65 
Serum NEFA, mEq/mL      
Close-up  0.39 ± 0.05 0.27 ± 0.05 0.16 < 0.01 0.23 
Postpartum 0.79 ± 0.09 1.01 ± 0.09 0.15 0.03 0.24 
Change in Post- vs. Pre-
2
 + 0.40±0.09 + 0.68±0.09 0.04 -- -- 
Serum BHBA, mmol/L      
Close-up  0.47 ± 0.04 0.44 ± 0.04 0.53 0.02 0.42 
Postpartum 0.88 ± 0.11 1.20 ± 0.11 0.06 < 0.01 0.40 
Milk yield, kg/d
3
 41.7 ± 2.23 41.2 ± 2.23 0.82 < 0.01 0.85 
3.5% FCM yield, kg/d
4
 46.4 ± 2.67 47.4 ± 2.45 0.79 < 0.01 0.09 
ECM yield, kg/d
5
 47.7 ± 2.43 45.9 ± 2.39 0.61 0.15 0.87 
Milk Fat      
% 4.47 ± 0.21 4.43 ± 0.19 0.86 0.07 0.94 
kg/d 1.78 ± 0.11 1.81 ± 0.10 0.83 0.10 0.27 
Milk protein      
% 3.26 ± 0.09 3.04 ± 0.09 0.10 < 0.01 0.63 
kg/d 1.32 ± 0.07 1.21 ± 0.07 0.32 0.09 0.26 
Milk lactose       
% 4.60 ± 0.09  4.71 ± 0.09 0.42 < 0.01 < 0.01 
kg/d 1.89 ± 0.12  1.93 ± 0.12 0.78 < 0.01 < 0.01 
1
DMI and NEL intake were analyzed based on daily data. 
2
Estimates and contrast were made to compare the effect of close-up dietary energy planes on 
serum NEFA change of postpartum vs. close-up period. Dataset is composed of serum NEFA 
concentrations at -14, -8, and -3 d for close-up period and 2, 8, 14, and 21 d postpartum of each 
animal with 7 cows per treatment.  
3
Milk yield was analyzed based on daily data. 
4
Fat-corrected milk = 0.4324 × (milk yield) + 16.2162 × (fat yield). Milk samples from the first 
week were not used to calculate FCM. 
5
Energy-corrected milk = (0.327 × milk yield) + (12.95 × fat yield) + (7.2 × protein yield).  
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Table S5.1. Gene symbol, full name and subcellular localization and mRNA abundance for 
genes investigated, genes were categorized with the major function involved 
Gene Symbol 
Full Gene Name from 
NCBI 
Subcellular 
Localization
1
 
mRNA Abundance
2
 
d -10 d +7 d +21 
de novo FA 
synthesis 
 
 
   
ACLY ATP citrate lyase CP 12.39 5.28 2.99 
ACACA acetyl-Coenzyme A 
carboxylase alpha 
CP/MIT 11.68 0.86 2.49 
FASN fatty acid synthase CP 147.96 3.24 14.85 
SCD stearoyl-CoA desaturase ER/ME 586.87 5.34 5.93 
LCFA uptake       
LPL lipoprotein lipase EM/PM 24.85 1.93 15.2 
ACSS2 acyl-CoA synthetase 
short-chain family 
member 2 
CP 35.65 1.07 2.07 
ACSL1 acyl-CoA synthetase 
long-chain 
ER/MOM/PE
M 
3.62 0.72 36.4 
Cytosolic 
NADPH and 
glycerol 
production 
 
    
G6PD glucose-6-phosphate 
dehydrogenase 
CP 18.73 3.06 17.67 
IDH1 isocitrate dehydrogenase 
1 (NADP
+
) 
CP 15.58 1.82 9.91 
PCK1 phosphoenolpyruvate 
carboxykinase 1 
CP 0.56 0.12 0.01 
TAG synthesis      
GPAM glycerol-3-phosphate 
acyltransferase 
ME/MIM/MO
M 
36.04 2.55 1.02 
DGAT2 diacylglycerol O-
acyltransferase 2 
ER 118.46 7.72 3.9 
Lipolysis       
PNPLA2 patatin-like phospholipase 
domain containing 2 CP/LP/PM 13.52 5.92 80.72 
ABHD5 abhydrolase domain 
containing 5 
CP/LP 0.6 0.26 0.61 
LIPE hormone-sensitive lipase CP/MIT/PM 20.17 10.2 37.47 
ADRB1 adrenergic receptor, beta 
1 
ME/PM 0.02 0.04 0.19 
ADRB2 adrenergic receptor, beta 
2 
ME/PM 1.32 1.9 5.17 
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Table S5.1. (cont.) 
Gene Symbol 
Full Gene Name from 
NCBI 
Subcellular 
Localization
1
 
mRNA Abundance
2
 
d -10 d +7 d +21 
Transcriptional 
regulation  
 
    
CEBPA CCAAT/enhancer 
binding protein, alpha 
NU 0.26 0.23 3.25 
SREBF1 sterol regulatory element 
binding transcription 
factor 1 
ER/NU 3.14 0.79 3.5 
PPARG peroxisome proliferator-
activated receptor gamma 
NU/CP 9.38 4.01 4.93 
Insulin signaling 
pathway 
 
    
INSR insulin receptor PM 0.36 0.32 2.55 
IRS1 insulin receptor substrate 
1 
CP/PM 0.49 0.16 <0.01 
SLC2A4 solute carrier family 2 
(facilitated glucose 
transporter), member 4 
CP/PM 1.24 0.37 2.14 
PDE3B phosphodiesterase 3B, 
cGMP-inhibited 
CP/ER/ME/G
O 
4.95 2.26 4.64 
Receptors, 
adipokine and 
signaling proteins 
 
    
ANGPTL4 angiopoietin-like 4 EM 8.99 28.15 6.72 
Total mRNA abundance of tested genes  1076.8 88.3 264.3 
1
 Subcellular localization abbreviations: CP = cytoplasm; EM = extracellular matrix; ER = endoplasmic 
reticulum; GO = golgi apparatus; LP: lipid droplet; ME = membrane; MIM = mitochondrial inner 
membrane; MIT = mitochondrion; MOM = mitochondrial outer membrane; NU = nucleus; PEM = 
peroxisomal membrane; PM = plasma membrane.  
2
 Calculation of relative mRNA abundance refered to Chapter 2; the mRNA abundance of each gene at 
every biopsy day was listed instead of the percentage of mRNA abundance of each gene among all the 
genes tested.  
 
  
217 
 
Table S5.2. GenBank accession number, hybridization position, sequence, and amplicon size of 
primers used to analyze gene expression in qPCR. 
Accession # Gene Primers
1
 Sequence (5’-3’)2 Size3 
NM_001076063.1 ABHD5 F: 1141 CTGCAGATGATGTGGGAAAGC 100 
  R: 1240 GACTGCCTGGTTCTCGTGTCA  
AJ132890 ACACA F: 3709 CATCTTGTCCGAAACGTCGAT 101 
  R: 3809 CCCTTCGAACATACACCTCCA  
BC108138 ACLY F: 2287 GTTCTCCTCCGAGGTCCAGTT 104 
  R: 2390 CAAACACTCCAGCCTCCTTCA  
BC119914 ACSL1 F: 1929 GTGGGCTCCTTTGAAGAACTGT 120 
  R: 2047 ATAGATGCCTTTGACCTGTTCAAAT  
BC134532 ACSS2 F: 1881 GGCGAATGCCTCTACTGCTT 100 
  R: 1970 GGCCAATCTTTTCTCTAATCTGCTT  
BC140488 ADIPOQ F: 211 GATCCAGGTCTTGTTGGTCCTAA 109 
  R: 319 GAGCGGTATACATAGGCACTTTCTC  
AF188187 ADRB1
4
 F:  CAGAACTCACGGAAGACGAGC  
  R:  AAGGTGGCGCTGGACC  
Z86037 ADRB2
5
 F:  TCAAAAGCCACGGACCCC  
  R:  ACTATCGTAACTAAGTGTTCCCT  
DY208485 AGPAT6 F: 171 AAGCAAGTTGCCCATCCTCA 101 
  R: 271 AAACTGTGGCTCCAATTTCGA  
NM_173986 AKT1 F: 1565 CACGTGCTCTGGACGCTTC 102 
  R: 1666 ATGGCGAGGTTCCACTCAAAC  
XM_864913.3 AKT2 F: 4646 GCCTCCAGCCGCTTCAC 100 
  R: 4745 GCAGCAAACTGGAGACCAGAT  
DQ355521.1 ANGPTL4 F: 28 AGGAAGAGGCTGCCCAAGAT 108 
  R: 136 CCCTCTCTCCCTCTTCAAACAG  
X91503 CD36 F: 743 GTACAGATGCAGCCTCATTTCC 81 
  R: 823 TGGACCTGCAAATATCAGAGGA  
NM_176784.2 CEBPA F:  GCAAAGCCAAGAAGTCCG  
  R:  GGCTCAGTTGTTCCACCCGCTT  
BT030532.1 DGAT2 F: 389 CATGTACACATTCTGCACCGATT 100 
  R: 488 TGACCTCCTGCCACCTTTCT  
BC148954.1 ELOVL6 F: 439 AGCACCCGAACTAGGAGATACAAT 102 
  R: 540 TACCAGGAGTACAGAAGCACAGTGA  
DV778074 FABP4 F: 402 TGGTGCTGGAATGTGTCATGA 101 
  R: 502 TGGAGTTCGATGCAAACGTC  
CR552737 FASN F: 6383 ACCTCGTGAAGGCTGTGACTCA 92 
  R: 6474 TGAGTCGAGGCCAAGGTCTGAA  
XM_583090.4 FOXO1 F: 716 GCTCCTGGTGGATGCTCAAT 105 
  R: 820 GGCCTCGGCTCTTAGCAAAT  
XM_583628.4 G6PD F: 408 CAACCAGCTGTCCAACCACAT 100 
  R: 507 CACCATGAGGTTCTGGACCAT  
AY748827.1 GHR F: 156 ATCCAGTCCTAGAGACAAATTCTTCTG 100 
  R: 255 TTAGCCCCATCTGTCCAGTGA  
AY515690 GPAM F: 1963 GCAGGTTTATCCAGTATGGCATT 63 
  R: 2026 GGACTGATATCTTCCTGATCATCTTG  
DQ403090.1 IDH1 F: 1061 ATGGCTCTCTTGGCATGATGA 100 
  R: 1161 CATTCGGTAGTGACGGGTTACA  
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Table S5.2. (cont.)
 
Accession # Gene Primers
1
 Sequence (5’-3’)2 Size3 
XM_589325 INSIG1 F: 438 AAAGTTAGCAGTCGCGTCGTC 120 
  R: 557 TTGTGTGGCTCTCCAAGGTGA  
XM_614207 INSIG2 F: 494 TCCAGTGTGATGCGGTGTGTA 109 
  R: 602 TGGATAGTGCAGCCAGTGTGA  
AY574999 INSR F: 245 CCCTTCGAGAAAGTGGTGAACA 84 
  R: 328 AGCCTGAAGCTCGATGCGATAG  
CR551751 IRS1 F: 73 TGTTGACTGAACTGCACGTTCT 112 
  R: 184 CATGTGGCCAGCTAAGTCCTT  
EF140760.1 LIPE F: 1674 TCAGTGTCCAAGACAGAGCCAAT 106 
  R: 1779 CATGCAGCTTCAGGCTTTTG  
DV797268 LPIN1 F: 147 TGGCCACCAGAATAAAGCATG 101 
  R: 247 GCTGACGCTGGACAACAGG  
BC118091 LPL F: 327 ACACAGCTGAGGACACTTGCC 101 
  R: 427 GCCATGGATCACCACAAAGG  
XM_001255565.2 MLXIPL F: 2529 CCTGACGGATCCAGACTGTATACC 91 
  R: 2619 AGGGTCTGTCCAGCACTATAAAGATT  
XM_612999.4 NR3C1 F: 395 AAGCACCCCCAGTAGAGAAGAA 100 
  R: 494 CACAGTAGCTCCTCCCCTTAGG  
XM_618666.4 PDE3B F: 2235 CGTCCTACATGCTGTTTGGTATCT 100 
  R: 2334 AGGGTTAATTGCTGTTTCATTTCC  
DV814745 PLIN1 F: 443 GATCGCCTCTGAGCTGAAGG 108 
  R: 550 AGAGCGGCCCCTAGGATTT  
NM_001046005.1 PNPLA2 F: 765 CACCAGCATCCAGTTCAACCT 102 
  R: 866 CTGTAGCCCTGTTTGCACATCT  
NM_181024 PPARG F: 135 CCAAATATCGGTGGGAGTCG 101 
  R: 235 ACAGCGAAGGGCTCACTCTC  
DV935188 SCAP F: 990 CCATGTGCACTTCAAGGAGGA 108 
  R: 1097 ATGTCGATCTTGCGTGTGGAG  
AY241933 SCD F: 665 TCCTGTTGTTGTGCTTCATCC 101 
  R: 765 GGCATAACGGAATAAGGTGGC  
NM_001033625 SLC27A1 F: 861 GGCAAGGGCATGGATGATC 96 
  R: 951 GCGGTAGTACCTGCTGTGCAC  
M60448 SLC2A1 F: 275 CCCCCAGAAGGTGATTGAAG 135 
  R: 409 GAACCAATCATGCCTCCCAC  
AY458600.1 SLC2A4 F: 79 CCTTGGTCCTTGCCGTATTC 102 
  R: 180 TGTAGCTCTGTTCAATCACCTTCTG  
TC263657 SREBF1 F: 143 CCAGCTGACAGCTCCATTGA 67 
  R: 209 TGCGCGCCACAAGGA  
AY656814 THRSP F: 631 CTACCTTCCTCTGAGCACCAGTTC 151 
  R: 781 ACACACTGACCAGGTGACAGACA  
NM_001101893.1 ZFP423 F: 4490 CGTGATGTGATTGCTTGGCTATT 119 
  R: 4599 CATAGTTTTAATCACTGTCCGGTGAA  
1
 F: forward primer; R: reverse primer; number: start of hybridization position  
2
 Exon-exon junctions are underlined 
3
 Amplicon size expressed as base pair (bp) 
4 and 5
 Primer sequence cited from: Sumner JM, McNamara JP. Expression of lipolytic genes in 
the adipose tissue of pregnant and lactating Holstein dairy cattle. J Dairy Sci. 2007; 90:5237-
5246. 
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Figure 5.1. Daily DMI (kg/d) from -21 to 28 d relative to parturition for cows either fed 
controlled energy diet (CON, n = 7) or moderate energy diet (OVE, n = 7) during close-up dry 
period (-21 d to parturition). All animals were given controlled energy diet during far-off dry 
period (-50 to -22 d) and the same lactation diet for ad libitum intake post-calving. Values are 
expressed as mean ± SE. Data from far-off, close-up and postpartum periods were analyzed 
separately. Far-off (data not shown): Group difference, P = 0.57; day, P = 0.2; G×D, P = 0.15. 
Close-up: Trt, P = 0.05; day, P = 0.02; T×D, P = 0.53. Postpartum: Trt, P = 0.92; day, P < 0.01; 
T×D, P < 0.02. 
 
Figure 5.2. Daily milk yield (kg/d) from parturition until 30 d in lactation. Data from 7 animals 
of each treatment were included. Values are expressed as mean ± SE. Trt, P = 0.82; day, P < 
0.01; T×D, P = 0.85. 
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Figure 5.3. Weekly whole-body energy balance (% of requirements) from -3 to 4 wk relative to 
parturition. Data from 7 animals of each treatment were included. Values are expressed as mean 
± SE. Data from close-up and postpartum were analyzed separately. Close-up period: Trt, P < 
0.01; week, P = 0.03; T×W, P = 0.23. Postpartum: Trt, P = 0.67; week, P < 0.01; T×W, P = 0.13. 
 
    
 
Figure 5.4. Liver lipid and triglyceride content (wt % of the wet tissue wt) at -10, 7 and 21 d 
relative to parturition. Data from 7 animals of each treatment were included. Values are 
expressed as mean ± SE. (A) Liver total lipid content. Trt, P = 0.02; week, P < 0.01; T×W, P = 
0.08. (B) Liver triglyceride content. Trt, P = 0.02; week, P < 0.01; T×W, P < 0.04.  
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Figure 5.5. Temporal concentrations of serum insulin and metabolites from -14 to 21 d relative 
to parturition. Data from 7 animals of each treatment were included. Values are expressed as 
mean ± SE. Data of prepartum and postpartum were analyzed separately. (A) serum insulin 
concentration (µg/L). Prepartum: Trt, P < 0.01; day, P < 0.01; T×D, P = 0.10. Postpartum: Trt, P 
= 0.12; day, P = 0.09; T×D, P = 0.65. 
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Figure 5.6. Relative mRNA expressions of genes involved in insulin signaling pathway in adipose tissue of transition dairy cows in 
response to close-up energy overfeeding. Each treatment contains 7 animals. Values are expressed as mean ± SE. The P values for 
main effect of treatment (Trt) and day and interaction of treatment and day (T×D) were listed only for those genes without significant 
interaction effect (P > 0.05). For genes with sigificant interaction effect (P < 0.05), contrasts were made between two treatments at the 
same biopsy date and significant difference (P < 0.05) were marked with lowercase (a and b). Contrast were also made between any 
two biopsy dates in the same treatment and significant difference (P < 0.05) between d -10 and d +7 or d +21 were marked with 
asterisks (*), and pond mark indicates significant difference (P < 0.05) between d +7 and d +21 for within each treatment.  
INSR
d -10 d +7 d +21
R
e
la
ti
v
e
 m
R
N
A
 E
x
p
re
s
s
io
n
2.8
3.2
3.6
4.0
4.4
4.8
5.2 CON
OVETrt	  0.77
Day	0.09
T×D	0.24
IRS1
d -10 d +7 d +21
0
2
4
6
8
10
12
Trt	  0.08
Day	< 0.01
T×D	0.63
GLUT4
d -10 d +7 d +21
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
PDE3B
d -10 d +7 d +21
1
2
3
4
5
6
7
8
Trt	  0.02
Day	< 0.01
T×D	0.31
223 
 
  
   
 
Figure 5.7. Relative mRNA expressions of genes associated with de novo FA synthesis (ACLY, ACACA, FASN, and SCD), cytosolic 
acetate activation (ACSS2) and cytosolic NADPH production (G6PD and IDH1) in adipose tissue of transition dairy cows in response 
to close-up energy overfeeding. Each treatment contains 7 animals. Values are expressed as mean ± SE. See Figure 5.6 for 
significance mark explanation. 
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Figure 5.8. Relative mRNA expressions of genes associated with LCFA import and activation (LPL and ACSL1), TAG synthesis 
(GPAM and DGAT2) and glyceroneogenesis (PCK1) in adipose tissue of transition dairy cows in response to close-up energy 
overfeeding. Each treatment contains 7 animals. Values are expressed as mean ± SE. See Figure 5.6 for significance mark explanation.
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Figure 5.9. Relative mRNA expressions of genes associated with lipolysis in adipose tissue of transition dairy cows in response to 
close-up energy overfeeding. Each treatment contains 7 animals. Values are expressed as mean ± SE. See Figure 5.6 for significance 
mark explanation.
ATGL
d -10 d +7 d +21
R
e
la
ti
v
e
 m
R
N
A
 E
x
p
re
s
s
io
n
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0 CON
OVE
a
b a
b
*
*
#
*
ABHD5
d -10 d +7 d +21
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
Trt	  0.03
Day	< 0.01
T×D	0.09
LIPE
d -10 d +7 d +21
1.0
1.5
2.0
2.5
3.0
Trt	  0.28
Day	0.09
T×D	0.23
ADRB2
d -10 d +7 d +21
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
Trt	  0.47
Day	< 0.01
T×D	0.15
226 
 
  
 
     
Figure 5.10. Relative mRNA expressions of transcriptional factors (CEBPA, PPARG, and SREBF1), fasting induced adipose factor 
(ANGPTL4) and growth hormone receptor (GHR) in adipose tissue of transition dairy cows in response to close-up energy 
overfeeding. Each treatment contains 7 animals. Values are expressed as mean ± SE. See Figure 5.6 for explanations of significance 
mark. 
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Figure 5.11. IRS1 tyrosine phosphorylation (IRS1-pY) in vitro. Phosphorylation level, expressed as arbitrary units, is calculated by 
dividing the absorption value of IRS1 tyrosine phosphorylation by absorption value of total IRS1. Data for d -10 are from 7 animals of 
each treatment, and data for d +7 are from 6 animals of each treatment. P values of main effect and interactions are listed in each panel. 
(A) IRS1-pY level without insulin challenge. Phosphorylation level are determined in adipose tissues that were minced and incubated 
in culture medium at 37°C for 30 min; (B) IRS1-pY level after insulin challenge. Phosphorylation level were determined in minced 
adipose tissue that were challenged with hyperphysiological bovine insulin for 15, 30, and 60 min. (C) Temporal tyrosine 
phosphorylation level of IRS1 before and after insulin challenge. All the P values for main effects and interactions are based on the 
data of IRS1-pY after insulin challenge. Least significant mean for 0 min are the values shown in (A).  
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CHAPTER 6 
 
SUMMARY AND CONCLUSIONS 
 
Experiment 1and 2 (chapters 3, 4, and 5) were conducted to evaluate the effect of dietary 
energy plane (moderate energy diet, OVE vs. controlled energy diet, CON) on transcriptomic 
change of mesenteric (MAT), omental (OAT), and subcutaneous (SAT) adipose tissues (AT) of 
multiparous non-pregnant non-lactating Holstein dairy cows through either quantitative PCR 
(qPCR) or microarray techniques (only for MAT and SAT in microarray), respectively.  
In experiment 1 (chapters 3 and 4), no significant interaction of main effects (energy 
level and AT site) was detected in gene expression, hence only main effects were discussed. 
Overfeeding energy significantly increased gene expression associated with de novo fatty acid 
synthesis (ACLY, ACACA, FASN, ELOVL6 and SCD), triglyceride synthesis (GPAM and LPIN1), 
fatty acid transportation (FABP4) transcriptional factors (PPARG and THRSP) and adipokines 
(LEP and CCL2). There was no treatment effect on mRNA profiles of genes related to uptake of 
preformed fatty acid (LPL, CD36 and ACSL1), lipolysis (HSL) and other pro-inflammatory 
cytokines (TNF, IL6 and IL1B), chemokine (CCL5) and acute phase protein (SAA3). The 
expression of SREBF1, of which the protein product was well-established lipogenic 
transcriptional factor in rodent liver, was decreased in response to energy overfeeding in AT. 
Visceral AT (MAT and OAT) exhibited higher expression genes involved in LCFA uptake, 
activation and transport (LPL, ACSL1 and FABP4) and esterification (GPAM, LPIN1) than those 
in SAT, whereas the mRNA expression of most genes participated in DNS (ACACA, FASN and 
SCD) were higher in SAT compared with visceral AT. Generally, visceral AT, particularly MAT, 
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showed higher expression of adipocytokines (ADIPOQ, LEP, IL1B, IL6, CCL2, CCL5 and SAA3) 
than SAT. In summary, overfeeding dietary energy may stimulate lipid accumulation (reflected 
by increased expression lipogenic and triglyceride synthesis genes) and adipocyte differentiation 
(represented by increased expression of classic mature adipocyte gene FABP4) equivalently in 
both visceral AT and SAT. The genes in DNS pathway showed greater sensitivity in response to 
increased energy intake in form of non-fiber carbohydrate (NFC) feeds. Our results highlight the 
central role of PPARγ, at least from mRNA level, in transcriptional regulation of lipogenic gene 
expression in bovine adipose tissue. The increased expression LEP may indicate the increased 
feedback signal from AT to inhibit feed intake. Most adipocytokines were not differentially 
expressed due to energy over-consumption, except higher expression of CCL2, which may 
contribute to increased chemotaxis of macrophage recruitment into AT and subsequently 
increased inflammation status. In comparison with the other, visceral AT may be more prone to 
utilize preformed fatty acid, whereas SAT may accumulate more lipids through DNS pathways. 
Visceral AT may have greater endocrine activity by secreting various adipokines including pro-
inflammatory cytokine, chemokine and acute phase protein, which may be more detrimental to 
animal health, especially hepatic integrity, due to the direct portal drainage to liver.  
In experiment 2, MAT and SAT from a subset of animals in Exp. 1 and 2 (5 animal from 
each dietary treatment) were analyzed for transcriptional adaptation of AT to over-consumption 
of energy through microarray technique. The statistics analysis revealed 409 and 310 
differentially expressed genes (DEG) (FDR ≤ 0.2; unadjusted P < 0.007) due to AT depot and 
dietary energy level, respectively. The bioinformatics analysis via dynamic impact approach 
(DIA) based on KEGG Pathway database uncovered that the most represented pathway in 
comparison between fat depots were extracellular matrix (ECM)-receptor interaction, focal 
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adhesion, adipocytokine signaling, butyrate, sphingolipid and amino acid metabolism, whereas 
overfeeding energy significantly impacted immune cell trafficking, metabolism of xenobiotics by 
cytochrome P450, and MAPK signaling pathway in AT of dairy cows. Consistently, functional 
analysis via GeneSpring GX 7 unveiled that extracellular region and cytoskeleton structure, 
blood vessel morphology, and regulation of protein and carboxylic acid metabolism were the 
most enriched cellular component (Cc) and biological process (Bp) in comparison of fat depot. 
Excess energy intake markedly impacted the functions of cell-substrate and cell-matrix adhesion, 
response to external stimuli and MAPK signaling in AT compared with controlled energy 
feeding.  
By looking into the DEG sets involved in the over-represented pathways and functions 
and the established connections among these DEGs primarily based on molecular studies cell 
culture, and rodent model and human subjects, we deducted that the signature difference between 
SAT and MAT may lie in the ECM component, angiogenic activity, cytoskeleton structure and 
endocrine functionality. SAT may be more active in modification of ECM components, 
particularly in collagen synthesis, whereas MAT may have greater potential in development of 
capillary network, cytoskeleton structure and be more subjected to the infiltration of immune 
cells. Compared with CON, overfeeding may induce adipocyte apoptosis by stimulating 
differentiation and hypertrophy of the cells, which can subsequently induce the recruitment of 
immune cells, the production of pro-inflammatory cytokines and exacerbate inflammation status. 
The transcriptomic evidence of current study highly implicated the involvement of MAPK-JNK 
pathway in energy overfeeding induced adipocyte differentiation and apoptosis.  
In experiment 3, 14 (a subset from a large herd study) Holstein dairy cows (≥ 2 parity) 
were used to study the effect of prepartal dietary plane of energy (close-up overfeeding energy, 
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Overfed vs. controlled energy feeding, Controlled) on physiological changes and milking 
performance of animals and transcriptional adaptation of SAT during transition period. Insulin 
sensitivity of SAT in periparturient period was evaluated by measuring the IRS1-tyrosine 
phosphorylation (IRS1-pY) in vitro after challenging with hyperphysiological bovine insulin. 
Compared with Controlled group, Overfed cows had greater prepartal energy balance due to the 
higher DMI, greater prepartal serum insulin and numerically lower prepartal and higher 
postpartal serum NEFA, but significant increase of postpartal serum NEFA, which indicated the 
greater lipolytic activity postpartum. Close-up overfeeding energy did not benefit milking 
performance (neither milk production nor milk components production or percentage), but 
increase hepatic lipid accumulation. The mRNA expression of lipogenic genes in AT were 
higher in Overfed than in Controlled at -10 d, but decreased to the similar level in both groups 
postpartum (7 and 21 d). Overfed cows had greater transcriptional profiles of lipolytic gene 
expression (ATGL and ABHD5) and lower in PDE3B mRNA at -10 and 7 d. A significant 
interaction of prepartal dietary energy plane (Overfed vs. Controlled) and time relative to 
parturition (-10 vs. 7 d) was detected in vitro for insulin-stimulated IRS1-pY in AT, of which 
Overfed had higher and lower IRS1-pY in pre- (-10 d) and early postpartum (7 d) than 
Controlled group. Furthermore, for both groups, the IRS1-pY was significantly depressed at 7 d 
than that in -10 d. Our results suggested that overfeeding did not compromise the AT insulin 
sensitivity in prepartum, hence the higher circulating insulin may stimulate lipogenesis (as 
supported by higher expression of lipogenic gene in AT) and help reduce lipolysis in late 
pregnancy (lower prepartal NEFA). The same expression pattern of ATGL and PPARG support 
the evidence from rodent AT study that ATGL is PPARγ target gene. Hence, we speculate that 
overfeeding increased adipogenesis, which is paralleled with increased expression of lipolytic 
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gene. Despite the greater expression of triglyceride lipase (ATGL), the potentially higher re-
esterification process and insulin‘s anti-lipolytic activity may override the lipolytic effects 
prepartum. In early lactation, the AT insulin sensitivity was markedly reduced in both groups as 
well as the lipogenic activitiy, which may be due to the overwhelming homeorhetic adaptation. 
The shift of metabolism from anabolism to catabolism during transition period favors 
mobilization of body reserves. The greater expression of ATGL and ABHD5, and lower 
expression of PDE3B in Overfed early postpartum may contribute to significantly increased 
lipolysis and reduced anti-lipolytic capacity in those animals. It turned out that increased 
lipolysis in response to prepartal overfeeding gives no benefit in milk production, but potentially 
compromise liver integrity and being detrimental to animal health postpartum. 
Overall Conclusion 
Dairy cow can easily over-consume energy during dry period, which resulted in increased 
BW and BCS. Our results clearly demonstrated the increased BCS was, at least partly, due to 
increased mRNA expression of lipogenic genes in AT. However, minor different response was 
observed when overfeeding energy in non-pregnant non-lactating cows (NPNL) compared with 
preparturient dairy cows. in NPNL, only genes associated with DNS (ACLY, ACACA, and FASN) 
was upregulated in response to energy overfeeding, whereas genes involved in both DNS and 
uptaking preformed FA (LPL and ACSL1) were increased prepartum in OVE vs. CON. Thus, 
such difference may associate with specific physiological state, which is characterized as altered 
hormonal environment and metabolic status. The signal of greater dietary energy plane that leads 
to increased mRNA expression of lipogenic genes is transducted by several ―mediators‖. Our 
results, from transcriptional perspective, highlighted the importance of PPARγ and CEBPα as the 
major transcriptional factor inducing lipogenic gene expression in bovine adipocyte. Prepartum 
233 
 
overfeeding energy in from of greater NFC feed ingredients was found to increase (despite 
numerically) propionate production in rumen fermentation (Richards et al., unpublished data), 
which results in increased hepatic glucogenesis and stimulates greater insulin secretion 
subsequently. We speculate the greater blood insulin concentration in OVE vs. CON serves as 
the external mediator induce the transactivity of PPARγ and CEBPα, and triggers lipogenesis in 
perparturient period.  
Reduced insulin response and utilization of glucose is an important metabolic adaptation 
of peripheral tissues in transition dairy cows (Bauman and Currie, 1980). Previous study from 
our group showed preparturient overfeeding energy resulted in increased blood insulin and 
glucose concentration prepartum and increase mobilization of body fat postpartum, which leads 
us to the hypothesis of exacerbated insulin resistance in peripheral tissue of transition dairy cows 
by energy overfeeding. In current study, we utilized IRS1-pY as an indicator for insulin 
effectiveness in AT. However, our results indicated that two stage feeding program (far-off CON 
and close-up OVE) did not comparomised AT insulin sensitivity in window from -10 to 7 d 
relative to parturition, but actually facilitated preparturient insulin signaling in AT as 
demonstrated by higher IRS-pY in OVE than CON at -10 d. Nevertheless, such results does not 
warrant us to exclude the possibility of incurred insulin resistance in dairy cows induced by long-
term energy overfeeding (such as 8 wk overfeeding in experiment 1, in which we found the 
reduced insulin-to-glucose ratio in OVE group), which maybe more resemble to obesity induced 
insulin resistance in non-ruminant animals. I speculate, at cellular level, the adipocyte 
differentiation induced by close-up OVE is still in the normal stage, whereas long-term OVE 
may cause the over-enlargement of adipocyte and resulted in pathogenesis of insulin resistance 
which should be deemed as the self-protection behavior to adipocyte per se.  
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Our result of IRS1-pY also clearly showed that AT is more insulin resistant in early 
lactation (at least in window < 7 DIM) than in late pregnancy (at least in window < -10 d), which, 
we speculate, contributes to sharply increase postparturient lipolysis in AT. Hence, any 
nutritional management (in pre- and/or postpartum) that can improve insulin sensitivity 
postpartum may rescue animal from over-mobilization of body fat, which triggers ketosis, fatty 
liver and other metabolic disorders in early lactation.  
Absolutely, our IRS1-pY results needs to be confirmed in futher research, and should be 
extended to more molecules involved in insulin signaling pathway, such as upstream INSR 
tyrosine kinase activity and downstream kinase activities.  
Another important finding of our research is the increased ATGL and ABHD5 expression 
in AT of OVE cows prepartum (-10 d) and early postpartum (7 d), which gave partial 
explanation of greater serum NEFA in OVE cow postpartum. Evidence from rodent study 
showed that ATGL is one of target gene of PPARγ (Kershaw et al., 2007). Our results showed the 
same expression pattern of ATGL and PPARG, hence, I propose that OVE increased PPARγ 
activity, which, in turn, stimulated ATGL mRNA expression. Certainly, such hypothesis needs to 
be tested in cellular study of bovine adipocytes in futher.  
Unlike our hypothesis, we did not find prevailing evidence that overfeeding increased 
mRNA expression of pro-inflammatory cytokines in AT (SAT, MAT and OAT). However, our 
results supported that overfeeding may result in increased portal drainage of pro-inflammatory 
cytokines produced from visceral AT to liver by increasing visceral AT mass, which is 
characterized by greater expression of gene encoding pro-inflammatory cytokines and 
chemokines (either due to visceral adipocyte or resident macrophages) than SAT.  
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In general, as supported by our results, we suggest that continues controlled feeding 
during dry period did not compromise production performance postpartum and is more beneficial 
to animal health postpartum by decreasing metabolic disorders.  
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APPENDIX A 
 
STUDY OF HEPATIC LIPID ACCUMULATION, FIBROSIS, AND AGGREGATION 
OF MATURE MACROPHAGES VIA HISTOCHEMICAL AND 
IMMUNOHISTOCHEMICAL TECHNIQUE 
 
ABSTRACT 
To evaluate the histological and pathological changes in liver of transition dairy cows, 
repeated liver biopsies were conducted in 17 Holstein dairy cows (≥ 2 parity) at -10, 7, and 21 d 
relative to parturition date (3 cows had all 3 biopsy samples, 7 cows had 2 samples, the 
remaining cows had only 1 sample). Formalin-fixed and paraffin-embedded liver sections were 
processed for hematoxylin and eosin (H&E) staining, and Masson‘s trichrome (MT) staining and 
counter-stained with hematoxylin. The H&E staining section gives the shape of hepatocyte and 
intracellular lipid droplets, and enables the observation for ballooning degree, Mallory body, and 
the aggregation of monocytes (primarily neutrophils and leukocytes), which indicates the 
different stages of progression of pathological development and hepatocyte apoptotic activity. 
Staining with MT distinguishes the hepatocytes from surrounding connective tissues by dying 
the collagen blue, which implicates hepatic fibrosis degree as a sign of increased cirrhosis. The 
whole slide (containing triplicate sections of each slice) was scanned using a NanoZoomer 
Digital Pathology (NDP) System (Hamamatsu Co., Bridgewater, NJ). ImageJ imaging software 
was used in attempt to calculate the lipid droplet area as the percentage of total section area from 
the scanned whole slide image. Immunohistochemistry was utilized to detect mature macrophage 
(including resident Kupffer cells and infiltrated macrophages) in formalin-fixed and paraffin-
embedded liver section (rat monoclonal F4/80 as primary antibody and rat ABC staining system: 
sc-2019; Santa Cruz Biotechnology, inc.). The image of the entire H&E stained section clearly 
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showed almost no lipid accumulation in hepatocyte at -10 d prepartum, but large occupation of 
intracellular lipid droplets was witnessed at 7 d postpartum (macrovesicular steatosis), which 
was sustained, and probably increased, at 21 d postpartum. Intriguingly, the most 
macrovesicularity was located in the perivenous area and exhibited a radiatial shape surrounding 
the central vein. In periportal zone, the hepatocytes were characterized by the formation of 
numerous small lipid droplets (microvesicularity) postpartum. The hepatocytes located in the 
intermediate zone had the least lipid storage. The infiltration of monocytes and suspected 
Mallory bodies in lipid-accumulated area was observed in a few samples of 21 d postpartum. 
Furthermore, no MT-stained collagen was observed in samples. We failed to detect mature 
macrophages in the liver sections. Although the exact reason for this is unknown, we speculate 
that incompatibility of the primary antibody may account for the failure of the experiment. 
Preliminary conclusions based on the limited number of replicates indicate that most postpartal 
fatty liver (non-clinical) in response to sharply increased lipid mobilization from peripheral 
tissues may develop into the macrovesicular stage. The correlations among lipid content, 
immune cell infiltration and activation, hepatocyte apoptosis, cirrhosis, and the clinical signs of 
the whole animal warrant further researches. The intention to quantify the lipid content by 
analyzing the surface lipid droplet area in hepatic section via ImageJ software requires future 
work to correlate the results given by ImageJ with the actual quantity analyzed through chemical 
method.   
 
INTRODUCTION  
Triglyceride (TAG) accumulation is commonly seen in early lactating dairy cows, 
particularly for high producing cows, which may be more vulnerable to develop into pathological 
conditions such as ketosis and fatty liver disease. Practically, the ratio of hepatic lipid to 
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glycogen exceeding 2:1 is considered as the alarm of pathological disorders (Grummer, 1993; 
Drackley et al., 2001). However the underlying mechanism for hepatic metabolic disorders 
induced by increased infiltration of lipid is still unclear. Accumulating evidence from studies of 
non-alcoholic fatty liver disease (NAFLD) with rodent models implicates the causative 
connection between hepatocyte lipid accumulation and endoplasmic reticulum (ER) stress, 
activation of immune cells, inflammation, and, consequently, steatohepatitis (Mollica et al., 
2011). In addition, chronic over-nutrition has been shown to induce liver inflammation due to 
increased release of pro-inflammatory cytokines from adipocytes (Tilg, 2010). Previous research  
from our research group demonstrated that cows overfed dietary energy during the dry period 
had increased postpartal hepatic lipid accumulation and were more susceptible to insults of 
ketosis and other metabolic disorders compared with cows fed controlled or restricted energy 
diets (Dann et al., 2006; Janovick et al., 2011). Therefore, we speculate that in addition to 
increased lipid infiltration per se, other mechanisms may also contribute to postpartal hepatic 
pathogenesis.  
In rodent models, hepatic steatosis histologically manifests as the accumulation of 
macrovesicular or microvesicular lipid droplets inside hepatocytes. The appearance of ballooning 
hepatocytes, Mallory bodies in swollen hepatocytes, and recruitment and activation of immune 
cells are closely associated with hepatic pathogenesis (Reddy and Rao, 2006). Kupffer cells 
represented more than 80% of tissue-resident macrophages in rats (Bouwens et al., 1986), the 
activation of which is the hallmark of inflammation (Baffy, 2009). Fibrosis of hepatic tissues is 
linked with liver cirrhosis (Paradis and Bedossa, 2008). Hepatocytes located in each zone 
(periportal, transition, and perivenous zones) are functionally different. From periportal to 
perivenous zone, there is a gradient decrease of oxygen concentration. Periportal hepatocytes are 
239 
 
more prominent in oxidative function, such as β-oxidation of fatty acids, whereas the perivenous 
zone is characterized by higher lipogenic activity (cited from Wikipedia website, refer to Bacon 
et al., 2006). Therefore, each zone may play different roles in pathological development of 
hepatosteatosis.  
To our knowledge, there is very limited literature recording hepatic histological changes 
of transition dairy cows. In the current study, we characterized the hepatic morphological 
alterations with focus on lipid accumulation and pathogenesis in periparturient dairy cows using 
the grading system from study of hepatic steatosis in a rodent animal model.   
 
MATERIALS AND METHODS 
Experimental Design, Diets, Animals, and Liver Biopsy  
This study used a subset of animals from a large herd study. Experimental design and 
dietary treatment were the same as described in Chapter 6. Liver biopsy was conducted at -10, 7, 
and 21 d relative to parturition date. However, the insufficient number of animal replicates and 
incomplete biopsies (only one or two biopsies were available) for several animals did not allow 
us to make any statistical analyses.  
Preparation for Tissue Section: Fixation, Dehydration, and Embedding  
An aliquot of liver tissue (ca. 0.5 × 0.5 × 0.5 cm
3
) was dissected immediately after biopsy, 
and immersed into 10% formalin solution (equivalent to 4% formaldehyde solution) for fixation 
of cellular morphology overnight (preferred) or longer. Then, the sample was put blocked into a 
cassette (with the sample number marked on cassette with pencil) and subjected to the 
dehydration process by sequentially passing through a series of increasing alcohol concentration 
solutions: 30%, 50%, 70%, 80%, 90%, 95%, and 100% for ca. 2 h for each step. After 
dehydration, tissue was cleared with xylene solution 3 × 10 min and finally embedded with 
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melting paraffin and cooled down for 60 min to be ready for sectioning. Multiple 5-micron 
sections were sliced, and triplicates of sections were placed on each glass slide (Histology Lab, 
College of Veterinary Medicine at University of Illinois at Urbana-Champaign).  
Hematoxylin and Esion (H&E) Staining 
Hematoxylin colors the nuclei blue, whereas counterstaining with eosin marks the 
cytoplasm pink. The empty original lipid droplet areas are not  stained, hence it appears white in 
light microscope. The glass slides containing liver tissue sections were dipped into the following 
solutions sequentially as below (protocol provided by Histology Lab, College of Veterinary 
Medicine at University of Illinois at Urbana-Champaign):  
1) De-paraffinizaion and re-hydration section: 
Xylene solution: 3 × 2 min each; 100% ethanol: 2 × 2 min each; 95% ethanol: 2 min; 
70% ethanol: 2 min; wash in running tap water: 2 min 
2) Hematoxylin (from Surgipath) staining: 2 min; 
Wash in running tap water: 2 min; dip in Define ca. 6 seconds; wash in running tap 
water: 1 min; 95% ethanol: 2 × 1 min each 
3) Eosin/Phloxine (from Richard Allen) staining: 30 sec 
4) Dehydration and clearance 
95% ethanol: 2 × 1 min each; 100% ethanol: 2 × 2 min each; xylene: 3 × 2 min each; 
5) Mount with xylene based mounting medium and coverslip slides.  
Masson’s Trichrome (MT) Staining  
MT is a tri-color staining, which is generally utilized to differentiate cells from 
surrounding connective tissues. Due to its coloration of collagen with blue, it is used 
histologically to determine the fibrosis development in hepatic tissue. H&E stained slides were 
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counterstained with MT in the current study, of which the nuclei were dark blue and cytoplasm 
dark pink (The protocol is provided by Histology Lab, College of Veterinary Medicine at 
University of Illinois at Urbana-Champaign).  
Solutions required: 1) Bouin‘s solution: 75 mL Picric acid (saturated aqueous solution), 
25 mL Formaldehyde (37 – 40%), 5 mL Glacial acetic acid; 2) Weigert‘s iron hematoxylin 
working solution: mixture of equal volume of solution A and B (make working solution just 
before use); solution A: 5 g Hematoxylin in 500 mL 95% ethanol; solution B: 20 mL Ferric 
chloride (29% aqueous solution), 5 mL Glacial acetic acid, 475 mL deionized water; 3) Biebrich 
Scarlet-Acid Fuchsin solution: 180 mL Biebrich scarlet (1% aqueous solution), 20 mL acid 
fuchsin (1% aqueous solution), 2 mL Glacial acetic acid; 4) phosphomolybdic/phosphotungstic 
acid solution (PPA): 5 g phosphomolybdic acid and 5 g phosphotungstic acid dissolved in 200 
mL deionized water; 5) Aniline Blue solution: 2.5 g Aniline blue, 2 mL Glacial acetic acid, 100 
mL deionized water; 6) Acetic water: 1 mL Glacial acetic acid, 99 mL deionized water.  
The slides were dipped into the following solutions sequentially as listed below:  
1) Bouin‘s solution: 1 hr at 60°C; 
2) Rinse in running water; 
3) Weigert‘s iron hematoxylin: 10 min; 
4) Biebrich scarlet-Acid fuchsin solution: 2 min; 
5) Rinse in distilled water (dH2O); 
6) PPA solution: 10 min; 
7) Quick rinse in dH2O; 
8) Aniline blue solution: 5 min; 
9) Rinse in dH2O; 
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10)  1% acetic water solution: 2-3 min; 
11)  Following step 4) and 5) described in H&E staining  
Determination of Hepatic Mature Macrophages via Immunohistochemical Technique 
The Emr1 (designated F4/80, EGF-like molecule containing mucin-like hormone receptor 
1) was characterized by an extracellular region with several N-terminal epidermal growth factor 
(EGF) domains, and predominantly expressed on surface of macrophages and serves as a marker 
for tissue-resident mature macrophage (Baud et al., 1995). In the current study, rat monoclonal 
F4/80 antibody (Ab) was utilized as primary Ab (catalogue #: sc-52664; Santa Cruz 
biotechnology, Inc.) combined using immunoperoxidase staining (ImmunoCruz
TM
 rat ABC 
staining system, catalogue #: sc-2019; Santa Cruz biotechnology, Inc.) to delineate bovine 
Kupffer cells. The principle for ABC staining is biotinylated secondary Ab that binds to primary 
Ab was connected to biotinylated horseradish peroxidase (HRP) by bridging of avidin, which is a 
tetrameric biotin-binding protein. With the addition of peroxidase substrate and chromogenic 
substance (3, 3‘-Diaminobenzidine, DAB, is used), the peroxidase connected to compound of 
F4/80-primary Ab-secondary Ab can catalyze the reaction and produce the colored products for 
visualization and quantification of the marked Kupffer cells.  
In prevention of masked antigen by formalin fixation and paraffin embedding, unmasking 
steps (heat treatment) were performed prior to application of primary antibody. Briefly, slides 
were placed in a container, covered with 10 mM sodium citrate buffer (pH 6.0), and heated at 
95°C for 5 min. Slides were allowed to cool in the buffer for approximately 20 min. Slides were 
washed in deionized water three times for 3 min each. Excess liquid was aspirated from slides.  
After antigen restoration, slides were incubated in primary Ab PBS solutions of 
differentially diluted concentrations (1:50, 1:100, and 1:200) to obtain the maximal signal. All 
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the following immunoperoxidase staining steps was carried out following the kit‘s protocol 
(ImmunoCruz
TM
 rat ABC staining system, catalogue #: sc-2019; Santa Cruz biotechnology, Inc.) 
 
RESULTS AND DISCUSSION 
We use cow 7979 as an example (shown in Figure A.1) to demonstrate the histological 
change and progression of lipid accumulation during transition period (biopsied at -10, 7, and 21 
d). By comparison with other cows, this cow had a very low grade of lipid accumulation 
postpartum, but the postpartal distribution of lipid droplet was still representative of the common 
situation as we found in other liver sections of most cows in current study. In the top picture of 
Figure A.1 (biopsy at -10 d), no visible lipid droplet was found in the whole section, which is 
consistent with the low circulating NEFA in cows at this time (refer to chapter 6, cows used here 
were from the same study as described in chapter 6). At 7 d postpartum (middle picture in Figure 
A.1), sporadic hepatocytes with single macro-lipid vesicle (macrovesicle) were observed in 
perivenious area, whereas the hepatocytes surround the periportal area was almost free of the 
lipid infiltration. Despite no excessive increase of lipid storage at 21 d postpartum (bottom pic. in 
Figure A.1), it is still obvious that the number of macrovesicular hepatocytes increased 
surrounding the hepatic vein together with the population of hepatocytes with a number of 
micro-lipid droplets in both perivenious and, to a less extent, periportal zone. Three pictures in 
Figure A.2 showed the liver sections of cow 8189 from biopsy at -10 (top), 7 (middle) and 21 d 
(bottom), respectively. Cow 8189 received the same dietary treatment as cow 7979 from dry-off 
until 30 days of lactation, but this cow experienced more drastic increase of hepatic lipids 
postpartum that can be visually determined very easily. Despite the substantial variation of lipid 
content between the two cows, the distribution and progression of hepatic lipid showed the same 
pattern as cow 7979.  
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In Figure A.3, we demonstrated the section (cow 8159, 21 d postpartum) of the most 
excessive postpartal lipid infiltration (visually determined) among all the samples in the current 
study. Intriguingly, the holistic view of section (top pic. in Figure A.3) clearly showed transition 
zone (intermediate area between perportal and perivenous area) colored the pinkest compared 
with other areas, which indicated the lowest fat storage in these hepatocytes. Furthermore, we 
observed the two colonies of aggregated immune cells (mostly neutrophils and lymphocytes) in 
the perivenous area of the greatest macrovesicular hepatocytes (bottom pic. in Figure A.3 and 
lower pic. in Figure A.4). A suspected Mallory body, which is considered an important hallmark 
of non-alcoholic steatohepatitis (NASH) in human individuals (Machado and Cortez-Pinto, 
2011), was observed in a remarkably enlarged hepatocyte in the perivenous area (upper picture 
in Figure A.4).  
No obvious MT-stained collagen was observed in slides under light microscope, hence 
we speculate that these animals did not progressed into fibrosis stage, the marker of liver 
cirrhosis (liver slides stained with MT were not scanned).   
We failed to mark Kupffer cell by using rat F4/80 primary Ab. In this experiment, we 
tried two methods to unmask antigen, which may be caused by formalin fixation and paraffin 
embedding, and three concentrations of primary Ab on several liver slides from different dairy 
cows; thus, we speculate the compatibility of primary Ab may be the reason for our lack of 
success. 
Based on the results from these individual cows, it seems that hepatic lipid infiltration 
initiated from perivenous zone with formation of numerous micro vacuoles of lipid droplets, 
which fused into a macro vacuole with continuation of higher circulating NEFA postpartum. The 
lipid occupation may start to extend to the periportal zone with the same progression pattern as 
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most hepatocytes in perivenous zone appeared to contain a single large lipid droplet. The 
transition zone is the area of the least vulnerability to accumulating lipid compared with other 
two zones. Such prioritized lipid storage pattern may result from zone-specific distribution of 
enzymes involved in TAG synthesis, which determines functional differences. We were not able 
to detect where Kupffer cells are primarily located, which requires further research. In addition, 
how hepatic lipid accumulation, infiltration and activation of immune cells, and inflammation 
status are correlated with the appearance of pathological disorders in cows should be the subject 
of further studies. 
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Figure A.1. Mild progression of hepatic lipid accumulation in liver sections of cow 7979 
biopsied at -10, 7 and 21 d relative to parturition. (in each figure, H: central vein; P: portal vein) 
Top: -10 d sample; middle: 7 d sample; bottom: 21 d sample (H&E, 10×). These samples were 
not analyzed for lipid and TAG content through chemical method. 
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Figure A.2. Progressive increase of lipid accumulation in liver sections of cow 8189 biopsied at 
-10, 7, and 21 d relative to parturition. (in each figure, H: central vein; P: portal vein) Top: -10 d 
sample; middle: 7 d sample; bottom: 21 d sample (H&E, 10×). Chemical analysis for sample of 
this cow at -10, 7 and 21 d were 4.0, 15.1 and 12.6% for lipid content and 0.41, 1.09 and 8.93% 
for TAG content. 
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Figure A.3. Liver section of cow 8159 biopsied at 21 d postpartum (H&E). Top: holistic view of 
lipid distribution (1.25×); middle: pattern of intracellular lipid storage (macrovesicular vs. 
microvesicular) and the distribution of each pattern (10×); bottom: immune cell infiltration (10×). 
Chemical analysis for sample of this cow at -10, 7 and 21 d were 3.9, 16.3 and 17.4% for lipid 
content and 0.32, 1.61 and 6.51% for TAG content. 
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Figure A.4. Liver sample section of cow 8159 biopsied at 21 d postpartum (H&E). Upper: 
Macro- vs. microvesicular lipid storage in hepatocytes and suspected Mallory body (40×). Lower: 
immune cell infiltration (40×) 
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Figure A.5. Basic structure and zonation of liver acinus lobule. The picture on the left showed 
the basic structure of liver lobule. In the picture on the right, CV: central vein, Z I: periportal 
zone, Z II: transition zone, Z III: perivenous zone.   
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